Document:

Securities Purchase Agreement

 EXHIBIT 10.2 
 SECURITIES PURCHASE AGREEMENT 
  

			
		  	       SECURITIES PURCHASE
 AGREEMENT dated as of September 25, 2006 by
 and among BOULDER SPECIALTY BRANDS,
 INC., a Delaware corporation (the “Company”) and
 the Persons
listed on Annex I hereto (the
 “Investors”).

 PREAMBLE 
 WHEREAS, the Company desires to sell to certain of the Investors and certain of the Investors, severally and not jointly, subject to the terms and
conditions hereof, desire to purchase from the Company an aggregate of 14,410,188 shares of Common Stock (as hereinafter defined) of the Company (the “Common Shares”); 
 WHEREAS, the Company desires to sell to certain of the Investors and certain of the Investors, severally and not jointly, subject to the terms and
conditions hereof, desire to purchase from the Company (a) an aggregate 15,388,889 shares of Series A Convertible Preferred Stock of the Company, $0.0001 par value per share (the “Series A Preferred Shares,” and together with
the Common Shares, the “Shares”), with the designations, preferences, and rights set forth in the Restated Certificate of Incorporation of the Company (the “Restated Certificate”) attached hereto as Exhibit
A, and (b) warrants in the form attached hereto as Exhibit B (the “Warrants,” and together with the Shares, the “Securities”), to purchase additional shares (the “Warrant Shares”) of
Common Stock as set forth in each applicable Warrant; and 
 WHEREAS, the Investors, severally and not jointly, wish to purchase the
Securities on the terms and subject to the conditions set forth herein. 
 NOW THEREFORE, in consideration of the foregoing and of the
agreements set forth below, the parties agree as follows: 
 ARTICLE I 
 SALE AND PURCHASE 
 1.1 Authorization of Issuance and Sale; Reservation of
Reserved Shares. 
 (a) Subject to the terms and conditions hereof, the Company shall have, prior to the Closing, authorized:
(A) the issuance and sale of the Series A Preferred Shares, the Common Shares, and the Warrants to the Investors, (B) the reservation of the Warrant Shares for issuance upon exercise of the Warrants, and (C) the reservation of
60,000,000 shares (the “Reserved Shares”) of the Common Stock of the Company, $0.0001 par value per share (the “Common Stock”), for issuance upon conversion of the Series A Preferred Shares. 
 (b) The Company’s agreement with each Investor is a separate agreement, and the sale of Securities to each Investor is a separate sale. No Investor
shall have any obligation to 

 purchase any Securities not purchased by another Investor. The Company and each of the Investors purchasing Common Shares
agree that the price per share for each Common Share shall be $7.46. The Company and each of the Investors purchasing Series A Preferred Shares and Warrants agree that the aggregate purchase price to be paid at the Closing in respect of such
Securities shall be $9.00 and shall be allocated between the Warrants and the Series A Preferred Shares in such amounts as shall be agreed to prior to the Closing by the Company and the Investors who have committed to purchase hereunder a majority
of the Series A Preferred Shares to be issued and shall, in any event, include the OZ Entities (as hereinafter defined)) and the GC Entities (as hereinafter defined) as approving Investors. No party hereto shall take a position inconsistent with
this allocation unless otherwise required by Law (as hereinafter defined). 
 (c) Each Investor set forth on Schedule 1.1(c) hereof
has elected to be subject to the provisions of Section 9(l) of the Restated Certificate and Section 3(g) of the Warrants and by executing this Agreement each such Investor hereby acknowledges such election. 
 1.2 Closings. 
 (a) The closing
of the sale of the Securities (the “Closing”) shall take place at the offices of O’Melveny & Myers LLP, Times Square Tower, 7 Times Square, New York, NY 10036, no later than three (3) Business Days after the
satisfaction of the conditions set forth in Article III (except for those conditions which by their nature are to be satisfied at Closing including the closing of the Merger (as hereinafter defined)) or at such other time and place as the
parties shall agree. The date of the Closing is referred to herein as the “Closing Date”. “Business Day” means any day except Saturday, Sunday and any day which shall be a federal legal holiday or a day on which
banking institutions in the State of New York are authorized or required by law or other governmental action to close. 
 (b) On the Closing
Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and each Investor agrees to purchase in the aggregate, severally and not jointly, the amount of Securities as set forth opposite its name on Annex I
hereto and each Investor shall pay its allocable portion of the aggregate purchase price for such Securities set forth opposite its name on Annex I hereto (the “Subscription Amounts”) with each such Investor’s
Subscription Amount to be paid by wire transfer to the account as specified in writing by the Company (which will be disbursed from the Escrow Account (as hereinafter defined) pursuant to the Escrow Agreement (as hereinafter defined). 
 (c) In the event an Investor (a “Non-Participating Investor”) (i) has breached its obligation to fund its Subscription Amount at
the Closing or (ii) elects not to fund its Subscription Amount at the Closing because all conditions to Closing have not been satisfied (and such Investor elects not to waive such applicable closing conditions), then each other Investor which
shall elect to fund its Subscription Amount (an “Over Subscription Investor”) may, in its sole discretion, elect to subscribe for and purchase, pro rata, based upon the aggregate Subscription Amounts committed by all
such electing Investors, the Securities to have been purchased by the Non-Participating Investor, in exchange for the applicable portion of the Non-Participating Investor’s Subscription Amount. Each Over Subscription Investor so purchasing its
full allotment thereof may also purchase its pro rata amount, based upon aggregate Subscription Amounts committed by all such Over Subscription Investors so purchasing their full allotments 
  

 2 

 thereof, of any Non-Participating Investor Securities not so purchased (the “Over-allotment Option”). In
the event, upon exercise of all Over-allotment Options, Over Subscription Investors have not elected to subscribe for and purchase all of the Securities to have been purchased by a Non-Participating Investor (the “Deficit Subscription
Amount”), then an additional Person or Persons (each a “Joinder Investor”) not then a party to this Agreement may become, upon the approval of the Requisite Investors, a party to this Agreement as an Investor subscribing
for and purchasing any or all of the Securities with respect to such Deficit Subscription Amount; provided, however, that each Joinder Investor be consented to by the Company (such consent not to be unreasonably withheld or delayed) in
its reasonable discretion; provided further, however, that the determination of the Company that the addition of a Joinder Investor to this Agreement is not acceptable solely due to the receipt of written legal advice from a nationally
recognized law firm that the addition of such Joinder Investor would result in the failure of the issuance of the Securities to be exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”) and the
rules and regulations promulgated thereunder, shall be deemed to be a valid exercise of the Company’s reasonable discretion. Each Joinder Investor shall be required to execute a counterpart to this Agreement, agreeing to be treated as an
Investor for all purposes under this Agreement and the Annexes to this Agreement shall be amended and revised, as applicable, to reflect the foregoing. The addition of a Joinder Investor as a party to this Agreement shall in no way relieve or be
deemed to provide a remedy or reduction in claims to be made against an Investor that has defaulted on its obligations hereunder. 
 (d) On
or prior to the third (3rd) Business Day prior to the Closing Date, after the satisfaction of all the conditions set forth in Article III (except for those conditions which by their nature are to be satisfied at Closing including the
closing of the Merger (as hereinafter defined)) and after the satisfaction of all the conditions set forth in the SB Merger Agreement (as hereinafter defined) (except for those conditions which by their nature are to be satisfied at closing of the
Merger), upon delivery to and receipt by the Investors of a certificate of the Chief Executive Officer of the Company that such applicable conditions have been satisfied, each Investor shall deliver its Subscription Amount, in United States dollars
and in immediately available funds, to the Escrow Agent in accordance with the wire instructions provided to such Investor by the Company. The Escrow Agreement shall provide that all payments made by each Investor as contemplated by this
Section 1.2(d) will be held by the Escrow Agent for each Investor’s benefit in an interest bearing escrow account (the “Escrow Account”) pursuant to the terms of an Escrow Agreement, to be entered into by and among
the Escrow Agent (the “Escrow Agent”), the Company and the Investors after the date hereof, in a form to be agreed to by the Requisite Investors in their reasonable discretion on behalf of the Investors (the “Escrow
Agreement”) . Such moneys placed in the Escrow Account shall be disbursed by the Escrow Agent with respect to an applicable Investor’s Subscription Amount either (i) to the Company (plus the interest earned thereon), upon the
satisfaction of the conditions to Closing set forth in Article III and consummation of the Closing (including the SB Transaction) as evidenced by the receipt by the Escrow Agent of a certificate from each applicable Investor consenting to the
determination that the conditions to the Closing have been satisfied or waived or (ii) back to the applicable Investor in an amount equal to such Investor’s Subscription Amount (plus the interest earned thereon) upon the earlier to occur
of (x) the termination of this Agreement with respect to the applicable Investor, or (y) in the event that the SB Transaction is not consummated within fifteen (15) calendar days after the date by which the Investors must deposit
their Subscription Amount into the Escrow Account pursuant to this Section 1.2(d), in each case in accordance with the terms of the Escrow Agreement. 
  

 3 

 (e) “Requisite Investors” means (x) prior to the Closing, Investors who have
committed to purchase hereunder a majority of the aggregate Subscription Amounts; provided, that the definition of Requisite Investors prior to Closing shall at all times include OZ Master Fund, Ltd., and OZ Global Special Investments Master
Fund, L.P. and/or their respective affiliates (collectively, the “OZ Entities”) and Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., GCM Little Arbor Partners, L.P.,
GCM Little Arbor Institutional Partners, L.P., and GCM Little Arbor Master Fund, Ltd. and/or their respective affiliates (collectively, the “GC Entities”) and (y) after the Closing, Investors holding a majority of the
Series A Preferred Shares (on an as converted basis without taking into account any restrictions on conversion set forth in Section 9(l) of the Restated Certificate) and Common Shares purchased hereunder voting together as one class.
“SB Transaction” means the merger of a special purpose subsidiary of the Company (the “Acquisition Subsidiary”) with and into SB pursuant to the SB Merger Agreement. The SB Transaction may also be referred to herein
as the “Merger.” “SB Merger Agreement” means the Agreement and Plan of Merger by and among the Company, a corporation previously and confidentially disclosed to the Investors (“SB”), and the
shareholders’ representative party thereto attached as Exhibit C hereto (as so amended without giving effect to an SB Amendment (as hereinafter defined) that has not been properly approved hereunder). 
 ARTICLE II 
 REPRESENTATION AND
WARRANTIES 
 2.1 Representations and Warranties of the Company. 
 The Company hereby represents and warrants to the Investors as of the date hereof and as of the Closing Date as follows (for purposes hereof,
knowledge” or “best knowledge” or words of similar import of the Company or any subsidiary means (i) actual knowledge of Stephen B. Hughes, Robert S. Gluck, Christopher W. Wolf and the other officers and key
employees of the Company or any of its subsidiaries and (ii) that knowledge which could have been acquired by such aforementioned individuals after making such due inquiry and exercising such due diligence as a prudent businessperson would have
made or exercised in the management of his or her business affairs, including due inquiry of those key employees and professionals of the Company or any of its subsidiaries who could reasonably be expected to have actual knowledge of the matters in
question): 
 (a) Organization. 
 Each of the Company and its subsidiaries is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, is duly qualified to do business and in good standing in each
other jurisdiction in which it is required to do so by Law and, as of the date hereof, has all requisite corporate power and authority to own, lease and operate the assets used in its business, to carry on its business as presently conducted and to
enter into the Documents, to perform its obligations thereunder, and to consummate the transactions contemplated thereby. As of the Closing Date, each of the Company and its subsidiaries has or 
  

 4 

 shall have all requisite corporate power and authority to own, lease and operate the assets used in its business, to
carry on its business as presently conducted and as proposed to be conducted following the closing of the Merger. Attached as Schedules 2.1(a)(i) and (ii), respectively, are correct and complete copies of the Certificate of Incorporation, as
in effect immediately before the filing of the Restated Certificate, and the By-laws of the Company, as in effect on the date hereof (the “Certificate of Incorporation” and the “By-laws,” respectively). For purposes
of this Agreement, the term “Documents” means (i) this Agreement, (ii) the Restated Certificate, (iii) the Warrants, (iv) the SB Merger Agreement, and (v) the Registration Rights Agreement to be entered into
at or prior to the Closing, in the form of Exhibit D hereto (as amended, the “Registration Rights Agreement”) and all other documents, agreements and instruments executed and delivered in connection herewith, in each case, as
amended, modified or supplemented from time to time. 
 (b) Subsidiaries. 
 (1) Except as set forth on Schedule 2.1(b), the Company has no subsidiaries or controlled Affiliates and does not otherwise own or control,
directly or indirectly, any equity or voting interest in any Person, nor has the Company made any commitment or subscribed for the purchase of any such equity or voting interest (other than the acquisition of SB pursuant to the SB Merger Agreement).
The term “Affiliate” means, with respect to any Person, any (a) director, officer, limited or general partner, member or stockholder holding 5% or more of the outstanding capital stock or other equity interests of such Person,
(b) any spouse, parent, sibling or descendant of such Person (or a spouse, parent, sibling or descendant of a Person specified in clause (i) above relating to such Person) and (c) other Person that, directly or indirectly, through one
or more intermediaries, controls, or is controlled by, or is under common control with, such Person. The term “control” includes, without limitation, the possession, directly or indirectly, of the power to direct the management and
policies of a Person, whether through the ownership of voting securities, by contract or otherwise. The term “Person” shall be construed in the broadest sense and means and includes any natural person, a partnership, a corporation,
an association, a joint stock company, a limited liability company, a trust, a joint venture, an unincorporated organization and other entity or Governmental Authority. The term “Governmental Authority” means any federal, state,
municipal, foreign or other government, governmental department, commission, board, bureau, agency or instrumentality, or any private or public court or tribunal. 
 (2) Except as set forth on Schedule 2.1(b), either the Company or one of its subsidiaries holds of record and owns beneficially all of the outstanding equity securities of each subsidiary of the Company, free
and clear of any Encumbrances. 
 (c) Authorization of the Documents; No Conflicts. 
 The Company and each of its subsidiaries, as applicable, has all requisite corporate power and authority to execute, deliver and perform the Documents and
to consummate the transactions contemplated thereby. The execution, delivery and performance by the Company and each of its subsidiaries, as applicable, of the Documents have been duly authorized by all requisite corporate action of the Company and
such subsidiary and no further action is required by the Company’s board of directors or its stockholder’s in connection 
  

 5 

 therewith other as set forth on Schedule 2.1(c), and each Document has been (or upon delivery will have been) duly
executed by the Company and each of its subsidiaries, as applicable, and when delivered in accordance with the terms hereof and thereof, will constitute a valid and binding obligation of the Company and such subsidiaries, as applicable, enforceable
against the Company and such subsidiaries, as applicable, in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting
creditor’s rights and to general equitable principles. The Company’s and each subsidiaries’, as applicable, execution, delivery and performance of the Documents to which it is a party, its consummation of the transactions contemplated
thereby and its compliance with the provisions thereof will not (a) violate any provision of any Law applicable to the Company, its subsidiaries, or any of its properties or assets including without limitation the Securities and Exchange
Commission, the Commodities Futures Trading Commission, the National Association of Securities Dealers (the “NASD” ) and the National Futures Association (the “NFA” ), applicable to the Company or its subsidiaries
or (b) conflict with or result in any breach of any of the terms, conditions or provisions of, or constitute (with due notice or lapse of time, or both) a default or give rise to any right of termination, cancellation or acceleration under, or
result in the creation of any Encumbrance upon any of the properties or assets of the Company, any subsidiary or under, the Certificate of Incorporation, Restated Certificate, By-laws (or such subsidiary’s certificate of incorporation or
formation, by-laws or other organizational or governance document) or any Contract. 
 (d) Authorization of Preferred Shares, Common
Shares, Warrants, Warrant Shares and Reserved Shares. 
 Subject to the approvals set forth on Schedule 2.1(c), as of the date
of the Closing, (i) the authorization, issuance, sale and delivery of the Securities and the SB Shares (as hereinafter defined) and the reservation of the Warrant Shares and the Reserved Shares will be duly authorized by all requisite corporate
and stockholder action on the part of the Company and its stockholders; (ii) the Securities and the SB Shares (as hereinafter defined), upon issuance pursuant to the terms of this Agreement, and upon their respective issuances in accordance
with the provisions of the Warrants and the Restated Certificate, the Warrant Shares and the Reserved Shares, respectively, will be, validly issued and outstanding, fully paid and nonassessable, with no personal liability attaching to the ownership
thereof and not subject to any preemptive rights, rights of first refusal or other similar rights of the shareholders of the Company. 
 (e)
No Consent or Approval Required. 
 Except as set forth on Schedules 2.1(c) and 2.1(e) hereto, no consent, approval or
authorization of, or declaration to or filing with (including pursuant to any federal or state securities laws), any Person is required for the valid authorization, execution and delivery by the Company or any of its subsidiaries of any Document or
for its consummation of the transactions contemplated thereby or for the valid authorization, issuance and delivery of the Securities or for the valid authorization, reservation, issuance and delivery of the Reserved Shares or Warrant Shares, other
than those consents, approvals, authorizations, declarations or filings which have been obtained or made, as the case may be. The only blue sky filings required in connection with the transactions contemplated hereby are in the states of California
and New York. 
  

 6 

 (f) Capitalization. 
 The capital stock of the Company immediately upon the consummation of the Closing shall consist solely of: (i) 250,000,000 shares of Common Stock, of
which: (A) 30,361,238 shares shall be or are issued and outstanding, subject to the exercise by existing shareholders of the Company of the right to convert their shares of Common Stock of the Company pursuant to Article XII of the Certificate
of Incorporation , (B) 12,760,840 shares shall be or are reserved for issuance upon the exercise of warrants (“Public Warrants”) granted in the Company’s initial public offering pursuant to the Warrant Agreement dated on
or about December 16, 2005, by and between the Company and Continental Stock Transfer & Trust Company, (C) 1,000,000 shares shall be or are reserved for issuance upon the exercise of warrants purchased by certain of the
Company’s founders pursuant to the Founding Director Warrant Purchase Agreement dated on or about December 16, 2005 between the Company and Stephen B. Hughes, James E. Lewis, Robert J. Gillespie, William E. Hooper, Robert F. McCarthy and
Michael R. O’Brien, (D) no more than 9,650,000 shares shall be or are reserved for issuance upon the exercise of options, convertible securities or grants of restricted stock to be issued pursuant to an option or incentive plan approved by
the Board of Directors of the Company, (E) no more than 1,340,483 shares may be issued pursuant to Section 2.13 of the SB Merger Agreement (the “SB Shares”), and (F) 60,000,000 shares shall be or are reserved
for issuance upon conversion of the Series A Preferred Shares and/or exercise of the Warrants; and (ii) 50,000,000 shares of authorized Preferred Stock, $0.0001 par value, 15,388,889 of which have been designated as Series A Convertible
Preferred Stock, $0.0001 par value of the Company and 34,611,111 of which have not been designated. 
 All of the Company’s and its
subsidiaries’ issued and outstanding shares of capital stock (or other equity securities) have been duly authorized and validly issued and are fully paid and nonassessable, with no personal liability attaching to the ownership thereof. Except
as provided in this Agreement, for shares of Common Stock that may be issued pursuant to Section 2.13 of the SB Merger Agreement, or as set forth on Schedule 2.1(f), (i) no subscription, warrant, option, convertible security
or other right (contingent or otherwise) to purchase or acquire any shares of capital stock of the Company or any of its subsidiaries is authorized or outstanding, (ii) neither the Company nor any of its subsidiaries has any obligation
(contingent or otherwise) to issue any subscription, warrant, option, convertible security or other such right or to issue or distribute to holders of any shares of its capital stock or other equity securities any evidences of indebtedness or assets
of the Company or such subsidiary, (iii) neither the Company nor any of its subsidiaries has any obligation (contingent or otherwise) to purchase, redeem or otherwise acquire any shares of its capital stock (or other equity securities) or any
interest therein or to pay any dividend or make any other distribution in respect thereof, and (iv) there are no outstanding or authorized stock appreciation, phantom stock or similar rights with respect to the Company or any of its
subsidiaries. All of the issued and outstanding shares of the Company’s and its subsidiaries’ capital stock (or other equity securities) have been offered, issued and sold by the Company or such subsidiary in compliance with applicable
federal and state securities Laws. 
 Immediately after the Closing, the Series A Preferred Shares in the aggregate shall represent (on an as
converted basis without taking into account any restrictions on conversion set forth in Section 9(l) of the Restated Certificate), at least 22.2508% of the Company’s Common Stock (calculated on a fully diluted basis and including as
outstanding 
  

 7 

 securities, shares of Common Stock authorized or reserved under the Company’s warrants (other than the Warrants
issued hereunder), 9,650,000 shares of Common Stock authorized or reserved for issuance upon the exercise of options, convertible securities or grants of restricted stock to be issued pursuant to an option or incentive plan approved by the Board of
Directors of the Company, and treating all outstanding securities of the Company that are convertible into or exercisable or exchangeable for, shares of Common Stock, as the maximum number of shares of Common Stock issuable with respect to such
securities at any time on or after the date of the Restated Certificate, and excluding from this calculation shares that may be issued pursuant to Section 2.13 of the SB Merger Agreement). 
 Immediately after the Closing, the Common Shares in the aggregate shall represent at least 20.8357% of the Company’s Common Stock (calculated on a
fully diluted basis and including as outstanding securities, shares of Common Stock authorized or reserved under the Company’s warrants (other than the Warrants issued hereunder), 9,650,000 shares of Common Stock authorized or reserved for
issuance upon the exercise of options, convertible securities or grants of restricted stock to be issued pursuant to an option or incentive plan approved by the Board of Directors of the Company, and treating all outstanding securities of the
Company that are convertible into or exercisable or exchangeable for, shares of Common Stock, as the maximum number of shares of Common Stock issuable with respect to such securities at any time on or after the date of the Restated Certificate and
excluding from this calculation shares that may be issued pursuant to Section 2.13 of the SB Merger Agreement). 
 Immediately
after the Closing, the Warrants in the aggregate shall represent (on an as exercised basis), at least 22.2508% of the Company’s Common Stock (calculated on a fully diluted basis, assuming the Redemption Date (as defined in the Restated
Certificate) with respect to all of the Series A Preferred Shares occurred immediately after the Closing and all Series A Preferred Shares had been redeemed (and assuming solely for purposes of this calculation that each of the Series A Preferred
Shares are redeemed for their respective Series A Purchase Price (as defined in the Restated Certificate)), and including as outstanding securities, shares of Common Stock authorized or reserved under the Company’s warrants, 9,650,000 shares of
Common Stock authorized or reserved for issuance upon the exercise of options, convertible securities or grants of restricted stock to be issued pursuant to an option or incentive plan approved by the Board of Directors of the Company, and treating
all outstanding securities of the Company that are convertible into or exercisable or exchangeable for, shares of Common Stock, as the maximum number of shares of Common Stock issuable with respect to such securities at any time on or after the date
of the Restated Certificate and excluding from this calculation shares that may be issued pursuant to Section 2.13 of the SB Merger Agreement). 
 (g) Defaults. 
 Except as set forth on Schedule 2.1(g) hereto, neither the Company nor
any of its subsidiaries is in default (i) under the Certificate of Incorporation or the By-laws (or such subsidiary’s certificate of incorporation or formation, by-laws or other organizational or governance document), or any Contract to
which the Company or such subsidiary is a party or by which the Company or such subsidiary or any of such Person’s properties are bound or affected or (ii) under any Law. There exists no condition, event or act which constitutes, or which,
after notice, lapse of time or both, would constitute, a default under any of the foregoing. The term 
  

 8 

 “Law” means, as to any Person, all provisions of laws, statutes, ordinances, rules, regulations,
permits, certificates or orders of any Governmental Authority applicable to such Person or any of its properties or assets, and all Judgments applicable to such Person, and the term “Judgments” means all judgments, injunctions,
citations, orders and decrees of all courts and arbitrators in proceedings or actions in which the Person in question is a party or by which any of its assets or properties is bound. 
 (h) SEC Reports, Financial Statements. 
 (1) Since December 21, 2005, the Company has filed all reports, registrations, schedules, forms, statements and other documents required to be filed by it under the Securities Act and the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), including pursuant to Section 13(a) or 15(d) thereof, and with any Governmental Authority, for the twelve months preceding the date hereof (or such shorter period as the Company was
required by law to file such reports) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”) on a timely basis or has
received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. Except as disclosed on Schedule 2.1(h), as of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Securities Exchange Commission (the “Commission”) promulgated thereunder including, but not limited to, the applicable
requirements of Regulation S-X promulgated under the Exchange Act and, to the extent applicable, the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”), and the rules and regulations of any other Governmental Authority with which the SEC
Reports were made or should have been made, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. Except as disclosed on Schedule 2.1(h), the financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Except as disclosed on Schedule 2.1(h), such financial statements have been prepared in accordance with United
States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. 
 (2) The Chief Executive Officer and the Chief Financial Officer of the Company have signed, and the Company has furnished to the Commission, all certifications required by Section 906 of Sarbanes-Oxley; such certifications contain no
qualifications or exceptions to the matters certified therein and have not been modified or withdrawn; and neither the Company nor any of its officers has received notice from any Governmental Authority questioning or challenging the accuracy,
completeness, form or manner of filing or submission of such certifications. To the Company’s knowledge, each director and executive officer of the Company has filed with the Commission on a timely basis all statements required by
Section 16(a) of the Exchange Act and the rules and regulations thereunder since December 21, 2005. 
  

 9 

 (i) Absence of Undisclosed Liabilities. 
 Except as set forth on Schedule 2.1(i), neither the Company nor any of its subsidiaries has any liability or obligation of any nature (whether
known or unknown, matured or unmatured, secured or unsecured, fixed or contingent, accrued or unaccrued) (“Liabilities”), except for (a) Liabilities disclosed in the latest audited balance sheet included in the SEC Reports (the
“Company Balance Sheet”), (b) Liabilities which have arisen since the date of the latest audited financial statements in the ordinary course of business and (c) contractual Liabilities incurred in the ordinary course of
business. 
 (j) Absence of Changes. 
 Since inception the Company has not conducted any operations except as set forth in the SEC Reports. Except as set forth on Schedule 2.1(j) hereto, since the date of the latest audited financial statements
included within the SEC Reports (the “Company Balance Sheet Date”), there has not been (i) any material adverse change in the business, affairs, operations, assets, properties, Liabilities, results of operations, condition
(financial or otherwise) or prospects of the Company or any of its subsidiaries (taken as a whole) (a “Material Adverse Change”), (ii) any borrowing or agreement to borrow funds or any Liability incurred by the Company or any
of its subsidiaries, other than current Liabilities incurred in the ordinary course of business consistent in type and amount with past practice, (iii) any asset or property of the Company or any of its subsidiaries made subject to any
Encumbrance of any kind, (iv) any waiver of any right of the Company or any of its subsidiaries, or the cancellation of any debt owed to or claim held by the Company or any of its subsidiaries, (v) any payment of dividends on, or other
distribution with respect to, or any direct or indirect redemption, purchase or acquisition of, any shares of the capital stock or other securities of the Company or any of its subsidiaries, (vi) any issuance of any stock, bond or other
security of the Company or any of its subsidiaries, (vii) any disposition of any tangible or intangible asset of the Company or any of its subsidiaries, (viii) any loan by the Company or any of its subsidiaries to any officer, director,
employee, consultant, agent, affiliate or stockholder of the Company or any of its subsidiaries (other than advances to such persons in the ordinary course of business consistent with past practice in connection with bona fide business expenses),
(ix) any damage, destruction or loss (whether or not covered by insurance) of any asset of the Company or any of its subsidiaries, (x) any extraordinary increase, direct or indirect, in the compensation paid or payable to any officer,
director, employee, consultant or agent of the Company or any of its subsidiaries, (xi) any change in the accounting methods, practices or policies followed by the Company or any of its subsidiaries or any change in depreciation or amortization
policies or rates theretofore adopted, which has not been adequately provided for or disclosed in the SEC Reports, or (xii) any agreement or commitment with respect to any of the foregoing matters. Except as disclosed on Schedule 2.1(j),
the Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement and the contemplated SB Transaction and as set forth on
Schedule 2.1(h), no event, liability or development has occurred or exists with respect to the Company or any subsidiary or their respective business, prospects, properties, operations or financial condition, 
  

 10 

 that would be required to be disclosed by the Company under applicable securities laws at the time this representation is
made that has not been publicly disclosed one (1) Trading Day prior to the date that this representation is made. “Trading Day” means a day on which the Common Stock is trading on a Trading Market. “Trading
Market” means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the Nasdaq Capital Market, the American Stock Exchange, the New York Stock Exchange, the Nasdaq Global
Market or the OTC Bulletin Board. 
 (k) Title to Assets, Properties and Rights. 
 Except as is set forth on Schedule 2.1(k), the Company and its subsidiaries have good and marketable title to all properties, interests in
properties and assets (real, personal, intangible or mixed) used by the Company and its subsidiaries in the conduct of their respective businesses, or necessary for use by the Company and its subsidiaries in the conduct of such businesses, free and
clear of all mortgages, Judgments, claims, liens, security interests, pledges, escrows, charges, pre-emptive rights, rights of first offer or first refusal or other encumbrances of any kind or character whatsoever (“Encumbrances”).

 (l) Intellectual Property Rights. 
 (i) The term “Intellectual Property Rights” means all industrial and intellectual property rights recognized under any
Laws or international conventions or agreements, and in any country or jurisdiction in the world, including, without limitation, patents, patent applications, and patent rights, trademarks, trademark applications and registrations, service marks,
service mark applications and registrations, domain names, domain name applications and registrations, trade dress, logos and designs, trade names, brands, product configurations, copyrights and copyright rights, copyright applications and
registrations, mask works, know-how, business methods, franchises, licenses, trade secrets, confidential information, proprietary processes and technology, data bases, source and object code, inventions, discoveries, technical advances, any manual,
formulae and/or documentation constituting, describing or related to the foregoing, and any and all goodwill connected with the foregoing. 
 (ii) Schedule 2.1(l)(ii) includes a list of all Intellectual Property Rights, other than general commercial software (e.g., “shrink wrap” licenses for Microsoft Word or Excel (“Retail
Licenses”)) that are owned by or licensed to the Company and its subsidiaries (the “Company Intellectual Property”). 
 (iii) The Company Intellectual Property is valid and subsisting and, except as indicated in Schedule 2.1(l)(ii) that any of the Company Intellectual Property is licensed from others, the Company or a subsidiary
is the exclusive owner of, and enjoys all rights of ownership with respect to, the Company Intellectual Property, free and clear of any Encumbrance, and no royalties, honoraria or fees are payable by the Company or any of its subsidiaries to other
Persons by reason of the ownership or use of the Company Intellectual Property. 
  

 11 

 (iv) The Company or a subsidiary owns, is licensed or otherwise possesses all
Intellectual Property Rights necessary to make, use, manufacture, market, import, export, sell, and offer to sell the Company’s and its subsidiaries’ current and contemplated products and services, except where any failure to own, license
or otherwise possess such Intellectual Property Rights would not reasonably be expected to have a Material Adverse Change. The Company Intellectual Property that falls within the scope of Title 35 of the United States Code is in compliance with the
same, including, but not limited to, 35 U.S.C. Section 112, Paragraph 1, in that the manner and process of making and using the inventions claimed therein has been disclosed in such full, clear, concise, and exact terms as to enable one skilled
in the art to make and use the same, and that the best mode contemplated by the inventors at the time of the invention of carrying out their inventions has been set forth. 
 (v) Neither the execution and delivery of this Agreement or SB Merger Agreement, nor the carrying on of the business of the Company and
its subsidiaries as currently conducted, will conflict with or result in a breach of the terms, conditions or provisions of, or constitute a default under, any contract or agreement regarding any Company Intellectual Property. 
 (vi) Except as described in Schedule 2.1(l)(vii), neither the Company nor any of its subsidiaries has received any threat, demand
or notice of claim from any Person, whether in writing or otherwise, asserting that the Company’s or a subsidiary’s use, manufacture, marketing, importation, export, offer to sell, or sale of products constitutes any infringement,
interference, violation, misappropriation, breach or wrongful use of the Intellectual Property Rights of any other Person, nor are they aware of any facts that indicate a likelihood of such infringement, interference, violation, misappropriation,
breach or wrongful use. Neither the Company nor any of its subsidiaries is a party to any Proceeding (as hereinafter defined) or outstanding decree, order, Judgment, agreement or stipulation restricting in any manner the use, transfer, or licensing
by the Company or any of its subsidiaries of any Intellectual Property Rights necessary to conduct its business as presently conducted or as proposed to be conducted, or which may affect the validity, use or enforceability of the Company
Intellectual Property. Neither the Company nor any of its subsidiaries has been named in any suit, action or Proceeding which involves a claim of infringement, misappropriation or violation of any Intellectual Property Rights of any third party. The
use, manufacturing, marketing, licensing and sale of the products of the Company and its subsidiaries as presently conducted and as proposed to be conducted do not infringe, misappropriate or violate any valid Intellectual Property Rights of any
third party. 
 (vii) Except as set forth on Schedule 2.1(l)(vii), all current and former employees of the Company and
its subsidiaries, and independent contractors of the Company and its subsidiaries, have executed written agreements with the Company or a subsidiary, (A) assigning to the Company or such subsidiary any and all Intellectual Property Rights that
were devised, developed or designed by such employee or independent contractor within the scope of their employment or engagement with the Company or such subsidiary and acknowledging that each piece of such intellectual property constitutes a
“work made for hire” for the Company or such subsidiary (each a 
  

 12 

 “Work for Hire”), and (B) providing for confidentiality, noncompetition and
nonsolicitation on the part of the employee. To the best knowledge of the Company, no employee of the Company or any of its subsidiaries has entered into any contract that restricts or limits in any way the scope or type of work in which he may be
engaged or requires him to transfer, assign, or disclose information concerning his Work for Hire to any Person other than the Company or any of its subsidiaries. The Company and each of its subsidiaries has exclusive ownership of all such Work for
Hire. 
 (viii) The Company and each of its subsidiaries has licensed copies of all Retail Licenses and does not possess any
pirated, illegally copied, bootleg or otherwise non-licensed copies of any Retail Licenses. 
 (m) Employment of Officers, Employees
and Consultants. 
 Except as set forth on Schedule 2.1(m), no Person has, or, may, assert any valid claim against the Company
or any of its subsidiaries with respect to: (a) employment not terminable at will by, or association with, the Company, of any of the present officers or employees of or consultants to the Company or any of its subsidiaries (collectively, the
“Designated Persons”) or (b) the use, in connection with any business presently conducted or proposed to be conducted by the Company or any of its subsidiaries or any of the Designated Persons, of any information which the
Company or any of its subsidiaries or any of the Designated Persons would be prohibited from using under any prior agreements or arrangements or any legal considerations applicable to unfair competition, trade secrets or proprietary information.

 (n) ERISA Plans. 
 (i) Except as set forth on Schedule 2.1(n), neither the Company nor any of its subsidiaries maintains nor is it a party to (or ever maintained or was a party to) any “employee welfare benefit plan,”
as defined in Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), or any other written, unwritten, formal or informal plan or agreement involving direct or indirect compensation other than
workers’ compensation, unemployment compensation and other government programs, under which the Company or any of its subsidiaries has any present or future obligation or Liability. Neither the Company nor any of its subsidiaries maintains nor
is it a party to (or ever maintained or was a party to) any “employee pension benefit plan,” as defined in Section 3(2) of ERISA, and neither the Company nor any of its subsidiaries contribute to any “multiemployer plan” as
defined in Section 3(37) of ERISA. 
 (ii) There is no Contract, plan or arrangement covering any employee or former
employee of the Company or any of its subsidiaries that, individually or collectively, could give rise to the payment of any amount that would not be deductible by the Company or such subsidiary by reason of Section 280G of the Code.

 (iii) Schedule 2.1(n) hereto lists each employment, severance or other similar Contract, arrangement or policy
(written or oral) providing for insurance coverage 
  

 13 

 (including any self-insured arrangements), non-statutory workers’ compensation, disability benefits,
supplemental unemployment benefits, vacation benefits, retirement benefits, deferred compensation, profit-sharing, bonuses, stock options, stock appreciation or other forms of incentive compensation or post-retirement insurance, compensation or
benefits entered into, maintained or contributed to by the Company or any of its subsidiaries. 
 (o) Agreements. 

Schedule 2.1(o) sets forth an accurate and complete list of all contracts, indentures, leases, agreements and instruments (each, a
“Contract” and collectively, the “Contracts”), whether written or oral (including any and all amendments, modifications, supplements and side letters with respect thereto) to which the Company or any of its
subsidiaries is a party, or by which such Person or any of such Person’s respective assets are bound. All of the Contracts are enforceable in all respects in accordance with their terms and neither the Company nor any of its subsidiaries nor
any other party thereto, is in breach or in default under (and no event has occurred which with notice or the passage of time or both would constitute a breach or default under) any such Contract. Except as set forth on Schedule 2.1(o)
hereto, no Person has indicated that it may terminate or cancel any Contract. Except as set forth on Schedule 2.1(o) hereto, no party to any Contract has any rights of setoff, bankers lien or similar rights with respect to any amounts due on
any such Contract. Except as set forth on Schedule 2.1(o) hereto, no Contract or Law restricts or inhibits in any way the Company’s or any subsidiary’s right or ability to conduct its business in the United States or any other
jurisdiction in which it currently conducts or proposes to conduct its business or to use any Intellectual Property Rights or other rights related to the conduct of such business. 
 (p) Compliance; Licenses and Permits; Environmental Matters. 
 (i) The Company and each of its subsidiaries has complied in all material respects with, and is not in violation in any respect of, any
Law. The Company and each of its subsidiaries has ownership and valid rights to all licenses and permits of all Governmental Authorities (collectively, “Permits”) which are required for the conduct of the business presently or
previously conducted by the Company or any of its subsidiaries, which Permits are in full force and effect, and no violations or non-compliances are outstanding or uncured with respect to any such Permits and no Proceeding is pending or, to the best
knowledge of the Company, threatened to revoke or limit any such Permits. Schedule 2.1(p) attached hereto lists all Permits of the Company or any of its subsidiaries which are used in or relate to such Person’s business, copies of which
have been previously delivered to the Investors. No condition or event has occurred which, with notice or the passage of time or both, would constitute a violation of any Law or Permit. 
 (ii) The Company and each of its subsidiaries is in compliance with all Environmental and Safety Requirements, and there are no
Proceedings pending or, to the best knowledge of the Company, threatened against the Company or any of its subsidiaries alleging any failure to so comply or involving any of its past operations or any real property currently used by the Company or
any of its subsidiaries. Neither the 
  

 14 

 Company nor any of its subsidiaries has received any written or oral notice or report with respect to it
or its facilities regarding any (A) actual or alleged violation of Environmental and Safety Requirements or (B) actual or potential Liability arising under Environmental Safety Requirements, including, without limitation, any
investigatory, remedial or corrective obligation. Neither the Company nor any of its subsidiaries has expressly assumed or undertaken any Liability of any other Person under any Environmental and Safety Requirements. Neither the Company nor any of
its subsidiaries has treated, stored, disposed of, arranged for or permitted the disposal of, transported, handled or released any substance, or owned or operated any real property in a manner that has given rise to Liabilities pursuant to CERCLA,
SWDA or any other Environmental and Safety Requirement, including any Liability for response costs, corrective action costs, personal injury, property damage, natural resources damage or attorney fees, or any investigative, corrective or remedial
obligations. “Environmental and Safety Requirements” means all Laws, orders, contractual obligations and all common law concerning public health and safety, worker health and safety, and pollution or protection of the environment,
including, without limitation, all those relating to the presence, use, production, generation, handling, transportation, treatment, storage, disposal, distribution, labeling, testing, processing, discharge, release, threatened release, control or
cleanup of any hazardous materials, substances or wastes, chemical substances or mixtures, pesticides, pollutants, contaminants, toxic chemicals, petroleum products or byproducts, asbestos, polychlorinated biphenyls, noise or radiation, including,
but not limited to, the SWDA, the Clean Air Act, as amended, 42 U.S.C. §§ 7401 et seq., the Federal Water Pollution Control Act, as amended, 33 U.S.C. §§ 1251 et seq., the Emergency Planning and Community Right-to-Know Act, as
amended, 42 U.S.C. §§ 11001 et seq., CERCLA, the Hazardous Materials Transportation Uniform Safety Act, as amended, 49 U.S.C. §§ 5101 et seq., the Occupational Safety and Health Act of 1970, as amended, and the rules and
regulations promulgated thereunder. “CERCLA” means the Comprehensive Environmental Response, Compensation, and Liability Act, as amended, and the rules and regulations promulgated thereunder. “SWDA” means the Solid
Waste Disposal Act, as amended, and the rules and regulations promulgated thereunder. 
 (q) Labor Relations; Employees.

 The Company’s and each of its subsidiaries’ employees as of the date hereof are listed on Schedule 2.1(q). Except as set
forth on Schedule 2.1(q) hereto, (i) neither the Company nor any of its subsidiaries is delinquent in payments to any of its employees for any wages, salaries, commissions, bonuses or other direct compensation for any services performed
by them prior to the Closing Date or amounts required to be reimbursed to such employees, (ii) there is no labor strike, dispute, slowdown or stoppage actually pending or, to the best knowledge of the Company, threatened against or involving
the Company or any of its subsidiaries and (iii) neither the Company nor any of its subsidiaries is a party to or bound by any collective bargaining agreement and neither any grievance nor any arbitration proceeding arising out of or under any
collective bargaining agreement is pending and no such claim has been asserted. 
  

 15 

 (r) Litigation. 
 Except as set forth on Schedule 2.1(r) hereto, there is no action, suit, customer claim, counterclaim, proceeding or investigation at law or in
equity or by or before any Governmental Authority or other agency (collectively, “Proceedings”) now pending or, to the best knowledge of the Company, threatened against or by the Company or any of its subsidiaries, or affecting the
Company or, to the best knowledge of the Company, its directors or officers, or any of the Company’s subsidiaries or any of their respective assets or properties, nor does there exist any basis for any such pending or threatened Proceeding.
There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any subsidiary or any current or former director or officer thereof. The Commission has not
issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any subsidiary under the Exchange Act or the Securities Act. There are no disagreements of any kind presently existing, or
reasonably anticipate by the Company or any subsidiary to arise between accountants and lawyers formerly or presently engaged by the Company or any subsidiary and the Company and any subsidiary, including with out limitation, any dispute with
respect to any fees owed to its accountants and lawyers. 
 (s) Tax Matters. 
 Except as set forth on Schedule 2.1(s) hereto, (i) the Company and each of its subsidiaries has timely filed all Tax returns, declarations of
estimated Tax, Tax reports, information returns and statements (including all attachments thereto) (collectively, the “Returns”) required to be filed by it prior to the Closing Date; (ii) as of the time of filing, the Returns
were true, complete and correct and the Company and each of its subsidiaries has paid all Taxes required to be paid, whether or not shown on the Returns to be due; (iii) the Company and each of its subsidiaries has timely paid or made
provisions on its books and records for all Taxes payable for any period that ended on or before the Closing Date and for any period that began on or before the Closing Date and ends after the Closing Date, to the extent such Taxes are attributable
to income earned or accrued in the portion of any such period ending on the Closing Date; (iv) neither the Company nor any of its subsidiaries is delinquent in the payment of any Taxes, nor has the Company or any of its subsidiaries requested
any extension of time within which to file any Return, which Return has not since been filed; (v) there are no pending Tax audits of any Returns of the Company or any of its subsidiaries; (vi) no Encumbrance with respect to Taxes has been
filed and no deficiency or addition to Taxes, interest or penalties for any Taxes with respect to any income, properties or operations of the Company or any of its subsidiaries has been proposed, asserted or assessed against the Company or any of
its subsidiaries; (vii) neither the Company nor any of its subsidiaries has been granted any extension of the statute of limitations applicable to any Return or other Tax claim; (viii) the Company has never been a “United States real
property holding corporation” as defined in Section 897(c)(2) of the Internal Revenue Code of 1986, as amended (the “Code”) and Section 1.897-2(b) of the Regulations promulgated thereunder nor will it become one upon
the consummation of the transaction contemplated herein; (ix) the Company, each of its subsidiaries, and each of their respective predecessors has complied with all applicable Laws relating to the payment and withholding of Taxes and has
withheld and paid over all amounts required by Law to be withheld and paid from the wages or salaries of employees, and neither the Company nor any of its subsidiaries is liable for any Taxes for failure to comply with such Laws; (x) No claim
has ever been made in writing by a governmental authority in a jurisdiction where any of the Company 
  

 16 

 and the Company subsidiaries does not file Returns that it is or may be subject to taxation by that jurisdiction;
(xi) there are no Tax sharing agreements or similar arrangements (including indemnity arrangements) with respect to or involving any of the Company and the Company subsidiaries; and (xii) neither the Company nor any of the Company
subsidiaries has entered into any transaction identified as a “listed transaction” for purposes of Treasury Regulations Sections 1.6011-4(b)(2) or 301.6111-2(b)(2). “Tax” means any of the Taxes and
“Taxes” means, with respect to any Person, (A) all income Taxes (including any tax on or based upon net income, or gross income, or income as specially defined, or earnings, or profits, or selected items of income, earnings or
profits) and all gross receipts, sales, use, ad valorem, transfer, franchise, license, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property or windfall profits taxes, alternative or add-on minimum taxes, customs
duties or other taxes, fees, assessments or charges of any kind whatsoever, together with any interest and any penalties, additions to tax or additional amounts imposed by any taxing authority (domestic or foreign) on such Person and (B) any
Liability for the payment of any amount of the type described in the immediately preceding clause (A) as a result of (1) being a “transferee” (within the meaning of Section 6901 of the Code or any other applicable law) or
successor of another Person, (2) being a member of an affiliated, combined, consolidated or unitary group or (3) any Contractual Liability. 
 (t) Related Party Transactions. 
 Except as set forth on Schedule 2.1(t) hereto, no
current or former stockholder, director, officer or employee of the Company or any of its subsidiaries, nor any “associate” (as defined in the rules and regulations promulgated under the Securities Act), of the Company or any of its
subsidiaries is presently, or since the inception of the Company has been, directly or indirectly through his, her or its affiliation with any other Person, a party to any transaction with the Company or any of its subsidiaries, providing for the
furnishing of services by or to, or rental of real or personal property from or to, or otherwise requiring cash payments to or by any such Person (other than the payment of salaries and benefits to employees in the ordinary course of business).

 (u) Offering Exemption. 
 (1) Assuming the accuracy of the representations of the Investors in Section 2.2(a) the offering, sale, and issuance of the Securities, Warrant Shares and the Reserved Shares are, or will be, exempt from
registration under the Securities Act and the rules and regulations promulgated thereunder, such offering, sale and issuance is also exempt from registration under applicable state securities and “blue sky” laws, and such offering, sale
and issuance does not contravene the rules and the regulations of the Trading Market. The Company has made or will make all requisite filings and has taken or will take all action necessary to be taken to comply with such state securities or
“blue sky” laws. 
 (2) Assuming the accuracy of the representations of the Investors set forth in Section 2.2(a),
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior or concurrent offerings by the Company for purposes of the 
  

 17 

 Securities Act, any state securities laws or any applicable stockholder approval provisions, including, without
limitation, under the rules and regulations of any Trading Market on which any of the securities of the Company are listed or designated. 
 (3) Neither the Company nor any Person acting on behalf of the Company had offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the
Investors and certain “accredited investors” as defined in Rule 501 under the Securities Act and “qualified institutional buyers” as defined in Rule 144A(a) under the Securities Act. 
 (v) Insurance. 
 The Company
and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and each of its subsidiaries are
engaged, including, but not limited to, directors and officers insurance coverage, and such insurance contracts and policies are accurate and complete. Neither the Company nor any of its subsidiaries has any reason to believe that it will not be
able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business. 
 (w) Sarbanes-Oxley; Controls and Procedures. 
 The Company and its subsidiaries are in compliance with all provisions of Sarbanes-Oxley which are applicable to it as of the date hereof. The Company and all of its subsidiaries, giving effect to the consummation of
the SB Transaction, will be in compliance with all provisions of Sarbanes-Oxley which are applicable to it as of the Closing Date except as permitted pursuant to the transitions rules of The Nasdaq Stock Market’s Marketplace Rules with respect
to SB and its subsidiaries. Except as disclosed on Schedule 2.1(w), the Company and its subsidiaries have established and maintain and will, upon consummation of the SB Transaction, maintain an effective system of internal control over
financial reporting (as such term is defined in the Exchange Act ) regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with GAAP and includes policies and procedures that
(i) pertain to maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the issuer; (ii) provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the issuer; and (iii) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the issuer’s assets that could result in a Material Adverse Change on the financial statements. Except as disclosed on Schedule
2.1(w), the Company and its subsidiaries have established and maintain and will, upon consummation of the SB Transaction, maintain disclosure controls and procedures (as defined in Exchange Act) that are effective in ensuring that information
required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, including, without
limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in 
  

 18 

 the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s
management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company’s certifying officers have evaluated
the effectiveness of the Company’s disclosure controls and procedures and presented in the applicable SEC Reports their conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the periods covered by such
SEC Reports based on such evaluation. Since the last such evaluation date, there has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the
Company’s internal control over financial reporting, and no significant deficiencies or material weaknesses in internal controls over financial reporting, or other factors that could significantly affect the Company’s internal control over
financial reporting, have been identified. 
 (x) Investment Company. 
 Neither the Company nor any of its subsidiaries is (either independently or as a consolidated group) an “investment company” within the meaning
of the Investment Company Act of 1940, as amended. The Company and each of its subsidiaries shall conduct their business in a manner so that they will not become subject to the Investment Company Act, as amended. The Company is not governed by or
subject to Section 7(b) or Rule 419 of the Securities Act. 
 (y) Listing and Maintenance Requirements. 
 The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and the Company has taken no action designed to, or likely to have the
effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as specified in the SEC Reports, the Company
has not, in the two (2) years preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements for continued listing of the Common Stock
on the applicable Trading Market, including the eligibility rules thereunder. Upon satisfaction of the conditions precedent set forth in Article III hereof with respect to stockholder approval of the issuance of the Securities, the issuance
and sale of the Securities under the Documents shall not contravene the rules and regulations of the Trading Market on which the Common Stock is currently listed or quoted or the rules and regulations of the Nasdaq’s Global Market or Capital
Market. 
 (z) Application of Takeover Protections. 
 Except to the extent the Company has authorized but not issued shares of preferred stock of the Company, $0.0001 par value per share as set forth in the
Certificate of Incorporation, the Company and its Board of Directors have or prior to Closing shall have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter 
  

 19 

 documents) or the laws of its state of incorporation that is or could become applicable to the Investors as a result of
the Investors and the Company fulfilling their obligations or exercising their rights under the Documents, including without limitation as a result of the Company’s issuance of the Securities and the Investors’ ownership of the Securities.

 (aa) Foreign Corrupt Practices. 
 Neither the Company, any of its subsidiaries, nor any agent or other person acting on behalf of the Company, has (i) directly or indirectly, used any corrupt funds for unlawful contributions, gifts, entertainment
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of
the Foreign Corrupt Practices Act of 1977, as amended. 
 (bb) Accountants. 
 The Company’s accountants are Ehrhardt Keefe Steiner & Hottman, P.C. Such accountants, who the Company expects will express their opinion
with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K, or Form 10-KSB, if applicable, for the year ending December 31, 2006, are an independent registered public accounting firm as required by
the Securities Act and registered with the Public Company Accounting Oversight Board. The Company expects such accountants to consent to the inclusion of their opinion on such financial statements into the registration statement and the prospectus
which forms a part thereof. 
 (cc) No Manipulation of Stock. 
 The Company has not taken and will not take, any action designed to or that could reasonably be expected to cause or result in stabilization or
manipulation of the price of the Common Stock to facilitate the transactions contemplated hereby or the sale or resale of the shares of Common Stock. 
 (dd) SB Transaction. 
 All of the representations and warranties of SB and the SB stockholders
contained in the SB Merger Agreement or any other agreement, instrument or document entered into in connection with the SB Transaction are incorporated by reference herein and are hereby deemed to be made by the Company to the Investors. All of the
representations and warranties of the Company contained in the SB Merger Agreement or any other agreement, instrument or document entered into in connection with the Merger are incorporated by reference herein and are hereby deemed to be made by the
Company to the Investors. The Company and its subsidiaries have not agreed to any material amendments or supplements of, or any material amendment or supplement to, or waived any provision or material rights or any condition precedent to closing the
merger pursuant to the SB Merger Agreement (including the waiver of the right of the Company to terminate the SB Merger Agreement or not to consummate the closing of the merger pursuant to the SB Merger Agreement including pursuant to
Section 2.8(b) 
  

 20 

 thereunder) contained in the SB Merger Agreement or any other agreement, instrument or document entered into with respect
to the SB Transaction (in each case, an “SB Amendment”). The Company shall not agree to any SB Amendment without the prior written consent of the Requisite Investors. In the event that the Company agrees to any amendment,
supplement, or waiver of the SB Merger Agreement or any other agreement, instrument or document entered into with respect to the SB Transaction that is not an SB Amendment, the Company shall provide each Investor, within one (1) Business Day,
notice of such amendment or waiver and the terms thereof. The Company represents that it has provided the Investors with the final, valid and complete copy of the executed SB Merger Agreement and each other agreement, instrument and document entered
into in connection therewith and the Company represents that no items were included in the disclosure schedules which adversely affects the business, operations, affairs, prospects, condition, properties or assets of the Company or SB as of the date
hereof. 
 (ee) Brokers. 
 Except for Citigroup Global Markets, Inc. and Banc of America Securities, LLC, neither the Company nor any of its subsidiaries, nor any of the officers, directors, employees or stockholders of the Company or any of its subsidiaries, has
employed any broker or finder in connection with the transactions contemplated by this Agreement. 
 (ff) Registration Rights.

 Except as set forth in the Registration Rights Agreement or on Schedule 2.1(ff), no Person has any right to cause the Company or any
of its subsidiaries to effect the registration under the Securities Act of any shares of Common Stock or any other securities (including debt securities) of the Company or any of its subsidiaries. 
 (gg) Disclosure. 
 None of the
Documents, any other document provided to the Investors by the Company pursuant to the Documents, or the portion of the Executive Summary, provided by Citigroup Global Markets, Inc. dated July 2006, describing the business of the Company, SB and its
subsidiaries, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading as of the date thereof or the Closing
Date. There is no fact known to the Company which adversely affects or in the future may adversely affect the business, operations, affairs, prospects, condition, properties or assets of the Company. 
 (hh) Use of Proceeds. 
 The
proceeds received by the Company from the sale of the Securities shall be used by the Company for payment of a portion of the cash consideration to be paid to SB stockholders in the Merger and for working capital purposes following the SB
Transaction. 
  

 21 

 2.2 Representations of the Investors. 
 Each Investor, severally and not jointly, represents to the Company as follows: 
 (a) Investment Representations. 
 (i) Such Investor is acquiring the Securities for its own account, for investment and not with a view to the distribution thereof, nor with any present intention of distributing the same. 
 (ii) Such Investor understands that the Securities have not been, and any shares of capital stock issuable upon conversion of the Series A
Preferred Shares and the exercise of the Warrants will not be, registered under the Securities Act, by reason of their issuance in a transaction exempt from the registration requirements of the Securities Act, and that they must be held indefinitely
unless a subsequent disposition thereof is registered under the Securities Act or is exempt from registration. 
 (iii) Such
Investor understands that the exemption from registration afforded by Rule 144 (the provisions of which are known to such Investor) promulgated under the Securities Act depends on the satisfaction of various conditions and that, if applicable, Rule
144 may only afford the basis for sales under certain circumstances and only in limited amounts. 
 (iv) Such Investor has had
a reasonable time prior to the date hereof to ask questions and receive answers concerning the terms and conditions of the offering of the Securities, and to obtain any additional information which the Company possesses or could acquire without
unreasonable effort or expense, and has generally such knowledge and experience in business and financial matters and with respect to investments in securities of privately held companies as to enable such Investor to understand and evaluate the
risks of such investment and form an investment decision with respect thereto. The foregoing representation, however, shall not limit or modify the representations and warranties of the Company contained in this Agreement or any other Document or
the right of the Investors to rely thereon. 
 (v) If such Investor is not the OZ Entities or the GC Entities, then such
Investor is not relying on any representation, warranty, statement, act (including the fact that one or more OZ Entity or GC Entity is an Investor) or investment expertise of any OZ Entity or GC Entity in making such Investor’s decision to
purchase the Securities. 
 (vi) Such Investor is an “accredited investor,” as such term is defined in Rule 501 or a
“qualified institutional buyer” as such term is defined in Rule 144A (the provisions of which are known to such Investor) promulgated under the Securities Act. 
 (vii) Each Investor is an entity duly organized, validly existing and in good standing under the laws of the applicable jurisdiction of
its formation. Such Investor has all requisite power and authority to execute, deliver and perform the Documents to which such Investor is a party and to consummate the transactions contemplated by the Documents to which such Investor is a party.
The execution, delivery and performance by each Investor, as applicable, of the Documents to which such Investor is a party have been duly authorized by all requisite action of such Investor and each Document to which such Investor is a party
constitutes a valid and binding obligation of such Investor, enforceable against such Investor in accordance with its terms. 
  

 22 

 (b) Brokers and Finders. 
 No Person acting on behalf or under the authority of such Investor is or will be entitled to any broker’s, finder’s, or similar fee or
commission in connection with the transactions contemplated hereby. 
 2.3 Relationship Among Investors. 
 Each Investor acknowledges that it has, and agrees that it shall continue to, make independent decisions concerning the investment in the Securities
purchased hereby and exercising or refraining from exercising any rights under any of the Documents and no inference, presumption or conclusion that such Investors constitute a “Group” within the meaning of Section 13(d)(3) of the
Exchange Act or Rule 13d-5 thereunder (“Group”) shall be raised from the fact that the Investors collectively may exercise or refrain from exercising any rights in the same manner, that such Investors may be represented by a single
law firm or advisor or that any rights or agreements were negotiated with the Company at the same time or amended or modified with the Company and the Investors in the same or a similar manner or pursuant to a single document. 
 ARTICLE III 
 PRIOR OR SIMULTANEOUS
ACTIONS 
 3.1 Closing Conditions. 
 The obligations of each applicable party at the Closing to consummate the transactions contemplated at the Closing shall be subject to the fulfillment, or waiver by the parties, of each of the following conditions:

 (a) The approval of the Company’s stockholders shall have been obtained for each of (A) the issuance of the Securities; and
(B) the filing of the Restated Certificate. 
 (b) On or prior to the Closing Date, the SB Transaction shall have been approved by the
Company’s stockholders and the SB stockholders. 
 (c) On or prior to the Closing Date, the SB Transaction shall have been consummated
in accordance with its terms (with no SB Amendment which has not been properly approved pursuant to the terms hereof). 
 (d) No court,
arbitrator or Governmental Authority shall have issued any order restraining the consummation of the transactions contemplated by this Agreement, and no proceeding challenging this Agreement or the transactions contemplated hereby or seeking to
prohibit or materially delay the Closing shall have been instituted by any Person before any court, arbitrator or Governmental Authority and be pending. 
  

 23 

 (e) Restated Certificate. The Restated Certificate shall have been filed with and accepted by the
Secretary of State of the State of Delaware and shall have become effective. 
 (f) Escrow Agreement. The Escrow Agreement shall have
been executed and delivered by the Company, Escrow Agent and all other parties thereto and be in full force and effect. 
 3.2 Investor
Closing Conditions. 
 The obligation of each of the Investors to purchase the Securities at the Closing is subject to the
fulfillment, or the waiver by such Investor, of each of the following conditions on or before the Closing Date: 
 (a) Accuracy of
Representations and Warranties. The representations and warranties of the Company contained in the Documents shall be true and correct in all material respects (except those representations and warranties that are qualified as to materiality,
which shall be true and correct in all respects) as of the date of this Agreement and the date of the Closing as if made on and as of the Closing, and the Investors shall have received a certificate of an officer of the Company to such effect on the
Closing Date. 
 (b) Compliance with Covenants. The Company shall have performed and complied in all material respects (except those
covenants that are qualified as to materiality, which shall have performed and complied in all respects) with all agreements and covenants contained in the Documents as of the date of the Closing, and the Investors shall have received a certificate
of an officer of the Company attesting as to such compliance. 
 (c) No Material Adverse Change. No Material Adverse Effect (as
defined in the SB Merger Agreement) shall have occurred (or shall be reasonably likely to occur) since December 31, 2005 nor shall there exist any condition or fact which has, or would reasonably be likely to have, a Material Adverse Effect on
the Closing Date, in each case, with respect to SB and its subsidiaries, and no Material Adverse Change shall have occurred (or shall be reasonably likely to occur) since the Company Balance Sheet Date, with respect to the Company and its
subsidiaries. 
 (d) Registration Rights Agreements. 
 (1) The Registration Rights Agreement shall have been executed and delivered by the Company thereto and shall be in full force and effect. 
 (2) The Registration Rights Agreement dated on or about December 16, 2005 by and among the Company and the parties thereto (the “Founders
Registration Rights Agreement”) shall have been amended and restated to reflect the amendments to certain provisions as set forth on Exhibit E. 
 (e) Required Consents. All consents, approvals and other actions of, and notices and filings with, all Persons as may be necessary or required with respect to the execution and delivery by the parties of the
Documents, and the consummation by the parties of the transactions contemplated thereby, including the SB Transaction have been obtained or made 
  

 24 

 including all filings, consents and approvals required under the HSR Act and/or any other Law concerning competition
matters, any state securities laws and Sections 141, 228, 242 and 245 of the General Corporation Law of the State of Delaware, and an authorized officer of the Company shall deliver a certificate to each Investor to such effect on the Closing Date.

 (f) Authorizing Actions of the Company. Prior to the Closing Date, the Investors shall have received certified copies of all
requisite corporate and stockholder actions taken by the Company to authorize the Company’s execution and delivery of the Documents to which it is a party and its consummation of the transactions contemplated thereby, and such other documents
and other instruments as the Investors or their counsel may reasonably request including a certificate signed by the Secretary of the Company, dated as of the Closing Date, as to: (i) a copy, certified by the Secretary of the Company, of the
resolutions of the Board of Directors of the Company evidencing approval of the Documents and consummation of the transactions contemplated therein and other matters contemplated hereby; (ii) a copy, certified by the Secretary of the Company,
of the By-laws of the Company; (iii) certified copies of all documents evidencing other necessary corporate or other action and governmental approvals, if any, with respect to this Agreement; (iv) certifying the names, titles and
signatures of the officers of the Company authorized to sign this Agreement and other documents or certificates to be delivered pursuant to this Agreement by the Company or any of its officers, together with the true signatures of such officers; and
(v) a copy, certified by the Secretary of the Company and certified by the Secretary of State of Delaware, of the Certificate of Incorporation of the Company as in effect on the Closing Date. The Investors shall have received (i) a
certificate of the Secretary of State of the State of Delaware, dated as of a recent date as to the due incorporation or organization of the Company and each of its subsidiaries and its good standing in such jurisdiction and (ii) a facsimile,
telegram, telex or other acceptable method of confirmation from said Secretary as of the close of business on the next Business Day preceding the Closing Date as to the continued good standing of the Company. 
 (g) Opinion of Counsel. The Investors shall have received the opinion dated as of the Closing Date from counsel to the Company in a form to be
agreed to by the Requisite Investors, in their reasonable discretion on behalf of the Investors, and the Company, in its reasonable discretion. In addition, the Investors shall be recipients of, and shall be entitled to rely upon, and receive
reliance letters with respect to, each of the legal opinions delivered by counsel to the Company to SB and by counsel to SB to the Company pursuant to the SB Merger Agreement. 
 (h) Payment of Fees. On or prior to the date of the Closing, the Company shall have reimbursed the fees and expenses as provided in
Section 7.1 hereof. 
 (i) Warrants; Stock Certificates. On the date of the Closing, the Investors purchasing Series A
Preferred Shares or, with respect to the OZ Entities and the GC Entities their designees (who shall be Credit Suisse Attn: Edward Mcalea; 11 Madison Ave; New York, NY 10010 with respect to the OZ Entities (such account numbers to be separately
provided to the Company), and shall be Goldman, Sachs & Co. Attn: Michael Daly; One New York Plaza; 44th Floor; New York, NY 10004 with respect to the GC Entities (such account numbers to be separately provided to the Company)) shall
have received Warrants evidencing their purchase of the Warrants hereunder, and the Investors shall have received a copy of the irrevocable 
  

 25 

 instructions to the Company’s transfer agent instructing the transfer agent to deliver, on an expedited basis, a
certificate evidencing the applicable Shares registered in the name of each Investor. 
 (j) De-Listing Suspension of Trading. From
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission (except for any suspension of trading of limited duration agreed to by the Company or relating to the announcement of the SB
Transaction, which suspension shall be terminated prior to the Closing), and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg Financial Markets shall not have been suspended or limited, nor shall a
banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its
effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of each Investor, makes it impracticable or inadvisable to purchase the Securities at the Closing. 
 (k) Financing. 
 (1) Investors shall
have in the aggregate purchased Securities for a total Subscription Amount equal to the greater of (x) two hundred and forty million dollars ($240,000,000) and (y) such amount, together with the net proceeds of the closing of the debt
financing as set forth in Section 3.2(k)(2) below and cash otherwise available to the Company, as shall be required for the Company to consummate the transactions contemplated by the SB Merger Agreement including all fees and expenses
incurred by the Company in connection with the Documents and the consummation of the transactions contemplated thereby including the SB Merger Agreement and consummation of the Merger. In determining the amounts (i) available from the debt
financing for purposes of the foregoing clause (y), committed amounts under the revolving credit facility to be entered into at Closing and referenced in the Financing Letter shall not be taken into account, except in the event the maximum
number of SB Shares permitted to be issued pursuant to the SB Merger Agreement are issued, then an amount of up to $10,000,000 of such revolving credit facility shall be so taken into account solely to the extent such amount is used to consummate
the redemption of shares of Common Stock issued in the Company’s initial public offering solely as, and to the extent, set forth in Article XII of the Company’s Certificate of Incorporation in effect immediately prior to the
filing of this Restated Certificate and (ii) of cash available to the Company for purposes of the foregoing clause (y), $2,000,000 cash of the Company to be used in the ongoing operation of the Company and its subsidiaries (including SB
and its subsidiaries) shall not be taken into account; with such two hundred and forty million dollars ($240,000,000) or other greater amount being held in escrow pursuant to the Escrow Agreement. 
 (2) The Company shall have closed on one hundred and eighty million dollars ($180,000,000) of debt financing, one hundred and sixty million dollars
($160,000,000) of debt financing of which shall be fully funded at Closing, in connection with the SB Transaction on terms and conditions set forth in the Financing Letter (as hereinafter defined); provided, however, in the event the
maximum number of SB Shares permitted to be issued pursuant to the SB Merger Agreement are issued, then the Company shall fully fund on such additional amount of debt financing (in excess of $160,000,000), not to exceed an additional 
  

 26 

 $10,000,000, as may be required to consummate the redemption of shares of Common Stock issued in the Company’s
initial public offering solely as, and to the extent, set forth in Article XII of the Company’s Certificate of Incorporation in effect immediately prior to the filing of this Restated Certificate. 
 3.3 Company Obligations to Close. 
 The obligations of the Company at the Closing to consummate the transactions contemplated at the Closing with respect to the Investors shall be subject to the fulfillment, or waiver by the Company, of the following conditions: 

(a) All representations and warranties of the Investors contained herein shall remain true and correct in all material respects (except those
representations and warranties that are qualified as to materiality, which shall be true and correct in all respects) as of the Closing Date, as if made at and as of the Closing Date. 
 (b) The Investors shall have performed all of their covenants (except those covenants that are qualified as to materiality, which shall have performed
and complied in all respects) and agreements to be performed on or prior to the Closing Date. 
 (c) The applicable waiting period (and any
extension thereof) applicable to the purchase and sale of the Securities under the HSR Act or any other Law relating to competition matters shall have terminated or expired. 
 (d) All consents, approvals and other actions of, and notices and filings with, all Persons as may be necessary or required with respect to the execution
and delivery by the parties hereto of the Documents, and the consummation by the parties of the transactions contemplated thereby, have been obtained or made including all filings, any state securities laws and Sections 141, 228, 242 and 245 of the
General Corporation Law of the State of Delaware. 
 (e) With respect to each Investor, such Investor’s Subscription Amount shall be
delivered by wire transfer to the account as specified in writing by the Company (which will be disbursed from the Escrow Account pursuant to the Escrow Agreement) except the Company shall be obligated to consummate the Closing with respect to those
Investors whose funds have been provided if the Company shall consummate the closing of the Merger regardless of whether all Investors have funded or not. 
 (f) From the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission (except for any suspension of trading of limited duration agreed to by the Company, which
suspension shall be terminated prior to the Closing), and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg Financial Markets shall not have been suspended or limited, nor shall a banking moratorium
have been declared either by the United States or New York State authorities. 
  

 27 

 ARTICLE IV 
 COVENANTS 
 4.1 Conduct Pending Closing; Non-Solicitation. 
 (a) From and after the date hereof until the Closing Date, except as contemplated by the Documents and unless otherwise consented to in writing by the
Requisite Investors, the Company and Acquisition Subsidiary shall (i) conduct its business substantially as presently conducted and only in the ordinary course and (ii) shall not, and shall cause its subsidiaries and each of their
respective Affiliates not to (A) enter into or agree to an SB Amendment, and (B) directly or indirectly, consent to any request made by SB or its representatives pursuant to the SB Merger Agreement (whether pursuant to covenants governing
pre-closing periods or otherwise, except for consents as to requests made by SB with respect to Sections 4.2(d), (e), (f), (g) and (l) of the SB Merger Agreement with respect to immaterial matters). The Requisite Investors shall
respond to consent requests pursuant to this Section 4.1(a) within a reasonable time frame, but in no event later than ten (10) days after the date on which the Investors receive a written request for such consent in the manner set
forth in Section 7.4. 
 (b) Investors have received true and correct executed copies of a commitment letter from certain lenders
(the “Financing Letter”) in the signed version previously delivered to the Investors, pursuant to which such lenders have committed to provide to the Company debt financing in the amounts set forth therein, subject only to the terms
and conditions set forth therein. The Financing Letter shall not be amended or modified prior to the date of this Agreement and, as of the date hereof, the respective commitments contained in the Financing Letter have not been withdrawn or rescinded
in any respect. From and after the date hereof until the Closing Date, except as contemplated by the Documents and unless otherwise consented to in writing by the OZ Entities in their sole discretion, the Company shall not amend or modify the
Financing Letter. 
 (c) The Company shall give prompt notice to the Investors of (i) any representation or warranty made by it
contained in this Agreement becoming untrue or inaccurate in any material respect (including any representation or warranty made in the SB Merger Agreement) or (ii) the failure by it or any subsidiary to comply with or satisfy in any material
respect any covenant, condition or agreement to be complied with or satisfied by it or any subsidiary under this Agreement; provided, however, that no such notification shall affect the representations, warranties, covenants or
agreement of the parties or the conditions to the obligations of the parties or indemnification rights under this Agreement, except as set forth in Section 5.2(b). After the date hereof and prior to the Closing Date, the Company shall
not have the right to update the disclosure schedules to this Agreement; provided, however, that the Company shall have the right to update the disclosure schedules solely to reflect Contracts entered into or other affirmative actions
taken by the Company after the date hereof and prior to the Closing to the extent such Contracts or actions are entered into in connection with consummating the transactions contemplated by the SB Merger Agreement and to the extent such Contracts
and other actions are permitted to be entered into or taken by the Company pursuant to this Agreement (including pursuant to Section 4.1 hereof); provided further, however, that the disclosure schedules shall in no event be
deemed to be updated (including pursuant to this Section 4.1(c)) and no items will be deemed to be disclosed as such for purposes of determining whether or not the conditions precedent set forth in Section 3.2(c) have been
satisfied. 
 (d) The parties shall use their reasonable best efforts to ensure that all conditions to the Closing set forth in
Section 3.1 (with respect to either the Company or an 
  

 28 

 Investor, as applicable), Section 3.2 (with respect to the Company) and Section 3.3 (with respect
to the Investors) are satisfied on or prior to the Closing Date, including executing and delivering all documents required to be delivered by the Company at the Closing and taking any and all actions which may be necessary on its part to cause each
other party to the Documents to so execute and deliver each Document. 
 (e) Stockholders Meeting. As promptly as possible after the
date hereof the Company will prepare, and in no event later than ten (10) calendar days after receipt of the financial statements required to be included in the proxy statement or information statement relating to the transactions contemplated
by the SB Merger Agreement (the “Proxy Statement”), the Company shall file a preliminary Proxy Statement with the Commission. The Company will respond to any comments of the Commission and use its commercially reasonable efforts to
mail the Proxy Statement to its stockholders at the earliest practicable time. As soon as practicable following its approval by the Commission, the Company shall distribute the Proxy Statement to its stockholders and, pursuant thereto, shall hold a
special meeting of its stockholders, for the purpose of voting on the transactions contemplated by this Agreement including the offering of the Securities and the Merger (the “Stockholders Meeting”). Such efforts will include,
without limitation, the preparation, delivery and dissemination of the Proxy Statement, prepared in accordance with the Exchange Act, to the stockholders of the Company soliciting their vote in favor of the transactions contemplated hereby (the
“Stockholder Approval”) and containing advice that the Board of Directors recommends that the stockholders approve the transactions contemplated by this Agreement. The Company shall deliver copies of the Proxy Statement to each
Investor and such Investor’s counsel at least two (2) Business Days prior to the dissemination of the Proxy Statement to the stockholders of the Company. 
 (f) Prior to Closing, the Company shall not and shall cause each subsidiary and its subsidiaries’ officers and directors not to, and each of the foregoing shall not permit their respective agents,
representatives, advisors or subsidiaries to (whether directly or indirectly) (i) solicit, initiate or take any action knowingly to facilitate the submission of inquiries, proposals or offers (“Acquisition Proposals”) from any
Third Party relating to (A) any acquisition or purchase of assets of the Company and its subsidiaries other than in the ordinary course of business consistent with past practice, (B) the purchase of any equity security of the Company or
any of its subsidiaries (including a self tender offer) or any security that is convertible, exchangeable or exercisable for any equity security, other than Securities issued hereunder, or pursuant to any equity incentive plans approved by the
Requisite Investors or that may be issued pursuant to Section 2.13 of the SB Merger Agreement, (C) any merger, consolidation, business combination, sale of substantially all assets, recapitalization, liquidation, dissolution or
similar transaction involving the Company or any of its subsidiaries (except for the acquisition of SB and its subsidiaries pursuant to the SB Merger Agreement), or (D) any other transaction the consummation of which would, or could reasonably
be expected to impede, interfere with, prevent or materially delay the transactions contemplated by this Agreement (each of the foregoing items set forth in (A) through (D), an “Alternative Transaction”), or agree to or endorse
any Alternative Transaction, or (ii) enter into or participate in any discussions or negotiations regarding any of the foregoing, or furnish to any Third Party any information with respect to its business, properties or assets in connection
with any of the foregoing, or otherwise cooperate in any way with, or knowingly assist or participate in, facilitate or encourage, any effort or attempt by any Third Party (other than the Investors) to do or seek any of the foregoing. 
  

 29 

 Subject to the provisions of the previous sentence, the Company shall immediately cease and cause its subsidiaries and
its and their advisors, agents and other intermediaries to cease any and all existing activities, discussions or negotiations with any Third Party conducted heretofore with respect to any of the foregoing, except to advise such Third Party of the
existence of the provisions of this Section, and shall use its best efforts to cause any such parties in possession of confidential information about the Company that was furnished by or on behalf of the Company to return or destroy all such
information in the possession of any such Third Party or in the possession of any agent or advisor of any such Third Party; provided, however, that the foregoing shall not prohibit the Company (either directly or indirectly through
advisors, agents or other intermediaries) from (i) following receipt of a bona fide Acquisition Proposal, taking and disclosing to its stockholders a position contemplated by Rule 14d-9 or Rule 14e-2(a) under the Exchange Act or otherwise
making disclosure to its stockholders and/or (ii) taking any action that the Board of the Company shall have concluded in good faith after consultation with outside counsel that such action is required to prevent the Board of the Company from
breaching its fiduciary duties to the stockholders of the Company under applicable law (it being understood that the Board of the Company may rely on the written advice of its outside counsel in good faith and the Investors agree not to take a
contrary position to any such written advice). “Third Party” means any person or Group, other than the Investors or any of their respective Affiliates. 
 4.2 Transfer Restrictions. 
 (a) The Company and each Investor expressly acknowledge that the
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or an exemption from the registration requirements of
the Securities Act, including pursuant to Section 4(2), Rule 144 or any other applicable exemption, to the Company or to an Affiliate of a Investor or in connection with a pledge as contemplated in Section 4.2(b), the Company may
require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor, a form of which opinion shall have been reasonably agreed to prior to the Closing or promptly thereafter by each of the Company and the
Requisite Investors, which form of legal opinion may be used, and shall be accepted, thereafter with respect to all such transfers, to the effect that such transfer does not require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights of a Investor under this Agreement and the Registration Rights Agreement. 
 (b) The Investors agree to the imprinting, so long as is required by this Section 4.2(b), of a legend on any of the Securities in the
following form: 
 THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A 
  

 30 

 TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. 
 (c) The Company and the Investors acknowledge and agree that any Investor may, as permitted by law, from time to time pledge pursuant to a bona fide
margin agreement or grant a security interest in some or all of the Securities and, if required under the terms of such arrangement, such Investor may, as permitted by law, transfer pledged or secured Securities to the pledgees or secured parties.
Such a pledge or transfer would not be subject to approval or consent of the Company, provided that, upon the reasonable request of the Company, a legal opinion of legal counsel to the pledgee, secured party or pledgor shall be obtained. At the
Company’s expense, so long as the Securities are subject to the legend required by this Section 4.2, the Company will use its reasonable commercial efforts to execute and deliver such reasonable documentation as a pledgee or secured
party of Securities may reasonably request in connection with a pledge or transfer of the Securities. The foregoing does not affect such Investor’s obligations pursuant to Section 4.2(a). 
 (d) Certificates evidencing the Securities shall not contain any legend (including the legend set forth in Section 4.2(b)), (i) while a
registration statement (including the Registration Statement (as such term is defined in the Registration Rights Agreement)) covering the resale of such security is effective under the Securities Act, or (ii) following any sale of such
Securities pursuant to Rule 144, or (iii) if such Securities are eligible for sale under Rule 144(k), or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and
pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Company’s transfer agent promptly after the Closing Date if required by the Company’s transfer agent to effect the
removal of the legend hereunder as permitted pursuant to the previous sentence. The Company agrees that following the Closing Date or at such time as such legend is no longer required under this Section 4.2(d), it will, no later than
three (3) Trading Days following the delivery by a Investor to the Company or the Company’s transfer agent of a certificate (in the case of a transfer, in the proper form for transfer) representing Shares issued with a restrictive legend
(such third Trading Day, the “Legend Removal Date”), deliver or cause to be delivered to such Investor a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation
on its records or give instructions to any transfer agent of the Company that enlarge the restrictions on transfer set forth in this Section. Certificates for Securities subject to legend removal hereunder shall be transmitted by the transfer agent
of the Company to the Investors by crediting the account of the Investor’s prime broker with the Depository Trust Company System. 
  

 31 

 (e) Each Investor, severally and not jointly with the other Investors, agrees that the removal of the
restrictive legend from certificates representing Securities as set forth in this Section 4.2 is predicated upon the Company’s reliance that the Investor will sell any Securities pursuant to either the registration requirements of
the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom. 
 4.3 Furnishing of
Information. 
 The Company covenants that it will timely file the reports required to be filed by it under the Securities Act and the
Exchange Act and the rules and regulations adopted by the Commission thereunder (or, if the Company is not required to file such reports, it will, upon the request of any Investor holding Securities purchased hereunder made after the first
anniversary of the Closing Date, make publicly available such information as necessary to permit sales pursuant to Rule 144 under the Securities Act), and it will take such further action as any such Investor may reasonably request, all to the
extent required from time to time to enable such Investor to sell Securities without registration under the Securities Act within the limitation of the exemptions provided by (a) Rule 144 under the Securities Act, as such Rule may be amended
from time to time, or (b) any similar rule or regulation hereafter adopted by the Commission. 
 4.4 Integration.

 The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Investors or that would be
integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is
obtained before the closing of such subsequent transaction. 
 4.5 Securities Laws Disclosure, Publicity. 
 The Company shall, on or before 5:00 p.m. Eastern time on the fourth (4th) Business Day following the date hereof, issue a Current Report on Form 8-K, reasonably acceptable to the Requisite Investors, disclosing all such
information required to be disclosed pursuant to the rules and regulations of the Commission, including the material terms of the transactions contemplated hereby, and shall attach the Documents thereto. The Investors shall not issue any press
release or otherwise make any such public statement without the prior consent of the Company, which consent shall not unreasonably be withheld, except if such disclosure is required by law, in which case the disclosing party shall promptly provide
the Company with prior notice of such public statement or communication. No Investor shall be named in a press release or any other public disclosure or announcement to be issued by another Investor or the Company without the prior written consent
of the Investor to be named, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the Investor to be so disclosed with prior notice of such public statement or communication. 
  

 32 

 4.6 Non-Public Information. 
 The Company covenants and agrees that neither it nor any other Person acting on its behalf will provide any Investor or its agents or counsel with any
information that constitutes material non-public information, unless prior thereto such Investor shall have executed a written agreement regarding the confidentiality and use of such information. The Company understands and confirms that each
Investor shall be relying on the foregoing representations in effecting transactions in securities of the Company. The Company covenants and agrees that all material, non-public information provided to the Investors will be publicly disclosed in the
preliminary Proxy Statement to be filed pursuant to Section 4.1(e). 
 4.7 No Registration. 
 The Company agrees not to issue any securities pursuant to any registration statement or register for resale on behalf of others any securities prior to
the date that is ninety (90) days after the Effectiveness Date (as such term is defined in the Registration Rights Agreement), except for (i) securities subject to a registration statement on Form S-8, (ii) the resale of shares of
Common Stock underlying outstanding warrants, and (iii) securities issued in connection with an acquisition by the Company, whether by merger, consolidation, sale of assets, sale or exchange of stock or otherwise. 
 4.8 Termination Fee. 
 Upon
receipt of any termination or similar fee under the terms of the SB Merger Agreement, the Company shall pay to each Investor two percent (2%) of such Investor’s Subscription Amount, to the extent that the Company has sufficient funds to
pay such amounts after payment of any costs and expenses incurred by the Company in the collection of any such termination fee. 
 4.9
Reservation of Common Stock. 
 Prior to the Closing, the Company shall have reserved and the Company shall thereafter continue to
reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Common Shares, Reserved Shares or Warrant Shares pursuant to this Agreement.

 4.10 Equal Treatment of Investors. 
 No consideration shall be offered or paid to any holder of a class of Securities to amend or consent to a waiver or modification of any provision of any of the Documents unless the same consideration is also offered
to all of the holders of the same class of Securities. Except as set forth in the SEC Reports, the Company has not entered into any transaction document or agreement with any other party prior to the Closing Date with respect to the offering of the
Company’s securities except as contemplated hereby and except as contemplated by the SB Merger Agreement. The Company has not entered into any transaction document or agreement with any Investor in connection with the purchase by such Investor
of its Securities (including by any amendment, supplement or side letter thereto or by any other agreement), containing more favorable terms than as set forth in the Documents. 
  

 33 

 4.11 Short Sales. 
 Each Investor acknowledges the Commission’s position, and such Investor will adhere to such position, set forth in Item 65, Section 5 under
Section A, of the Manual of Publicly Available Telephone Interpretations, dated July 1997, compiled by the Office of Chief Counsel, Division of Corporation Finance. Notwithstanding the foregoing, in the case of an Investor that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Investor’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of
such Investor’s assets, the acknowledgement and adherence obligation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by
this Agreement. 
 4.12 Delivery of Securities After Closing. 
 The Company shall deliver, or cause to be delivered, certificates evidencing the respective Shares purchased by each Investor to such Investor or, with
respect to the OZ Entities and the GC Entities their designees (who shall be Credit Suisse Attn: Edward Mcalea; 11 Madison Ave; New York, NY 10010 with respect to the OZ Entities (such account numbers to be separately provided to the Company), and
shall be shall be Goldman, Sachs & Co. Attn: Michael Daly; One New York Plaza; 44th Floor; New York, NY 10004 with respect to the GC Entities (such account numbers to be separately provided to the Company)) with respect to the GC Entities)
within three (3) Trading Days of the Closing Date. 
 4.13 Nasdaq Listing. 
 (a) The Company shall file to list all of its Common Stock, including without limitation, the Common Shares, the Reserved Shares and the Warrant Shares,
on Nasdaq’s Global Market or Capital Market or the American Stock Exchange by the date that is fourteen (14) calendar days after the Closing Date and shall list its Common Stock, including, without limitation, the Common Shares, the
Reserved Shares and the Warrant Shares, by the date that is ninety (90) calendar days after the Closing Date; and at any time when such Common Stock is listed on the Nasdaq’s Capital Market or the American Stock Exchange, the Company shall
use its best efforts to promptly seek to list all of its Common Stock on Nasdaq’s Global Market, including, without limitation, the Common Shares, the Reserved Shares and the Warrant Shares, if at any time it becomes eligible to do so. The
Company shall maintain the listing of shares of its Common Stock, including without limitation, the Common Shares, the Reserved Shares and the Warrant Shares, on the Over-the-Counter Bulletin Board until such time as it has listed the shares of
Common Stock, including without limitation, the Common Shares, the Reserved Shares and the Warrant Shares, on Nasdaq’s Global Market or Capital Market or the American Stock Exchange and thereafter shall maintain such listing. 
 (b) The Company shall file with The Portal Market of The Nasdaq Stock Market, Inc. (“Portal”) to designate all of the Series A Preferred
Shares as “Portal Trading Securities” on Portal to the extent the Series A Preferred Shares are eligible for such qualification and listing, promptly following the date hereof and the Series A Preferred Shares shall be designated as such
by the date that is fourteen (14) calendar days after the Closing Date. Each Investor acknowledges that Series A Preferred Shares of shareholders which are not “qualified institutional buyers” as defined in Rule 144A(a) under the
Securities Act may not be eligible for trading via Portal. 
  

 34 

 (c) If the Company fails to list, designate, and/or maintain such listing as set forth in
Section 4.13 (a) and/or (b), the holders of the Series A Preferred Shares purchased hereunder shall have the rights set forth in Section 9(e) of the Restated Certificate and Section 4(c) of the
Warrants. 
 (d) If the Company fails to list, and/or maintain such listing as set forth in Section 4.13(a) (each a
“Default”), each holder of Common Shares purchased hereunder shall have the right to be issued by the Company, on each ninety (90) day anniversary of the date of the occurrence of the Default (if the applicable Default shall
not have been cured by such date) until the applicable Default is cured with respect to each Common Share so purchased, a fractional share of Common Stock calculated by dividing (x) the decrease in the Conversion Price (as defined in the
Restated Certificate) of a Series A Preferred Share as a result of the same Default pursuant to Section 9(e) of Article IV of the Restated Certificate for the same period by (y) $7.46 (subject to equitable adjustment
as a result of any stock dividend, stock split, combination, reverse split, reclassification or similar event after the Closing Date). The Company and Investors shall treat any shares issued pursuant to this Section 4.13(d) or pursuant
to Section 2(b) of the Registration Rights Agreement as an adjustment to the Subscription Amounts of each applicable Investor for Tax purposes and shall file their Returns accordingly, unless otherwise required by applicable Law or
change in applicable Law causes any such payment not to be so treated. 
 (1) For the sake of clarity and by example, in the event a Default
has occurred for the first time and continues for six (6) consecutive months, (i) the Conversion Price of a Series A Preferred Share would be decreased by one-percent (1%) of the original $9.00 Conversion Price for the first ninety
(90) days so as to be reduced by $0.09 to $8.91, (ii) the Conversion Price of a Series A Preferred Share would be decreased by an additional one-percent (1%) of the $9.00 Conversion Price for the second ninety (90) days so as to
be reduced by $0.09 to $8.82, (iii) each holder of a share of Common Stock purchased hereunder shall be entitled to receive 0.012064 shares of Common Stock for the first ninety (90) days, and (iv) each holder of a share of Common
Stock purchased hereunder shall be entitled to receive an additional 0.012064 shares of Common Stock for the second ninety (90) days. 
 4.14 Redemption of Preferred Shares. 
 (a) Notwithstanding anything in the Restated Certificate to the contrary, in
the event the Company provides a Redemption Notice (as defined in the Restated Certificate) and the redemption by the Company of the Series A Preferred Shares of a holder thereof pursuant to the terms of the Redemption Notice at such time would
cause such holder of Series A Preferred Shares or such holder’s Affiliates (each an “Additional Redemption Holder”) to recognize dividend income pursuant to the Code or the other applicable rules and regulations of any taxing
authority (in each case as reasonably determined by the applicable Additional Redemption Holder) then each such Additional Redemption Holder shall not be required in such holder’s sole discretion, subject to the terms of
Section 4.14(b), to have all or any portion of its Series A Preferred Shares redeemed in accordance with this provision; provided, that upon delivery of a 
  

 35 

 Redemption Notice, such Redemption Notice and the Company’s obligation to redeem the Series A Preferred Shares
thereunder, shall be irrevocable by the Company (unless waived by such Applicable Redemption Holder) until such redemption shall have been effected pursuant to Section 4.14(b). 
 (b) Notwithstanding anything in Section 4.14(a) to the contrary, at such time as either (x) the Additional Redemption Holder shall have
sold sufficient shares of Common Stock, Warrants, Public Warrants or other securities of the Company convertible or exercisable for Common Stock (“Convertible Securities”) (“Additional Redeemed Securities”) held by
such Additional Redemption Holder, or (y) except to the extent Section 16 of the Exchange Act, and the rules and regulations promulgated thereunder and/or the provisions of the HSR Act and/or any other Law concerning competition matters
would arise in the same or a similar manner as set forth in Sections 7(c) and 7(d) of the Restated Certificate (the benefit of which may be waived by the affected Additional Redeemed Holder) the Company shall redeem, or a third party
purchaser made available by the Company shall purchase, sufficient Additional Redeemed Securities held by such Additional Redemption Holder, in each case, such that such Additional Redemption Holder would not recognize dividend income with respect
to the redemption of such holder’s Series A Preferred Shares or Additional Redeemed Securities (if any), then, the redemption of the Series A Preferred Shares held as of the date of the Redemption Notice with respect to such Additional
Redemption Holder shall be consummated promptly thereafter. The Company shall redeem no more than the minimum number of Additional Redeemed Securities from an Additional Redemption Holder that is necessary to ensure that the Applicable Redeemed
Holder would not (as reasonably determined by the Additional Redemption Holder) recognize dividend income with respect to the redemption of such holder’s Series A Preferred Shares and Additional Redeemed Securities (if any); provided,
however, that the Company shall redeem or any Company provided third party purchaser shall purchase Additional Redeemed Securities on the same terms and conditions and at the same price (with respect to each type of Additional Redeemed
Securities determined to be sold by each applicable Additional Redemption Holder) from each Additional Redemption Holder. 
 (c) The
Corporation shall purchase the Additional Redeemed Securities in the following order of priority based upon the type of Additional Redeemed Securities held by the applicable Additional Redemption Holder: 
 (i) first, shares of Common Stock held by each Applicable Additional Redemption Holder, if any; 
 (ii) second, if an Additional Redemption Holder has not (as reasonably determined by the Additional Redemption Holder) had sufficient
Additional Redeemed Securities redeemed (pursuant to clause (c)(i) above) so as to avoid the recognition of dividend income on the redemption of such holder’s Series A Preferred Shares, then repurchase of the warrants issued pursuant to the
Public Warrant Agreement held by each applicable Additional Redemption Holder, if any; and 
 (iii) thereafter, if an
Additional Redemption Holder has not (as reasonably determined by the Additional Redemption Holder) had sufficient Additional Redeemed Securities redeemed (pursuant to clauses (c)(i) and (c)(ii) above) so as to avoid the recognition of dividend
income on the redemption of such holder’s Series A Preferred Shares, then repurchase of the Warrants held by each applicable Additional Redemption Holder, if any. 
  

 36 

 (d) Shares of Common Stock held by an applicable Additional Redemption Holder to be redeemed pursuant to
Section 4.14(a), shall be redeemed or purchased at a price per share equal to the Fair Market Value (as hereinafter defined) thereof as of the date of consummation of the redemption. Public Warrants held by an applicable Additional
Redemption Holder to be redeemed pursuant to Section 4.14(a), shall be redeemed or purchased at a price per such Public Warrant equal to the Fair Market Value (as hereinafter defined) thereof as of the date of consummation of the
redemption. Warrants issued hereunder and held by an applicable Additional Redemption Holder to be redeemed pursuant to Section 4.14(a), shall be redeemed or purchased at a price per such Warrant equal to the Fair Market Value (as
hereinafter defined) thereof as of the date of consummation of the redemption. 
 (e) For purposes of this Section 4.14, the
“Fair Market Value” as of a particular date shall be determined as follows: (i) if shares of Common Stock, Public Warrants, Warrants or other Convertible Securities are traded on a securities exchange including the New York
Stock Exchange, American Stock Exchange and NASDAQ Stock Exchange) or through the NASDAQ Global Market or Capital Market or other over-the-counter market, the Fair Market Value shall be deemed to be the average of the closing sales prices of such
shares, warrants or other Convertible Securities on such exchange over the thirty (30) day period ending three (3) days prior to the date of determination of the Fair Market Value; or (ii) if no public market exists for the shares of
Common Stock, Public Warrants, Warrants, or other Convertible Securities, the Fair Market Value shall (subject to the applicable Additional Redemption Holders’ right to dispute such valuation as described below) be determined in good faith by
the Board of Directors of the Company; provided, however, that the calculation of the Fair Market Value of a Warrant issued hereunder for purposes of this provision only shall be made using the Black-Scholes Option Pricing Model which
shall assume for purposes of such calculation that the volatility underlying the Common Stock price be an amount that is the greater of (x) the average volatility for the trailing 250 Trading Days from the date of determination, (y) 50%,
or (z) the implied volatility of the Public Warrants (if Public Warrants are outstanding and listed for trading as of the date of determination) as calculated by The Bloomberg Professional data services. If the applicable Additional Redemption
Holders holding a majority of Series A Preferred Shares which have not waived their rights under this Section 4.14 disagree with the Board of Directors’ determination of the Fair Market Value, such holders may submit a notice of
disagreement to the Company. During the three (3) Business Days immediately following the Company’s receipt of such notice, such holders and the Company shall negotiate in good faith to determine a mutually agreeable resolution. If the
parties remain unable to reach agreement after such period, they shall engage one of the “Big 4” accounting firms reasonably acceptable to each such party to resolve such dispute (the “Valuation Firm”). Each of such
holders and the Company shall provide (at each’s own expense) the Valuation Firm with copies of any documents, analyses or other information within its possession or control that the Valuation Firm reasonably requests in order to resolve such
dispute. The Valuation Firm shall determine the Fair Market Value as soon as practicable after its engagement to resolve the dispute using customary valuation techniques for other companies or businesses in the same or similar industries as the
Company (and shall not apply any discount due to the fact that the Common Stock, Public Warrants or other securities may constitute “restricted securities”, may be illiquid 
  

 37 

 or represent a minority interest in the Company but shall utilize the Black-Scholes Option Pricing Model and the
volatility assumption set forth in the proviso to the first sentence of this Section 4.14(e)). The Valuation’s Firm’s determination shall be binding, and not subject to challenge or collateral attack for any reason other than
manifest error. The Company shall pay all fees, costs and expenses of the Valuation Firm in connection with its engagement to resolve such dispute (the “Valuation Cost”); provided, however, that if the Valuation Firm’s
determination of the Fair Market Value is in excess of 50% lower than said holders’ proposed Fair Market Value, then the fees and expenses of the Valuation Firm shall be shared (with respect to the holders of the Series A Preferred Shares
involved in the dispute, pro rata in accordance with their respective ownership percentages) in the same proportion that the Company’s position, on the one hand, and the holders’ position, on the other hand, initially presented to
the Valuation Firm (based on the aggregate of all differences taken as a whole) bear to the final resolution as determined by the Valuation Firm. 
 (f) Notwithstanding anything to the contrary, any Additional Redemption Holder shall be entitled to waive the right to have any Additional Redeemed Securities redeemed by the Company or purchased by any Company provided third party pursuant
to this Section 4.14. 
 ARTICLE V 
 REMEDIES 
 5.1 Survival. 
 Irrespective of any investigation, inquiry or examination made by, for or on behalf of any Investor, or the acceptance by any Investor of any certificate
or opinion, the representations, warranties and covenants contained herein shall survive the Closing. 
 5.2 Indemnification.

 The Company shall indemnify, defend and hold the Investors and their respective officers, directors, members, partners, affiliates,
employees, agents and representatives (collectively, “Indemnitees”) harmless against all liability, loss, and damage (including taxes thereon) together with all reasonable costs and expenses related thereto (including reasonable
legal fees and expenses), relating to or arising from (i) the untruth, inaccuracy or breach of any of the representations or warranties contained in the Documents (regardless of whether such representations, or warranties have terminated or
expired pursuant to the SB Merger Agreement) and made or deemed made on, or as of, the Closing Date, (ii) the breach of any covenants or agreements of the Company contained in the Documents, (iii) the execution or delivery of any Document
or any other agreement or instrument contemplated hereby or thereby, the performance by the Company of its obligations under the Documents or the consummation by the Company of the transactions contemplated hereby or thereby, and (iv) any
actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing (including as may be commenced by third parties), whether based in contract, tort or any other theory and regardless of whether any Indemnitee is a
party thereto. In the event that any Indemnitee claims any such right of indemnification, such Indemnitee shall provide to the Company written notice thereof, together with reasonable detail regarding such claims and in the event that such claim
involves third party claims, allow the Company at its expense to defend such claim(s) on the Indemnitee’s behalf. 
  

 38 

 5.3 Remedies 
 In addition to being entitled to exercise all rights provided herein or granted by Law, including recovery of damages, each of the Investors and the Company will be entitled to specific performance under the
Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agrees to waive in any action for specific performance of
any such obligation the defense that a remedy at law would be adequate (including, without limitation, as set forth in Section 4.13). 
 5.4 Liquidated Damages. 
 The Company’s obligations to pay any partial liquidated damages or other amounts owing
under the Documents (including, without limitation, as set forth in Section 4.13) is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid
notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been cancelled. 
 5.5 Trust Assets. 
 (a) As an inducement to the Company to consider the Investor’s
subscription herein, and for other valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each Investor hereby agrees that it will not now or at any time prior to the Closing have any claim to, or make any claim
against, the Trust Assets (as defined below) in excess of such portion of the Trust Assets the Company is permitted to access pursuant to the Investment Management Trust Agreement dated on or about December 16, 2005 (the “Trust
Agreement”) whether such claim arises as a result of, in connection with or relating in any way directly or indirectly to, the financing contemplated herein and regardless of whether such claim arises based on contract, tort, equity or any
other theory of legal liability (any and all such claims are collectively referred to hereafter as the “Claims”); provided, however, that this waiver will be terminated and of no force and effect in the event that the
Company consummates a business combination, including the SB Transaction, and the funds held in the Trust are released from being held as Trust Assets. 
 (b) Each Investor recognizes and understands that as of August 31, 2006 the Company has on deposit approximately $99,543,000 in a trust (the “Trust”) where it has and will accumulate interest
(the initial funds plus interest are referred to hereafter as the “Trust Assets”). The Trust Assets are to be held for the exclusive benefit of the Company’s stockholders to the extent set forth in the Trust Agreement and
either distributed as part of the consummation of a business combination between the Company and a business entity or entities meeting certain requirements, the payment of federal and state income taxes on the earned interest or returned to the
Company’s stockholders. As of July 31, 2006, the Company owned liquid assets of approximately $1,300,000 outside of the Trust which it intends to use for its working capital and other corporate purposes (the “Non-Trust
Assets”), it being understood that this Section 5.5 is not intended to apply to, nor restrict access to, the Non-Trust Assets. 
  

 39 

 (c) In the event that the Investor commences any action or proceeding based upon, in connection with,
relating to or arising out of the financing contemplated herein or in any other way directly or indirectly related to the financing, seeking, in whole or in part, relief against the Trusts Assets, whether in the form of money damages or injunctive
relief, in which the Company prevails in whole on all counts as determined by a final adjudicated non-appealable judgment, then the Company shall be entitled to recover from such party(s) who commenced the action or proceeding, the legal fees and
associated costs required to defend such action. 
 ARTICLE VI 
 TERMINATION 
 6.1 Termination. 
 This Agreement shall terminate with respect to an Investor on the earlier of (i) February 16, 2007 (the “Final Termination
Date”) if the Closing shall not have occurred prior thereto; provided, however, if as of the Final Termination Date all the closing conditions set forth in Article III have been satisfied (except for those conditions
which by their nature are to be satisfied at Closing including the closing of the Merger) but for the fact that the Stockholders Meeting shall not have been held solely due to the fact that the Commission had not as of yet granted approval for, or
rejected, the Proxy Statement, then the Company and the Requisite Investors shall discuss in good faith as to whether it is reasonable and practicable to expect Commission approval within a reasonable period of time thereafter, and in the event the
Company and the Requisite Investors agree that such approval is reasonably likely within a reasonable period of time thereafter, the Company and such Requisite Investors may, but none of such parties shall be obligated to, agree upon a new Final
Termination Date; (ii) if the Company’s stockholders (as required by Law and as required by the Company’s Certificate of Incorporation) fail to approve the Merger and the issuance of the Securities upon receipt of the Proxy Statement
and holding of a valid Stockholder Meeting; (iii) by the Requisite Investors (A) if the preliminary Proxy Statement shall not have been filed with the Commission on or before the tenth (10th) calendar day after the receipt of the applicable financial information, as set forth in Section 4.1(e) or (B) if the Proxy Statement
shall not have been sent to the Company’s stockholders by January 10, 2007; provided, however, in the event final Commission approval of the Proxy Statement has not been received by January 5, 2007 then the Company and
the Requisite Investors shall discuss in good faith as to whether it is reasonable and practicable to expect Commission approval within a reasonable period of time thereafter, and in the event the Company and the Requisite Investors agree that such
approval is reasonably likely within a reasonable period of time thereafter, the Company and such Requisite Investors may, but none of such parties shall be obligated to, agree upon a new Final Termination Date; (iv) the date that any permanent
injunction or other order of a Governmental Authority preventing the Closing shall have become effective or (v) the date of the termination of the SB Merger Agreement (each of the events in clauses (i)-(v), a “Termination
Date”); provided, however, that no such termination will affect the right of any party to initiate legal action for any breach by the other party (or parties). If the Closing has not occurred as of the Termination Date with
respect to an Investor, the Company shall direct the Escrow Agent to return the funds held in the Escrow Account on behalf of such applicable Investor to such Investor (together with interest thereon) pursuant to the terms of the Escrow Agreement.

  

 40 

 6.2 Effect of Termination. 
 In the event of a termination of this Agreement, this Agreement shall forthwith become void and there shall be no liability or obligation on the part of
the Investors or the Company or their respective officers, directors or Affiliates after the Termination Date; provided that Section 6.1, this Section 6.2 and Article VII shall survive any such Termination
Date; provided further, that nothing herein shall relieve any party for liability for any breach of any pre-Termination Date obligation. 
 ARTICLE VII 
 MISCELLANEOUS 
 7.1 Fees and Expenses. 
 The
Company shall pay all of its expenses incurred in connection with the preparation, execution and delivery of the Documents and the consummation of the transactions contemplated thereby and shall pay at Closing (to the extent Closing shall have
occurred) any and all fees related to filings required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) made as a result of the acquisition of the Securities on the Closing Date or any other
Law relating to competition matters up to $45,000 per Investor with respect thereto, whether or not the transactions contemplated hereby are consummated or the Agreement is terminated on a Termination Date. In addition, the Company shall pay, and
hold the Investors and their representatives harmless against all liability for the payment of: (i) up to $700,000 of the fees and charges of O’Melveny & Myers LLP, counsel to certain of the Investors, incurred in connection with
the preparation, execution and delivery of the Documents and the consummation of the transactions contemplated thereby, (ii) all reasonable costs and expenses incurred from time to time by the Investors in connection with their monitoring and
enforcement of the Company’s performance of and compliance with all agreements and conditions contained in the Documents on its part to be performed or complied with, (iii) the reasonable costs and expenses (including fees and expenses of
counsel, accountants and other advisors) incurred by the Investors in connection with any amendment or waiver of any Document, (iv) any reasonable costs incurred by the Investors in rendering assistance to the Company or any of their
subsidiaries at the request of the Company, (it being understood that the Investors are not obligated to render, and may charge additional fees for, such assistance), (v) the reasonable fees and expenses incurred by the Investors in any filing
with any Governmental Authority with respect to the Company or any of its subsidiaries that mentions any Investor or its affiliates, (vi) any stamp or similar taxes which may be determined to be payable in connection with the execution and
delivery and performance of any Document or any modification, amendment or alteration of any Document, and all issue taxes in respect of the issuance of any Securities, Reserved Shares or Warrant Shares (or any other securities issued in respect
thereof), and (vii) up to $50,000 of the fees and charges of Goodwin Procter, LLP, counsel to Citigroup Global Markets, Inc., the Company’s placement agent and advisor on the transactions contemplated hereby. The provisions of this Section
are automatically assignable to any Person who acquires any Securities pursuant to Section 7.2. The Company hereby acknowledges that, 
  

 41 

 in the event a Closing occurs, its obligation to reimburse the Investors for the fees and charges of
O’Melveny & Myers LLP and to reimburse the fees and charges of Goodwin Procter, LLP pursuant to this Section 7.1 shall be fulfilled at the Closing by permitting the Investors to deduct such fees and charges from the
proceeds payable by the Investors to the Company as set forth on Annex I and to wire such amounts directly to O’Melveny & Myers LLP and Goodwin Procter, LLP, as applicable at the Closing. 
 7.2 Assignment; Parties in Interest. 
 This Agreement shall bind and inure to the benefit of the parties and each of their respective successors and permitted assigns. The Company may not assign either this Agreement or any of its rights, interests, or obligations hereunder. Any
Investor may assign any of its rights hereunder; provided, however, that the assignee agrees to be bound by, and entitled to the benefits of, this Agreement as an original party hereto; provided, further, however,
assignments by an Investor prior to Closing (other than to its Affiliates) shall require the Company’s prior approval (not to be unreasonably withheld or delayed) of the assignee in the Company’s reasonable discretion solely to the extent
the Company has received written legal advice from a nationally recognized law firm that the assignment to such assignee would result in the failure of issuance of the Securities hereunder to be exempt from registration under the Securities Act.

 7.3 Entire Agreement; Severability. 
 This Agreement contains the entire understanding of the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings among the parties with respect to such subject matter
(including, on the Closing Date, any confidentiality or non-disclosure agreement entered into by any of the Investors or their Affiliates with the Company prior to the date hereof, each of which shall be automatically terminated upon the Closing
Date (including the provisions thereof that purport to survive the termination thereof)). It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under the law and public
policies applied in each jurisdiction in which enforcement is sought. Accordingly, in the event that any provision of this Agreement would be held in any jurisdiction to be invalid, prohibited or unenforceable for any reason, such provision, as to
such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could
be more narrowly drawn so as not be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or
enforceability of such provision in any other jurisdiction. 
 7.4 Notices. 
 All notices, claims, certificates, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if
personally delivered or if sent by nationally-recognized overnight courier, by telecopy, electronic transmission or by registered or certified mail, return receipt requested and postage prepaid, addressed as follows: 
 if to the Company: 
 Boulder
Specialty Brands, Inc. 
 6106 Sunrise Ranch Drive 
 Longmont, Colorado 80503 
 Telephone: 303-682-1978 
 Attention: Robert S. Gluck 
  

 42 

 with a copy to: 
 Davis & Kuelthau, s.c. 
 111 East Kilbourn Avenue, Suite 1400 
 Milwaukee, Wisconsin 53202 
 Fax: 414-276-9369 
 Telephone: 414-276-0200 
 Attention: Norman J. Matar 
 and 
 Ellenoff Grossman & Schole LLP 
 370 Lexington Avenue, 19th Floor 
 New York, New York 10017 
 Telephone: 212-370-1300 
 Attention: Douglas S. Ellenoff 
 if to the Investors, to the address set forth on Annex I hereto; 
 or to such other address as the party to whom notice is to be given may have furnished to the other parties in writing in accordance herewith. Any such notice or communication shall be deemed to have been received
(a) in the case of personal delivery, on the date of such delivery if a Business Day or, if not a Business Day, the next succeeding Business Day, (b) in the case of nationally-recognized overnight courier, on the next Business Day after
the date when sent, (c) in the case of email, upon receipt of acknowledgment of receipt, (d) in the case of telecopy transmission, when received if a Business Day or, if not a Business Day, the next succeeding Business Day, and (e) in
the case of mailing, on the third Business Day following that on which the piece of mail containing such communication is posted. 
 7.5
Amendments; Waivers. 
 The terms and provisions of this Agreement may be modified, waived or amended pursuant to an instrument
signed by the Company and the Requisite Investors, except as otherwise permitted as set forth in Section 1.2(c) with respect to the addition of a Joinder Investor; provided, however, that any modification, amendment or
waiver that materially and adversely affects any Investor with respect to the rights or obligations in respect of such Investor’s Series A Preferred Shares or Common Shares purchased hereunder in a manner disproportionate to how it adversely
affects the rights or obligations in respect of such Securities of other Investors purchased hereunder shall not be effective without the prior written consent of such holder; provided further, however, that the conditions
precedent to Closing as set forth in 
  

 43 

 Sections 3.1 and 3.2 shall not be amended or waived with respect to any particular Investor without the prior
written consent of such Investor. In addition, the terms and provisions of each of the Warrants may be modified, amended, or waived pursuant to an instrument signed by the Company and the Requisite Investors; provided, however, that
any modification, amendment or waiver that materially and adversely affects any holder of a Warrant with respect to the rights or obligations in respect of such holder’s Warrants in a manner disproportionate to how it materially and adversely
affects the rights or obligations of the other holders in respect of their other Warrants shall not be effective without the prior written consent of such holder. Any waiver of any term or provision of this Agreement requested by any party hereto
must be granted in advance, in writing, by the Company (if an Investor is requesting such waiver) or by the Requisite Investors (if the Company is requesting such waiver), as the case may be, provided that any amendment that increases the
Subscription Amount of any Investor shall require consent of such Investor. 
 7.6 Counterparts. 
 This Agreement may be executed in any number of original or facsimile counterparts, and each such counterpart shall be deemed to be an original
instrument, but all such counterparts together shall constitute but one agreement. 
 7.7 Headings. 
 The section and paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. 
 7.8 Governing Law; Consent to Jurisdiction and Venue; Waiver of Jury Trial. 
 This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to any law or rule that
would cause the laws of any jurisdiction other than the State of New York to be applied. 
 ANY PROCEEDING AGAINST THE PARTIES RELATING IN
ANY WAY TO THIS AGREEMENT MAY BE BROUGHT AND ENFORCED IN THE COURTS OF THE STATE OF NEW YORK OR THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFOR, AND THE PARTIES
IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY SUCH PROCEEDING. EACH OF THE PARTIES IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION THAT THEY MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF
ANY SUCH PROCEEDING IN THE COURTS OF THE STATE OF NEW YORK LOCATED IN NEW YORK COUNTY OR THE SOUTHERN DISTRICT OF NEW YORK AND ANY CLAIM THAT ANY SUCH PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN ANY INCONVENIENT FORUM. ANY JUDGMENT MAY
BE ENTERED IN ANY COURT HAVING JURISDICTION THEREOF. 
  

 44 

 EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT. 
 7.9 Independent Nature of Investors’ Obligations and Rights

 The obligations of each Investor under any Document are several and not joint with the obligations of any other Investor, and no Investor
shall be responsible in any way for the performance of the obligations of any other Investor under any Document. The decision of each Investor to purchase Securities pursuant to the Documents has been made by such Investor independently of any other
Investor. Nothing contained herein or in any Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity. Each Investor
shall be entitled to independently protect and enforce its rights, including without limitation, the rights arising out of this Agreement or out of the other Documents, and it shall not be necessary for any other Investor to be joined as an
additional party in any proceeding for such purpose. Each Investor has been represented by its own separate legal counsel in their review and negotiation of the Documents. The Company has elected to provide all Investors with the same terms and
Documents for the convenience of the Company and not because it was required or requested to do so by the Investors. 
 * * * * 
  

 45 

 IN WITNESS WHEREOF, the parties have executed and delivered this Securities Purchase Agreement on
the date first above written. 
  

			
	BOULDER SPECIALTY BRANDS, INC.
		
	By:	 	 /s/ Stephen B. Hughes

	Name:	 	Stephen B. Hughes
	Title:	 	Chairman and Chief Executive Officer

			
	INVESTOR:
	
	OZ MASTER FUND, LTD.
		
	By:	 	OZ Management, L.L.C., its Investment Manager
		
	By:	 	 /s/ Joel Frank
  

	Name:	 	Joel Frank
	Title:	 	Chief Financial Officer
	
	OZ Global Special Investments Master Fund, L.P.
		
	By:	 	OZ Management, L.L.C., its Investment Manager
		
	By:	 	 /s/ Joel Frank
  

	Name:	 	Joel Frank
	Title:	 	Chief Financial Officer
	
	GPC LVII, LLC
		
	By:	 	OZ Management, L.L.C., its Investment Manager
		
	By:	 	 /s/ Joel Frank
  

	Name:	 	Joel Frank
	Title:	 	Chief Financial Officer
	
	Fleet Maritime, Inc.
		
	By:	 	OZ Management, L.L.C., its Investment Manager
		
	By:	 	 /s/ Joel Frank
  

	Name:	 	Joel Frank
	Title:	 	Chief Financial Officer

			
	INVESTOR:
	
	Aragon Trading Company, L.P.
		
	By:	 	 /s/ Brian Yeatman
  

	Name:	 	Brian Yeatman
	Title:	 	General Partner

			
	INVESTOR:
	
	Westmount Investments LLC
		
	By:	 	 /s/ Robert J. Gillespie
  

	Name:	 	Robert J. Gillespie
	Title:	 	Principal

			
	INVESTOR:
	
	Investcorp Interlachen Multi-Strategy Master Fund Limited
		
	By:	 	Interlachen Capital Group LP
		
	By:	 	 /s/ Gregg T. Colburn
  

	Name:	 	Gregg T. Colburn
	Title:	 	Authorized Signatory

			
	INVESTOR:
	
	UBS AG
		
	By:	 	 /s/ Chris Coward
  

	Name:	 	Chris Coward
	Title:	 	Director

			
	INVESTOR:
	
	Glenhill Capital Overseas Master Fund, L.P.
		
	By:	 	Glenhill Capital Overseas G.P. Ltd.
		
	By:	 	 /s/ Glenn J. Krevlin
  

	Name:	 	Glenn J. Krevlin
	Title:	 	Director

			
	INVESTOR:
	
	Glenhill Capital, L.P.
		
	By:	 	Glenhill Capital Management, LLC
		
	By:	 	 /s/ Glenn J. Krevlin

	Name:	 	Glenn J. Krevlin
	Title:	 	Managing Member

			
	INVESTOR:
	
	Glenview Capital Partners, L.P.
		
	By:	 	Glenview Capital Management, LLC its investment manager
		
	By:	 	 /s/ Richard Barrera

	Name:	 	Richard Barrera
	Title:	 	Managing Member
	
	Glenview Institutional Partners, L.P.
		
	By:	 	Glenview Capital Management, LLC its investment manager
		
	By:	 	 /s/ Richard Barrera
  

	Name:	 	Richard Barrera
	Title:	 	Managing Member
	
	GCM Little Arbor Partners, L.P.
		
	By:	 	Glenview Capital Management, LLC its investment manager
		
	By:	 	 /s/ Richard Barrera
  

	Name:	 	Richard Barrera
	Title:	 	Managing Member
	
	GCM Little Arbor Institutional Partners, L.P.
		
	By:	 	Glenview Capital Management, LLC its investment manager
		
	By:	 	 /s/ Richard Barrera
  

	Name:	 	Richard Barrera
	Title:	 	Managing Member
	
	GCM Little Arbor Master Fund Ltd.
		
	By:	 	Glenview Capital Management, LLC its investment manager

			
	By:	 	 /s/ Richard Barrera
  

	Name:	 	Richard Barrera
	Title:	 	Managing Member
	
	Glenview Capital Master Fund Ltd.
		
	By:	 	Glenview Capital Management, LLC its investment manager
		
	By:	 	 /s/ Richard Barrera
  

	Name:	 	Richard Barrera
	Title:	 	Managing Member

			
	INVESTOR:
	
	Fort Mason Partners, LP
	By:	 	Fort Mason Capital, LLC
		
	By:	 	 /s/ Dan German
  

	Name:	 	Dan German
	Title:	 	Managing Member

			
	INVESTOR:
	
	Fort Mason Master, LP
	By:	 	Fort Mason Capital, LLC
		
	By:	 	 /s/ Dan German
  

	Name:	 	Dan German
	Title:	 	Managing Member

			
	INVESTOR:
	
	Adage Capital Partners, L.P.
		
	By:	 	 /s/ D. Lehan
  

	Name:	 	D. Lehan
	Title:	 	C.O.O.

			
	INVESTOR:
	
	 Canyon Capital Advisors LLC, on behalf of
 its managed funds and accounts

		
	By:	 	 /s/ Joshua S. Friedman
  

	Name:	 	Joshua S. Friedman
	Title:	 	Authorized Signatory

			
	INVESTOR:
	
	Highbridge International LLC
	By:	 	Highbridge Capital Management, LLC
		
	By:	 	 /s/ Ari I. Storch
  

	Name:	 	Ari I. Storch
	Title:	 	Managing Director

			
	INVESTOR:
	
	Old Lane, L.P. on behalf of
	Old Lane US Master Fund, L.P.
		
	By:	 	 /s/ John Havens
  

	Name:	 	John Havens
	Title:	 	Managing Director

			
	INVESTOR:
	
	Old Lane, L.P. on behalf of
	Old Lane Cayman Master Fund, L.P.
		
	By:	 	 /s/ John Havens
  

	Name:	 	John Havens
	Title:	 	Managing Director

			
	INVESTOR:
	
	Old Lane, L.P. on behalf of
	Old Lane HMA Master Fund, L.P.
		
	By:	 	  

	Name:	 	John Havens
	Title:	 	Managing Director

			
	INVESTOR:
	
	SF Capital Partners Ltd.
		
	By:	 	  

	Name:	 	Brian H. Davidson
	Title:	 	Managing Director

			
	INVESTOR:
	
	Citigroup Global Markets, Inc.
		
	By:	 	 /s/ Tyler G. Dickson
  

	Name:	 	Tyler G. Dickson
	Title:	 	Managing Director

			
	INVESTOR:
	
	Kings Road Investments LTD
		
	By:	 	Kings Road
		
	By:	 	 /s/ Brandon L. Jones

	Name:	 	Brandon L. Jones
	Title:	 	Co-Head, Private Investments

  

 66 

 ANNEX I 
 SECURITIES TO BE PURCHASED BY INVESTORS 
  

										
	 Investor
	  	 (1)
 Number of Series
A Preferred
Shares Purchased
at Closing
	  	 (2)
 Number of
Warrant
Purchased at
Closing based
upon issued
Series A
Preferred Shares
	  	 (3)
 Number of
Common Shares
Purchased at
Closing
	  	 (4)
 Subscription
Amount

	 OZ Master Fund, Ltd.
 c/o Och-Ziff Capital Management
Group,
 L.L.C.
 9 West 57th St., 39th floor
 New York, NY 10019
 Telephone: (212) 790-0160
 Facsimile: (212) 790-0060
 Attn:  Joel M. Frank
            David
Stonehill
	  	7,382,953	  	7,382,953	  	2,266,025	  	$	83,351,123.50
					
	 OZ Global Special Investments Master
 Fund,
L.P.
 c/o Och-Ziff Capital Management Group,
 L.L.C.

9 West 57th St., 39th floor
 New York, NY 10019
 Telephone: (212) 790-0160
 Facsimile: (212) 790-0060
 Attn:  Joel M. Frank
            David Stonehill
	  	152,459	  	152,459	  	46,794	  	$	1,721,214.24
					
	 GPC LVII, LLC
 c/o Och-Ziff Capital Management
Group,
 L.L.C.
 9 West 57th St., 39th floor
 New York, NY 10019
 Telephone: (212) 790-0160
 Facsimile: (212) 790-0060
 Attn:  Joel M. Frank
            David
Stonehill
	  	93,560	  	93,560	  	28,716	  	$	1,056,261.36
					
	 Fleet Maritime, Inc.
 c/o Och-Ziff Capital Management
Group,
 L.L.C.
 9 West 57th St., 39th floor
 New York, NY 10019
 Telephone: (212) 790-0160
 Facsimile: (212) 790-0060
 Attn:  Joel M. Frank
            David
Stonehill
	  	90,472	  	90,472	  	27,768	  	$	1,021,397.28
					
	 in each case, with a copy to:
  
 O’MELVENY & MYERS LLP
 Times Square Tower
 7 Times Square
 New York, New York 10036
 Telephone: (212) 326-2000
 Facsimile: (212) 326-2061
 Attn:  Ilan S. Nissan, Esq.
	  		  		  		  		

										
	 Glenview Capital Partners, L.P.
 c/o Glenview Capital
Management, LLC
 767 Fifth Avenue, 44th Floor
 New York, NY
10153
 Telephone: 212.812.4700
 Facsimile:
212.812.4701
 Attn:  Mark Horowitz
	  	140,800	  	140,800	  	43,200	  	$	1,589,472.00
					
	 Glenview Institutional Partners, L.P.
 c/o Glenview
Capital Management, LLC
 767 Fifth Avenue, 44th Floor
 New York,
NY 10153
 Telephone: 212.812.4700
 Facsimile:
212.812.4701
 Attn:  Mark Horowitz
	  	824,000	  	824,000	  	252,900	  	$	9,302,634.00
					
	 GCM Little Arbor Partners, L.P.
 c/o Glenview
Capital Management, LLC
 767 Fifth Avenue, 44th Floor
 New York,
NY 10153
 Telephone: 212.812.4700
 Facsimile:
212.812.4701
 Attn:  Mark Horowitz
	  	7,000	  	7,000	  	2,200	  	$	79,412.00
					
	 GCM Little Arbor Institutional Partners, L.P.
 c/o
Glenview Capital Management, LLC
 767 Fifth Avenue, 44th Floor
 New York, NY 10153
 Telephone: 212.812.4700
 Facsimile:
212.812.4701
 Attn:  Mark Horowitz
	  	118,600	  	118,600	  	36,400	  	$	1,338,944.00
					
	 GCM Little Arbor Master Fund, Ltd.
 c/o Glenview Capital
Management, LLC
 767 Fifth Avenue, 44th Floor
 New York, NY
10153
 Telephone: 212.812.4700
 Facsimile:
212.812.4701
 Attn:  Mark Horowitz
	  	429,100	  	429,100	  	131,700	  	$	4,844,382.00
					
	 Glenview Capital Master Fund Ltd.
 c/o Glenview Capital
Management, LLC
 767 Fifth Avenue, 44th Floor
 New York, NY
10153
 Telephone: 212.812.4700
 Facsimile:
212.812.4701
 Attn:  Mark Horowitz
	  	1,788,833	  	1,788,833	  	549,015	  	$	20,195,148.90
					
	 Glenhill Capital, L.P.
 c/o Glenhill Capital Management,
L.L.C.
 598 Madison Ave., 12th Floor
 New York, NY 10022
 Telephone:
(646) 432-0625
 Facsimile: (646) 432-0666
 Attn:  Kevin Corb
	  	388,889	  	388,889	  	469,169	  	$	7,000,001.74

  

 68 

										
	 Glenhill Capital Overseas Master Fund LP
 c/o Glenhill
Capital Management, L.L.C.
 598 Madison Ave., 12th Floor
 New York, NY 10022
 Telephone:
(646) 432-0625
 Facsimile: (646) 432-0666
 Attn:  Kevin Corb
	  	166,667	  	166,667	  	201,072	  	$	3,000,000.12
					
	 in each case, with a copy to:
  
 Glenhill Capital Management, L.L.C.
 598 Madison Ave., 12th Floor
 New York, NY
10022
 Telephone: (646)432-0605
 Facsimile:
(646) 432-0666
 Attn:  Glenn Krevlin
	  		  		  		  		
					
	 Adage Capital Partners, L.P.
 200 Clarendon Street,
52nd Floor
 Boston, MA
02116
 Telephone: (617)867-2800
 Facsimile:
(617) 867-2801
	  	1,111,111	  	1,111,111	  	2,010,724	  	$	25,000,000.04
					
	 with a copy to:
  
 Schulte Roth & Zabel LLP
 919 Third Avenue
 New York, NY 10022
 Attn:  Peter Halasz, Esq.
	  		  		  		  		
					
	 SF Capital Partners Ltd.
 c/o Stark Offshore Management,
LLC
 3600 South Lake Drive
 St. Francis, WI 53235
 Attn: Brian H. Davidson
 Telephone: (414)294-7000
 Facsimile: (414) 294-7700
	  	0	  	0	  	1,340,483	  	$	10,000,003.18
					
	 Investcorp Interlachen Multi-Strategy
 Master Fund
Limited
 c/o Interlachen Capital Group LP
 800 Nicollet Mall,
Suite 2500
 Minneapolis, MN 55402
 Attn:  Gregg Colburn and Legal Department
 Telephone: (612)659-4407
 Facsimile: (612) 659-4457
	  	0	  	0	  	268,097	  	$	2,000,003.62
					
	 Aragon Trading Company, L.P.
 P.O. Box 178
 Glenbrook, NV 89413
 Telephone: (916)663-1823
 Facsimile: (916) 663-1824
	  	13,889	  	13,889	  	16,756	  	$	250,000.76
					
	 with a copy to:
  
 John Yeatman
 1313 Gold Hill Road
 Newcastle, CA 95658
	  		  		  		  		

										
	 Canyon Capital Advisors LLC
 9665 Wilshire
Blvd.
 Suite 200
 Beverly Hills, CA 90212
 Telephone: (310) 247-2700
 Facsimile: (310) 247-2700
	  	777,778	  	777,778	  	670,241	  	$	11,999,999.86
					
	 Citigroup Global Markets, Inc.
 390 Greenwich St.,
5th Floor
 New York, NY
10013
 Telephone: (212) 723-7916
 Facsimile:
(646) 291-5597
  
 with a copy to:
  
 Aren C. Leekong
 Colleen Gerard
 Brooke Gottshall
 390 Greenwich St.,
5th Floor
 New York, NY
10013
	  	0	  	0	  	3,016,086	  	$	22,500,001.56
					
	 Kings Road Investments, LTD.
 (Registration name: UBS
Securities, LLC
 F/B/O Kings Road Investments Ltd.)
 c/o Polygon
Investment Partners LP
 598 Madison Avenue 14th Floor
 New York, NY 10022
  
 with a copy to:
  
 Schulte Roth & Zabel LLP
 919 Third Avenue
 New
York, New York 10022
 Attention: Eleazer Klein, Esq.
 Telephone:
(212) 756-2376
 Facsimile: (212) 593-5955
	  	1,333,333	  	1,333,333	  	1,005,362	  	$	19,499,997.52
					
	 UBS AG
 Attention: Chris Coward
 1285 6th Ave
 NY, NY 10019
 Telephone: (212) 649-7588
 Facsimile: (212) 713-6222
	  	0	  	0	  	670,241	  	$	4,999,997.86
					
	 Fort Mason Master, LP
 4 Embarcadero Ctr, Ste
2050
 San Francisco, CA 94111
 Attn: KC Lynch
 Telephone: (415) 288-8100
 Facsimile: (415) 288-8113
	  	260,862	  	260,862	  	314,712	  	$	4,695,509.52
					
	 Fort Mason Partners, LP
 4 Embarcadero Ctr, Ste
2050
 San Francisco, CA 94111
 Attn: KC Lynch
 Telephone: (415) 288-8100
 Facsimile: (415) 288-8113
	  	16,916	  	16,916	  	20,409	  	$	304,495.14
					
	 Old Lane, L.P.
 on behalf of Old Lane US Master
Fund,
 L.P.
 Old Lane L.P.
 500 Park Avenue 2nd Floor

New York, NY 10022
	  	62,500	  	62,500	  	75,402	  	$	1,124,998.92

										
	 with a copy to:
  
 Frederick Yoon/Steven Weiss
 Old Lane L.P.
 500 Park Avenue 2nd Floor
 New York, NY 10022
 Telephone: (212) 572-3206
 Telephone: (212)572-3293
 Facsimile: (212) 572-2917
	  		  		  		  		
					
	 Old Lane, L.P.
 on behalf of Old Lane HMA Master
Fund,
 L.P.
 Old Lane L.P.
 500 Park Avenue 2nd Floor

New York, NY 10022
  
 with a copy to:
  
 Frederick Yoon/Steven Weiss

Old Lane L.P.
 500 Park Avenue 2nd Floor
 New York, NY 10022
 Telephone: (212) 572-3206
 Telephone: (212)572-3293
 Facsimile: (212) 572-2917
	  	41,111	  	41,111	  	49,598	  	$	740,000.08
					
	 Old Lane, L.P.
 on behalf of Old Lane Cayman
Master
 Fund, L.P.
 Old Lane L.P.
 500 Park Avenue 2nd Floor

New York, NY 10022
  
 with a copy to:
  
 Frederick Yoon/Steven Weiss

Old Lane L.P.
 500 Park Avenue 2nd Floor
 New York, NY 10022
 Telephone: (212) 572-3206
 Telephone: (212)572-3293
 Facsimile: (212) 572-2917
	  	174,167	  	174,167	  	210,121	  	$	3,135,005.66
					
	 Highbridge International LLC
 c/o Highbridge Capital
Management, LLC
 9 West 57th Street, 27th Floor
 New York, NY 10019
 Attn: Ari J. Storch/Adam J. Chill
 Telephone: (212) 287-4720
 Facsimile: (212) 751-0755
	  	0	  	0	  	670,241	  	$	4,999,997.86
					
	 Westmount Investments LLC
 350 West Passaic
Street
 Rochelle Park, NJ 07662
 Phone Number:
(201) 226-0701
 Fax Number: (201) 226-0703
  
 with copy to:
  
 Robert J. Gillespie
 c/o Westmount Investments LLC
 350
West Passaic Street
 Rochelle Park, NJ 07662
	  	13,889	  	13,889	  	16,756	  	$	250,000.76
		  	 	  	 	  	 	  	 	 
	TOTAL:	  	15,388,889.00	  	15,388,889.00	  	14,410,188.00	  	$	246,000,003.48
		  	 	  	 	  	 	  	 	 

 INDEX OF SCHEDULES & EXHIBITS 
  

			
		  	 Annex

		
	 Annex I:
	  	 Securities Purchased by Investors

		
		  	 Exhibits

		
	 Exhibit A:
	  	 Form of Restated Certificate of Incorporation

	 Exhibit B:
	  	 Form of Warrant

	 Exhibit C:
	  	 SB Merger Agreement

	 Exhibit D:
	  	 Form of Registration Rights Agreement

	 Exhibit E:
	  	 Terms to be included in Amended and Restated Founder Registration Rights Agreement

		
		  	 Schedules

		
	 Schedule 1.1(c)
	  	Conversion Blocker Election
	 Schedule 2.1(a)(i):
	  	 Articles of Incorporation

	 Schedule 2.1(a)(ii):
	  	 Bylaws

	 Schedule 2.1(b)
	  	 Subsidiaries

	 Schedule 2.1(c)
	  	 No Conflicts

	 Schedule 2.1(e):
	  	 Consents and Approvals

	 Schedule 2.1(f):
	  	 Fully Diluted Securities

	 Schedule 2.1(g):
	  	 Defaults

	 Schedule 2.1(h):
	  	 SEC Reports

	 Schedule 2.1(i):
	  	 Undisclosed Liabilities

	 Schedule 2.1(j):
	  	 Absence of Changes; Confidential Treatment

	 Schedule 2.1(k):
	  	 Encumbrances

	 Schedule 2.1(l)(ii):
	  	 Exceptions to Intellectual Property Rights

	 Schedule 2.1(m):
	  	 Employment Matters

	 Schedule 2.1(n):
	  	 Benefit Plans

	 Schedule 2.1(o):
	  	 Contracts

	 Schedule 2.1(p):
	  	 Permits

	 Schedule 2.1(q):
	  	 Employees

	 Schedule 2.1(r):
	  	 Litigation

	 Schedule 2.1(s):
	  	 Tax Matters

	 Schedule 2.1(t):
	  	 Related Party Transaction

	 Schedule 2.1(w):
	  	 Sarbanes-Oxley

	 Schedule 2.1(ff):
	  	 Registration Rights

 EXHIBIT A 
 Form of Restated Certificate of Incorporation 

 EXHIBIT B 
 Form of Warrant 

 EXHIBIT C 
 SB Merger Agreement 

 EXHIBIT D 
 Form of Registration Rights Agreement 

 SCHEDULE 1.1(c) 
  

	1.	Glenview Capital Partners, L.P. 

 Glenview
Institutional Partners, L.P. 
 GCM Little Arbor Partners, L.P. 
 GCM Little Arbor Institutional Partners, L.P. 
 GCM Little Arbor Master Fund, Ltd. 
 Glenview Capital Master Fund Ltd. 
  

	2.	Glenhill Capital, L.P. 

 Glenhill Capital
Overseas Management, L.L.C. 
  

	3.	Fort Mason Master, LP1 

 Fort Mason Partners, LP2 
  

	4.	OZ Master Fund, Ltd. 

 OZ Global Special
Investments Master Fund, L.P. 
 GPC LVII, LLC 
 Fleet Maritime, Inc. 
  

	5.	Kings Road Investments, Ltd 

 (Registration name:
UBS Securities, LLC F/B/O Kings Road Investments Ltd.) 
 6. Adage Capital Partners, L.P. (“Adage”) has elected to waive, and not be subject
to, the provisions of Section 9(l) of the Restated Certificate and Section 3(g) of the Warrants until such time (if any) as Adage has provided written notice to the Company that it has elected to be subject to such provisions, at which
time Adage shall be subject to such provisions and the foregoing waiver shall no longer be in effect. 
  

	1	Fort Mason have elected a 4.99% blocker. 

	2	Fort Mason have elected a 4.99% blocker. 

 Schedule 2.1(a)(i) 
 Certificate of Incorporation 
 Delaware 
 PAGE 1             
 The first State 
 I, HARRIET SMITH WINDSOR, SECRETARY OF STATE OF THE STATE
OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF “BOULDER SPECIALTY BRANDS, INC.”, FILED IN THIS OFFICE ON THE THIRTY-FIRST DAY OF MAY, A.D. 2005, AT 6:36 O’CLOCK P.M.

 A FILED COPY OF THIS CERTIFICATE HAS BEEN FORWARDED TO THE KENT COUNTY RECORDER OF DEEDS. 
  

							
	 	 	 	  	 	  	[LOGO]
				
		 		  	[LOGO]	  	Harriet Smith Windsor, Secretary of State
				
	3978002	 	8100	  		  	 AUTHENTICATION: 3917027

				
	050453502	 		  		  	DATE: 06-01-05

  

 CERTIFICATE OF INCORPORATION 
 OF 
 BOULDER SPECIALTY BRANDS, INC. 
 The undersigned, a natural person eighteen years of age or
older, hereby establishes a corporation pursuant to the General Corporation Law of the State of Delaware and adopts the following Certificate of Incorporation which reads in its entirety as follows: 
 ARTICLE I 
 NAME 
 The name of the corporation (hereinafter, the “Corporation”) is Boulder Specialty Brands, Inc. 
 ARTICLE II 
 ADDRESS AND REGISTERED
AGENT 
 The address of the Corporation’s registered office in the State of Delaware is Capitol Services, Inc., 615 South DuPont Highway, Dover,
Kent County, Delaware. The name of the Corporation’s registered agent at such address is Capitol Services, Inc. 
 ARTICLE III

 PURPOSE 
 The purpose of the
Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the “DGCL”). 
 ARTICLE IV 
 CAPITAL STOCK 
 Section 1. Authorized Shares. The aggregate number of shares which the Corporation shall have authority to issue is 76,000,000; of which 1,000,000 shares of
the par value of $0.0001 shall be designated Preferred Stock and 75,000,000 shares of the par value of $0.0001 shall be designated Common Stock. 
 Section 2. Preferred Stock Designation. The Board is hereby expressly authorized, by resolution or resolutions, to provide, out of the unissued shares of Preferred Stock, for series of Preferred Stock and, with respect to each
such series, to fix the number of shares constituting such series and the designation of such series, the voting powers (if any) of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any,
and any qualifications, limitations or restrictions thereof, of the shares of such series, to the full extent now or hereafter permitted by the laws of the State of Delaware and the DGCL. The powers, preferences and relative, participating, optional
and other special rights of each series of Preferred Stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding. 
 Section 3. Assessment of Stock. The capital stock of the Corporation, after the amount of the subscription price has been fully paid in, shall not be
assessable for any purpose, and no stock issued as fully paid shall ever be assessable or assessed. No stockholder of the Corporation is individually liable for the debts or liabilities of the Corporation. 
  

	
	State of Delaware
	Secretary of State
	Division of Corporations
	Delivered 06:41 PM 05/31/2005
	FILED 06:36 PM 05/31/2005
	SRV 050453502 - 3978002 FILE

  

 1 

 ARTICLE V 
 INCORPORATOR 
 The name and mailing address of the incorporater is Stephen B. Hughes, 6106 Sunrise Ranch Drive,
Longmont, Colorado 80503. The powers of the incorporator shall terminate upon the filing of this Certificate of Incorporation. 
 ARTICLE
VI 
 DIRECTORS 
 Section 1. Number of Directors. The members of the governing board of the Corporation are styled as directors. The board of directors of the Corporation shall be elected in such manner as shall be provided in the Bylaws of the
Corporation. The number of directors shall be not less than two (2) nor more than ten (10). The number of directors may be changed from time to time within this range in such manner as shall be provided in the Bylaws of the Corporation.

 Section 2. Initial Directors. The initial Board of Directors of this Corporation shall consist of two (2) members, but
the number may be increased or decreased in the manner provided in the Bylaws of this Corporation; provided, however, that, except as otherwise provided in the Bylaws of this Corporation, or except as otherwise provided for or fixed by or pursuant
to the provisions of Article IV of this Certificate of Incorporation relating to the rights of the holders of any series of Preferred Stock, the number of directors constituting the entire Board of Directors shall not be changed without the
affirmative vote of at least sixty-six and two-thirds percent (66 and 2/3%) of the issued and outstanding shares of Common Stock. As used in this Certificate of lncorporation, the term “entire board” means the total number of directors
that the Corporation would have if there were no vacancies or unfilled newly created directorships. Elections of directors need not be by written ballot except and to the extent provided in the Bylaws of the Corporation. The names and addresses of
the persons who are to serve as the initial directors of the Corporation upon the filing of this Certificate of Incorporation are: 
  

					
	 Name
	  	 Address
	  	 
	Stephen B. Hughes	  	6106 Sunrise Ranch Drive	  	
		  	Longmont, Colorado 805O3	  	
			
	James E. Lewis	  	6106 Sunrise Ranch Drive	  	
		  	Longmont, Colorado 80503	  	

 Section 3. Removal and Filling of Newly Created Directorships. Any one or more
directors may be removed at any time, with or without cause, by the affirmative vote of at least sixty-six and two-thirds percent (66 2/3%) of the issued and outstanding shares of Common Stock that are present or represented at a special meeting of stockholders called for such purpose, voting together as a single class. At the same meeting at which the
stockholders remove one or more directors, a successor or successors may be elected for the unexpired term of the director or directors removed. Except as set forth in this Article VI (3), directors shall not be subject to removal. Notwithstanding
the foregoing, whenever holders of outstanding shares of one or more series of Preferred Stock are entitled to elect directors of the Corporation pursuant to the provisions contained in the resolution or resolutions of the Board providing for the
establishment of any such series, any such director of the Corporation so elected may be removed only in accordance with the provisions of such resolution or resolutions. Except as otherwise provided for or fixed by or pursuant to the provisions of
Article IV of this Certificate of Incorporation relating to the rights of the holders of any series of Preferred Stock, newly created directorships resulting from any increase in the number of directors shall be filled by the Board by the
affirmative vote of a majority of the directors then in office, or by the stockholders holding at least sixty-six and two-thirds percent (66 2/3%) of the issued and outstanding shares of Common Stock that are present or represented at a special meeting of stockholders called for such purpose, voting together as a single class.

  

 2 

 Section 4. Election and Vacancies. Directors shall be elected at each annual meeting of
stockholders, and each director elected shall hold office until such director’s successor has been elected and qualified, subject, however, to earlier death, resignation or removal from office. Except as otherwise provided for or fixed by or
pursuant to the provisions of Article IV of this Certificate of Incorporation relating to the rights of the holders of any series of Preferred Stock, any vacancies on the Board resulting from death, resignation, removal or other cause shall be
filled by the Board by the affirmative vote of a majority of the remaining directors then in office, even though less than a quorum of the Board, or by a sole remaining director, or by the stockholders holding at least sixty-six and two-thirds
percent (66 2/3%) of the issued and outstanding shares of Common Stock that are present or represented at a
special meeting of stockholders called for such purpose, voting together as a single class. 
 Section 5. Advance Notice of
Nominations. Subject to Article XIII of this Certificate of Incorporation, advance notice of nominations for the election of directors shall be given in the manner and to the extent provided in the Bylaws of the Corporation. 
 Section 6. Payment of Expenses. In addition to any other rights of indemnification permitted by the laws of the State of Delaware, including
the DGCL, or as may be provided for by the Corporation in this Certificate of Incorporation, its Bylaws or by agreement, the expenses of officers and directors incurred in defending a civil or criminal action, suit or proceeding, involving alleged
acts or omissions of such officer or director in his or her capacity as an officer or director of the Corporation, must be paid, by the Corporation or through insurance purchased and maintained by the Corporation or through other financial
arrangements made by the Corporation, as they are incurred and in advance of the final disposition of the action, suit or proceeding, upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately
determined by a court of competent jurisdiction that he or she is not entitled to be indemnified by the Corporation. 
 Section 7.
Classification of Directors. Upon the closing of a firm commitment underwritten public offering of securities of the Corporation, the Board of Directors shall divide itself into three classes, as nearly equal in number as possible, with
respect to the time for which the directors shall severally hold office. Directors of the first class first chosen shall initially hold office for one year or until the first annual election following their election; directors of the second class
first chosen shall initially hold office for two years or until the second annual election following their election; and directors of the third class first chosen shall initially hold office for three years or until the third annual election
following their election; and, in each case, until their successors to the class of directors whose term shall expire at that time shall be elected to hold office for a term of three years, so that the term of office of one class of directors shall
expire in each year. Each director elected shall hold office until his successor shall be elected and shall qualify. 
 ARTICLE VII

 BYLAWS 
 The Board of Directors is
authorized to adopt, amend or repeal any and all provisions of the Bylaws of the Corporation by a vote of at least two-thirds of all directors who constitute the Board of Directors, except as and to the extent provided in the Bylaws. Notwithstanding
any other provision of this Certificate of Incorporation or the Bylaws of this Corporation (and notwithstanding that some lesser percentage may be specified by law), no provision of the Bylaws of the Corporation shall be amended, modified or
repealed by the stockholders of the Corporation, nor shall any provision of the Bylaws of the Corporation inconsistent with any such provision be adopted by the stockholders of the Corporation, unless approved by the affirmative vote of holders of
at least seventy-five (75%) of the issued and outstanding shares of Common Stock. Any purported amendment to the Bylaws which would add thereto a matter not expressly covered in the Bylaws prior to such purported amendment shall be deemed to
constitute the adoption of a Bylaw provision and not an amendment to the Bylaws. 
  

 3 

 ARTICLE VIII 
 MODIFICATION, AMENDMENT OR REPEAL OF DESIGNATED PROVISIONS 
 Notwithstanding any other provision of this Certificate
of Incorporation, the Bylaws of the Corporation or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of stock of the Corporation
required by law, this Certificate of Incorporation or as provided for or fixed by or pursuant to the provisions of Article IV of this Certificate of Incorporation relating to the rights of the holders of any series of Preferred Stock, the
affirmative vote (or consent under Article XIII, if such consent is then permitted) of at least seventy-five percent (75%) of the voting power of the then outstanding shares of the voting stock of the Corporation entitled to vote generally in
the election of directors, voting together as a single class, shall be required for the modification, amendment or repeal of all or any portion of Articles IV, VI, VII, this Article VIII, IX, X, XI, XII or XIII of this Certificate of Incorporation.

 ARTICLE IX 
 INDEMNIFICATION 
 Any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit
or proceeding, whether civil, criminal, administrative or investigative (whether or not by or in the right of the Corporation) by reason of the fact that he is or was a director, officer, incorporator, employee or agent of the Corporation, or is or
was serving at the request of the Corporation as a director, officer, incorporator, employee, partner, trustee or agent of another corporation, partnership, joint venture, trust or other enterprise (including an employee benefit plan), shall be
entitled to be indemnified by the Corporation to the full extent then permitted by the DGCL as it exists or as it may hereafter be amended against expenses (including counsel and expert witness fees and disbursements), judgments, fines (including
excise taxes assessed on a person with respect to an employee benefit plan) and amounts paid in settlement incurred by him or her in connection with such action, suit or proceeding. Such right of indemnification shall inure whether or not the claim
asserted is based on matters which antedate the adoption of this Article IX. Such right of indemnification shall continue as to a person who has ceased to be a director, officer, incorporator, employee, partner, trustee or agent and shall inure to
the benefit of the heirs and personal representatives of such a person. The indemnification provided by this Article IX shall not be deemed exclusive of any other rights which may be provided now or in the future under any provision currently in
effect or hereafter adopted in this Certificate of Incorporation, the Bylaws, by any agreement, by vote of stockholders, by resolution of disinterested directors, by provision of law or otherwise. 
 ARTICLE X 
 MONETARY DAMAGES

 No director of the Corporation shall be liable to the Corporation or any of its stockholders for monetary damages for breach of fiduciary duty as a
director, provided that this provision does not eliminate the liability of the director (i) for any breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which
involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of Title 8 of the Delaware Code or (iv) for any transaction from which the director derived an improper personal benefit. For purposes of the prior
sentence, the term “damages” shall, to the extent permitted by law, include, without limitation, any judgment, fine, amount paid in settlement, penalty, punitive damages, excise or other tax assessed with respect to an employee benefit
plan, or expense of any nature (including, without limitation, counsel and expert witness fees and disbursements). Each person who serves as a director of the Corporation while this Article X is in effect shall be deemed to be doing so in reliance
on the provisions of this Article X, and neither the amendment or repeal of this Article X, nor the adoption of any provision of this Certificate of Incorporation inconsistent with this Article X, shall apply to or have any effect on the liability
or alleged liability of any director or the Corporation for, arising out of, based upon or in connection with any acts or omissions of such director occurring prior to such amendment, repeal or adoption of an inconsistent 
  

 4 

 provision. The provisions of this Article X are cumulative and shall be in addition to and independent of any and all
other limitations on or eliminations of the liabilities of directors of the Corporation, as such, whether such limitations or eliminations arise under or are created by any law, rule, regulation, bylaw, agreement, vote of shareholders or
disinterested directors, or otherwise. If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to
the fullest extent permitted by the DGCL, as so amended, without any further amendment to this Certificate of Incorporation. 
 ARTICLE XI

 COMPROMISE OR ARRANGEMENT 
 Whenever
a compromise or arrangement is proposed between this Corporation and its creditors or any class of them and/or between this Corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may,
on the application in a summary way of this Corporation or of any creditor or stockholder thereof or on the application of any receiver or receivers appointed for this Corporation under the provisions of Section 291 of Title 8 of the Delaware
Code, or on the application of trustees in dissolution or of any receiver or receivers appointed for this Corporation under the provisions of Section 279 of Title 8 of the Delaware Code order a meeting of the creditors or class of creditors,
and/or of the stockholders or class of stockholders of this Corporation, as the case may be, to be summoned in such manner as the said court directs. If a majority in number representing three-fourths in value of the creditors or class of creditors,
and/or of the stockholders or class of stockholders of this Corporation, as the case may be, agree to any compromise or arrangement and to any reorganization of this Corporation as consequence of such compromise or arrangement, the said compromise
or arrangement and the said reorganization shall, if sanctioned by the court to which the said application has been made, be binding on all the creditors or class of creditors, and/or on all the stockholders or class of stockholders, of this
Corporation, as the case may be, and also on this Corporation. 
 ARTICLE XII 
 PROVISIONS RELATING TO BUSINESS COMBINATIONS 
 The following provisions
(i) through (iv) of this Article XII shall apply during the period commencing upon the filing of this Certificate of Incorporation and terminating upon the consummation of any Business Combination (as hereinafter defined) and may not be
amended prior to the consummation of any Business Combination. A “Business Combination” shall mean the acquisition by the Corporation, whether by merger, stock exchange, asset or stock acquisition or similar type of transaction, or a
combination of the foregoing, of one or more operating businesses that are in the food or beverage business (each a “Target Business”). 
 (i) Prior to the consummation of any Business Combination, the Corporation shall submit such Business Combination to its stockholders for approval regardless of whether the Business Combination is of a type which
normally would require such stockholder approval under the DGCL. In the event that a majority of the IPO Shares (defined below) cast at the meeting to approve the Business Combination are voted for the approval of such Business Combination, the
Corporation shall be authorized to consummate the Business Combination; provided that the Corporation shall not consummate any Business Combination if 20%, or more in interest of the holders of IPO Shares exercise their conversion rights described
in subparagraph (ii) below. 
 (ii) In the event that a Business Combination is approved in accordance with the above
paragraph (i) and is consummated by the Corporation, any stockholder of the Corporation holding shares of Common Stock (“IPO Shares”) issued in the Corporation’s initial public offering (“IPO”) of securities who voted
against the Business Combination may, contemporaneous with such vote, demand that the Corporation convert his, her or its IPO Shares into cash. If so demanded, the Corporation shall convert such shares at a per share conversion price equal to the
quotient determined by dividing (i) the amount in the Trust Fund (as defined below), inclusive of any interest thereon, calculated as of two business days prior to the proposed consummation of the Business Combination, by (ii) the total
number of IPO Shares. 
  

 5 

 “Trust Fund” shall mean the trust account established by the Corporation at the consummation of its IPO and
into which a designated portion of the net proceeds of the IPO are deposited. 
 (iii) In the event that the Corporation does
not consummate a Business Combination with one or more Target Businesses by the later of (1) 18 months after the consummation of the IPO or (2) 24 months after the consummation of the IPO in the event that either a letter of intent, an
agreement in principle or a definitive agreement to complete a Business Combination with one or more Target Businesses was executed but was not consummated within such 18 month period (such later date being referred to as the “Termination
Date”), the officers of the Corporation shall take all such action necessary to dissolve and liquidate the Corporation as soon as reasonably practicable. In the event that the Corporation is so dissolved and liquidated, only the holders of IPO
Shares shall be entitled to receive liquidating distributions and the Corporation shall pay no liquidating distributions with respect to any other shares of capital stock of the Corporation. 
 (iv) A holder of IPO Shares shall be entitled to receive distributions from the Trust Fund only in the event of a liquidation of the
Corporation in accordance with subparagraph (iii) above or in the event he, she or it demands conversion of his, hers, or its IPO Shares in accordance with subparagraph (ii) above. In no other circumstances shall a holder of IPO Shares
have any right or interest of any kind in or to the Trust Fund. 
 ARTICLE XIII 
 ACTION BY CONSENT 
 Effective upon the closing of a firm commitment underwritten public offering
of Common Stock of the Corporation and notwithstanding any other provision of this Certificate of Incorporation or the Bylaws of this Corporation, and notwithstanding anything to the contrary specified by law, no action required or permitted to be
taken at any annual or special meeting of the stockholders of this Corporation may be taken without such a meeting, and the power of stockholders of this Corporation to consent in writing to the taking of such action without a meeting, as
contemplated by Section 228 of the DGCL, is hereby specifically denied. 
 IN WITNESS WHEREOF, I made, signed and
sealed this Certificate of Incorporation this 31st day of May, 2005. 
  

	
	 /s/ Stephen B. Hughes

	 Stephen B. Hughes, Incorporator

 Schedule 2.1(a)(ii) 
 Bylaws 
 BYLAWS OF 
 BOULDER SPECIALTY BRANDS, INC. 
  

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
	 ARTICLE I — CORPORATE OFFICES
	  	1
			
	     1.1
	  	 REGISTERED OFFICE
	  	1
			
	     1.2
	  	 OTHER OFFICES
	  	1
		
	 ARTICLE II — MEETINGS OF STOCKHOLDERS
	  	1
			
	     2.1
	  	 PLACE OF MEETINGS
	  	1
			
	     2.2
	  	 ANNUAL MEETING
	  	1
			
	     2.3
	  	 SPECIAL MEETING
	  	1
			
	     2.4
	  	 NOTICE OF STOCKHOLDERS’ MEETINGS
	  	1
			
	     2.5
	  	 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE
	  	2
			
	     2.6
	  	 QUORUM
	  	2
			
	     2.7
	  	 ADJOURNED MEETING; NOTICE
	  	2
			
	     2.8
	  	 ADMINISTRATION OF THE MEETING
	  	2
			
	     2.9
	  	 VOTING
	  	3
			
	     2.10
	  	 STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING
	  	3
			
	     2.11
	  	 RECORD DATE FOR STOCKHOLDER NOTICE; VOTING; GIVING CONSENTS
	  	3
			
	     2.12
	  	 PROXIES
	  	4
			
	     2.13
	  	 LIST OF STOCKHOLDERS ENTITLED TO VOTE
	  	4
			
	     2.14
	  	 ADVANCE NOTICE OF STOCKHOLDER BUSINESS
	  	4
			
	     2.15
	  	 ADVANCE NOTICE OF DIRECTOR NOMINATIONS
	  	5
		
	 ARTICLE III — DIRECTORS
	  	6
			
	     3.1
	  	 POWERS
	  	6
			
	     3.2
	  	 NUMBER OF DIRECTORS
	  	6
			
	     3.3
	  	 ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS
	  	6
			
	     3.4
	  	 RESIGNATION AND VACANCIES
	  	6
			
	     3.5
	  	 PLACE OF MEETINGS; MEETINGS BY TELEPHONE
	  	6
			
	     3.6
	  	 REGULAR MEETINGS
	  	6
			
	     3.7
	  	 SPECIAL MEETINGS; NOTICE
	  	7
			
	     3.8
	  	 QUORUM
	  	7
			
	     3.9
	  	 WAIVER OF NOTICE
	  	7
			
	     3.10
	  	 BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING
	  	7
			
	     3.11
	  	 ADJOURNED MEETING; NOTICE
	  	7
			
	     3.12
	  	 FEES AND COMPENSATION OF DIRECTORS
	  	8
			
	     3.13
	  	 REMOVAL OF DIRECTORS
	  	8
			
	     3.14
	  	 INTERESTED DIRECTORS
	  	8
		
	 ARTICLE IV — COMMITTEES
	  	8
			
	     4.1
	  	 COMMITTEES OF DIRECTORS
	  	8
			
	     4.2
	  	 COMMITTEE MINUTES
	  	8
			
	     4.3
	  	 MEETINGS AND ACTION OF COMMITTEES
	  	8
		
	 ARTICLE V — OFFICERS
	  	9
			
	     5.1
	  	 OFFICERS
	  	9

  

 i 

 TABLE OF CONTENTS 
 (continued) 
  

					
	 	  	 	  	Page
			
	     5.2
	  	 APPOINTMENT OF OFFICERS
	  	9
			
	     5.3
	  	 SUBORDINATE OFFICERS
	  	9
			
	     5.4
	  	 REMOVAL AND RESIGNATION OF OFFICERS
	  	9
			
	     5.5
	  	 VACANCIES IN OFFICES
	  	9
			
	     5.6
	  	 REPRESENTATION OF SHARES OF OTHER CORPORATIONS
	  	10
			
	     5.7
	  	 AUTHORITY AND DUTIES OF OFFICERS
	  	10
		
	 ARTICLE VI — RECORDS AND REPORTS
	  	10
			
	     6.1
	  	 MAINTENANCE AND INSPECTION OF RECORDS
	  	10
			
	     6.2
	  	 INSPECTION BY DIRECTORS
	  	10
		
	 ARTICLE VII — GENERAL MATTERS
	  	10
			
	     7.1
	  	 CHECKS; DRAFTS; EVIDENCES OF INDEBTEDNESS
	  	10
			
	     7.2
	  	 EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS
	  	10
			
	     7.3
	  	 STOCK CERTIFICATES; PARTLY PAID SHARES
	  	11
			
	     7.4
	  	 SPECIAL DESIGNATION ON CERTIFICATES
	  	11
			
	     7.5
	  	 LOST CERTIFICATES
	  	11
			
	     7.6
	  	 DIVIDENDS
	  	11
			
	     7.7
	  	 FISCAL YEAR
	  	11
			
	     7.8
	  	 SEAL
	  	12
			
	     7.9
	  	 TRANSFER OF STOCK
	  	12
			
	     7.10
	  	 STOCK TRANSFER AGREEMENTS
	  	12
			
	     7.11
	  	 REGISTERED STOCKHOLDERS
	  	12
			
	     7.12
	  	 WAIVER OF NOTICE
	  	12
		
	 ARTICLE VIII — NOTICE BY ELECTRONIC TRANSMISSION
	  	12
			
	     8.1
	  	 NOTICE BY ELECTRONIC TRANSMISSION
	  	12
			
	     8.2
	  	 DEFINITION OF ELECTRONIC TRANSMISSION
	  	13
			
	     8.3
	  	 INAPPLICABILITY
	  	13
		
	 ARTICLE IX — INDEMNIFICATION OF DIRECTORS AND OFFICERS
	  	13
			
	     9.1
	  	 POWER TO INDEMNIFY IN ACTIONS, SUITS OR PROCEEDINGS OTHER THAN THOSE BY OR IN THE RIGHT OF THE CORPORATION
	  	13
			
	     9.2
	  	 POWER TO INDEMNIFY IN ACTIONS, SUITS OR PROCEEDINGS BY OR IN THE RIGHT OF THE CORPORATION
	  	14
			
	     9.3
	  	 AUTHORIZATION OF INDEMNIFICATION
	  	14
			
	     9.4
	  	 GOOD FAITH DEFINED
	  	14
			
	     9.5
	  	 INDEMNIFICATION BY A COURT
	  	14
			
	     9.6
	  	 EXPENSES PAYABLE IN ADVANCE
	  	15
			
	     9.7
	  	 NONEXCLUSIVITY OF INDEMNIFICATION AND ADVANCEMENT OF EXPENSES
	  	15
			
	     9.8
	  	 INSURANCE
	  	15
			
	     9.9
	  	 CERTAIN DEFINITIONS
	  	15
			
	     9.10
	  	 SURVIVAL OF INDEMNIFICATION AND ADVANCEMENT OF EXPENSES
	  	16
			
	     9.11
	  	 LIMITATION ON INDEMNIFICATION
	  	16
			
	     9.12
	  	 INDEMNIFICATION OF EMPLOYEES AND AGENTS
	  	16
			
	     9.13
	  	 EFFECT OF AMENDMENT OR REPEAL
	  	16
		
	 ARTICLE X — MISCELLANEOUS
	  	16
			
	     10.1
	  	 PROVISIONS OF CERTIFICATE GOVERN
	  	16
			
	     10.2
	  	 CONSTRUCTION; DEFINITIONS
	  	16
			
	     10.3
	  	 SEVERABILITY
	  	16
			
	     10.4
	  	 AMENDMENT
	  	16

 BYLAWS OF BOULDER SPECIALTY BRANDS, INC. 
  

 ARTICLE I — CORPORATE
OFFICES 
 1.1 REGISTERED OFFICE. 
 The registered office of Boulder Specialty Brands, Inc. shall be fixed in the corporation’s certificate of incorporation, as the same may be amended and/or restated from time to time (as so amended and/or restated, the
“Certificate”). 
 1.2 OTHER OFFICES. 
 The corporation’s Board of Directors (the “Board”) may at any time establish other offices at any place or places where the corporation is qualified to do business. 
 ARTICLE II — MEETINGS OF STOCKHOLDERS 
 2.1 PLACE OF MEETINGS. 
 Meetings of stockholders shall be held at any place within or outside the State of Delaware as designated
by the Board. The Board may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section 211(a)(2) of the Delaware
General Corporation Law (the “DGCL”). In the absence of any such designation or determination, stockholders’ meetings shall be held at the corporation’s principal executive office. 
 2.2 ANNUAL MEETING. 
 The annual meeting of
stockholders shall be held each year on a date and at a time designated by the Board. At the annual meeting, directors shall be elected and any other proper business may be transacted. 
 2.3 SPECIAL MEETING. 
 Unless otherwise
required by law or the Certificate, special meetings of the stockholders may be called at any time, for any purpose or purposes, only by (a) the Board, (b) the Chairperson of the Board, or (c) the chief executive officer. 

No business may be transacted at such special meeting other than the business specified in the notice to stockholders of such meeting. 
 2.4 NOTICE OF STOCKHOLDERS’ MEETINGS. 
 All notices of meetings of stockholders shall be sent or otherwise given in accordance with either Section 2.5 or Section 8.1 of these bylaws not less than ten (10) nor more than 60 days before the date of the meeting to each
stockholder entitled to vote at such meeting, except as otherwise required by applicable law. The notice shall specify the place, if any, date and hour of the meeting, the means of remote communication, if any, by which stockholders and proxy
holders may be deemed to be present in person and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. Any previously scheduled meeting of stockholders may be postponed, and, unless
the Certificate provides otherwise, any special meeting of the stockholders may be cancelled by resolution duly adopted by a majority of the Board members then in office upon public notice given prior to the date previously scheduled for such
meeting of stockholders. 
 Whenever notice is required to be given, under the DGCL, the Certificate or these bylaws, to any person with whom
communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any action or meeting
which shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action taken by the corporation is such as to
require the filing of a certificate with the Secretary of State of Delaware, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such persons with whom
communication is unlawful. 
 Whenever notice is required to be given, under any provision of the DGCL, the Certificate or these bylaws, to
any stockholder to whom (A) notice of two (2) consecutive annual meetings, or (B) all, and at least two (2), payments (if sent by first-class mail) of dividends or interest on securities during a 12 month period, have been mailed
addressed to such person at such person’s address as shown on the records of the corporation and have been returned undeliverable, the giving of such notice to such person shall not be required. Any action or meeting which shall be taken or
held without notice to such person shall have the same force and effect as if such notice had been duly given. If any such person shall deliver to the corporation a written notice setting forth such person’s then current address, the
requirement that notice be given to such person shall be reinstated. In the event that the action taken by the corporation is such as to require the filing of a certificate with the Secretary of State of Delaware, the certificate need not state that
notice was not given to persons to whom notice was not required to be given pursuant to Section 230(b) of the DGCL. 
 The exception in
subsection (A) of the above paragraph to the requirement that notice be given shall not be applicable to any notice returned as undeliverable if the notice was given by electronic transmission. 
  

 1 

 2.5 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE. 
 Notice of any meeting of stockholders shall be given: 
 (a) if mailed, when deposited in the United States mail, postage prepaid, directed to the stockholder at his or her address as it appears on the corporation’s records; 
 (b) if electronically transmitted, as provided in Section 8.1 of these bylaws; or 
 (c) otherwise, when delivered. 
 An affidavit of the secretary or an assistant secretary of the corporation or of the transfer agent or any other agent of the corporation that the notice has been given shall, in the absence of fraud, be prima facie evidence of the
facts stated therein. 
 Notice may be waived in accordance with Section 7.12 of these bylaws. 
 2.6 QUORUM. 
 Unless otherwise provided in
the Certificate or required by law, stockholders representing a majority of the voting power of the issued and outstanding capital stock of the corporation, present in person or represented by proxy, shall constitute a quorum for the transaction of
business at all meetings of the stockholders. If such quorum is not present or represented at any meeting of the stockholders, then the chairperson of the meeting, or the stockholders representing a majority of the voting power of the capital stock
at the meeting, present in person or represented by proxy, shall have power to adjourn the meeting from time to time until a quorum is present or represented. At such adjourned meeting at which a quorum is present or represented, any business may be
transacted that might have been transacted at the meeting as originally noticed. The stockholders present at a duly called meeting at which a quorum is present may continue to transact business until adjournment, notwithstanding the withdrawal of
enough stockholders to leave less than a quorum unless the number of stockholders who withdrew does not permit action to be taken by the stockholders in accordance with DGCL. 
 2.7 ADJOURNED MEETING; NOTICE. 
 When a
meeting is adjourned to another time or place, unless these bylaws otherwise require, notice need not be given of the adjourned meeting if the time, place if any thereof, and the means of remote communications if any by which stockholders and proxy
holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken. At the continuation of the adjourned meeting, the corporation may transact any business that might have
been transacted at the original meeting. If the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record
entitled to vote at the meeting in accordance with the provisions of Section 2.4 and Section 2.5 of these bylaws. 
 2.8
ADMINISTRATION OF THE MEETING. 
 Meetings of stockholders shall be presided over by the chief executive officer of the corporation. If the
chief executive officer will not be present at a meeting of stockholders, such meeting shall be presided over by such chairperson as the Board shall appoint, or, in the event that the Board shall fail to make such appointment, any officer of the
corporation elected by the Board. The secretary of the meeting shall be the secretary of the corporation, or, in the absence of the secretary of the corporation, such person as the chairperson of the meeting appoints. 
 The Board shall, in advance of any meeting of stockholders, appoint one (1) or more inspector(s), who may include individual(s) who serve the
corporation in other capacities, including without limitation as officers, employees or agents, to act at the meeting of stockholders and make a written report thereof. The Board may designate one (1) or more persons as alternate inspector(s)
to replace any inspector, who fails to act. If no inspector or alternate has been appointed or is able to act at a meeting of stockholders, the chairperson of the meeting shall appoint one (1) or more inspector(s) to act at the meeting. Each
inspector, before discharging his or her duties, shall take and sign an oath to faithfully execute the duties of inspector with strict impartiality and according to the best of his or her ability. The inspector(s) or alternate(s) shall have the
duties prescribed pursuant to Section 231 of the DGCL or other applicable law. 
  

 2 

 The Board shall be entitled to make such rules or regulations for the conduct of meetings of stockholders
as it shall deem necessary, appropriate or convenient to the extent not inconsistent with law, the corporation’s Certificate or these Bylaws, as they are in effect from time to time. Subject to such rules and regulations, if any, the
chairperson of the meeting shall have the right and authority to prescribe such rules, regulations and procedures and to do all acts as, in the judgment of such chairperson, are necessary, appropriate or convenient for the proper conduct of the
meeting, including without limitation establishing an agenda of business of the meeting, rules or regulations to maintain order, restrictions on entry to the meeting after the time fixed for commencement thereof and the fixing of the date and time
of the opening and closing of the polls for each matter upon which the stockholders will vote at a meeting (and shall announce such at the meeting). In the absence of any rule of procedure adopted by the Board, the chairperson shall make all
decisions regarding procedures to be followed in any meeting. 
 2.9 VOTING. 
 The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section 2.11 of these
bylaws, subject to Section 217 (relating to voting rights of fiduciaries, pledgors and joint owners of stock) and Section 218 (relating to voting trusts and other voting agreements) of the DGCL. 
 Except as otherwise provided in the provisions of Section 213 of the DGCL (relating to the fixing of a date for determination of stockholders of
record), each stockholder shall be entitled to that number of votes for each share of capital stock held by such stockholder as set forth in the Certificate. 
 In all matters, other than the election of directors and except as otherwise required by law, the Certificate or these bylaws, the affirmative vote of a majority of the voting power of the shares present or
represented by proxy at the meeting and entitled to vote on the subject matter shall be the act of the stockholders. Directors shall be elected by a plurality of the voting power of the shares present in person or represented by proxy at the meeting
and entitled to vote on the election of directors. 
 The stockholders of the corporation shall not have the right to cumulate their votes
for the election of directors of the corporation. 
 2.10 STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING. 
 Notwithstanding any statutory provision to the contrary, the shareholders shall have no power or authority to act by written consent in lieu of a meeting
unless expressly permitted to do so by the Certificate. 
 2.11 RECORD DATE FOR STOCKHOLDER NOTICE; VOTING; GIVING CONSENTS. 
 In order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof,
or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board
may fix, in advance, a record date, which record date shall not precede the date on which the resolution fixing the record date is adopted and which shall not be more than 60 nor less than ten (10) days before the date of such meeting, nor more
than 60 days prior to any other such action. 
 If the Board does not fix a record date in accordance with these bylaws and applicable law:

 (a) The record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at
the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. 
 (b) The record date for determining stockholders entitled to consent to corporate action in writing without a meeting, when no prior
action by the Board is necessary, shall be the first day on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the corporation. 
 (c) The record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board
adopts the resolution relating thereto. 
  

 3 

 A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders
shall apply to any adjournment of the meeting; provided, however, that the Board may fix a new record date for the adjourned meeting. 
 2.12
PROXIES. 
 Each stockholder entitled to vote at a meeting of stockholders may authorize another person or persons to act for such stockholder
by proxy authorized by an instrument in writing or by a transmission permitted by law and filed with the secretary of the corporation, but no such proxy shall be voted or acted upon after three (3) years from its date, unless the proxy provides
for a longer period. A stockholder may also authorize another person or persons to act for him, her or it as proxy in the manner(s) provided under Section 212(c) of the DGCL or as otherwise provided under Delaware law. The revocability of a
proxy that states on its face that it is irrevocable shall be governed by the provisions of Section 212 of the DGCL. 
 2.13 LIST OF
STOCKHOLDERS ENTITLED TO VOTE. 
 The officer who has charge of the stock ledger of the corporation shall prepare and make, at least ten
(10) days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of
each stockholder. The corporation shall not be required to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting
for a period of at least ten (10) days prior to the meeting: (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or
(b) during ordinary business hours, at the corporation’s principal place of business. 
 In the event that the corporation
determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available only to stockholders of the corporation. If the meeting is to be held at a place, then the list
shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means of remote communication, then the list shall also be
open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting. 
 2.14 ADVANCE NOTICE OF STOCKHOLDER BUSINESS. 
 Only such business shall be conducted as shall have been properly brought before a meeting of the stockholders of the corporation. To be properly brought before an annual meeting, business must be (a) specified in the notice of meeting
(or any supplement thereto) given by or at the direction of the Board, (b) otherwise properly brought before the meeting by or at the direction of the Board, or (c) a proper matter for stockholder action under the DGCL that has been
properly brought before the meeting by a stockholder (i) who is a stockholder of record on the date of the giving of the notice provided for in this Section 2.14 and on the record date for the determination of stockholders entitled to vote
at such annual meeting and (ii) who complies with the notice procedures set forth in this Section 2.14. For such business to be considered properly brought before the meeting by a stockholder such stockholder must, in addition to any other
applicable requirements, have given timely notice in proper form of such stockholder’s intent to bring such business before such meeting. To be timely, such stockholder’s notice must be delivered to or mailed and received by the secretary
of the corporation at the principal executive offices of the corporation not later than the close of business on the 90th day, nor earlier than the close of business on the 120th day, prior to the anniversary date of the
immediately preceding annual meeting; provided, however, that in the event that no annual meeting was held in the previous year or the annual meeting is called for a date that is not within thirty (30) days before or after such anniversary
date, notice by the stockholder to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which such notice of the date of the meeting was mailed or public disclosure of the date of the meeting was made, whichever occurs first. 
 To be in proper form, a stockholder’s notice to the secretary shall be in writing and shall set forth: 
 (a) the name and record address of the stockholder who intends to propose the business and the class or series and number of shares of
capital stock of the corporation which are owned beneficially or of record by such stockholder; 
  

 4 

 (b) a representation that the stockholder is a holder of record of stock of the
corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to introduce the business specified in the notice; 
 (c) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting; 
 (d) any material interest of the stockholder in such business; and 
 (e) any other information that is required to be provided by the stockholder pursuant to Regulation 14A under the Securities Exchange Act
of 1934, as amended (the “Exchange Act”). 
 Notwithstanding the foregoing, in order to include information with respect to a
stockholder proposal in the proxy statement and form of proxy for a stockholder’s meeting, stockholders must provide notice as required by, and otherwise comply with the requirements of, the Exchange Act and the regulations promulgated
thereunder. 
 No business shall be conducted at the annual meeting of stockholders except business brought before the annual meeting in
accordance with the procedures set forth in this Section 2.14. The chairperson of the meeting may refuse to acknowledge the proposal of any business not made in compliance with the foregoing procedure. 
 2.15 ADVANCE NOTICE OF DIRECTOR NOMINATIONS. 
 Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the corporation. To be properly brought before an annual meeting of stockholders, or any special meeting of
stockholders called for the purpose of electing directors, nominations for the election of director must be (a) specified in the notice of meeting (or any supplement thereto), (b) made by or at the direction of the Board (or any duly
authorized committee thereof) or (c) made by any stockholder of the corporation (i) who is a stockholder of record on the date of the giving of the notice provided for in this Section 2.15 and on the record date for the determination
of stockholders entitled to vote at such meeting and (ii) who complies with the notice procedures set forth in this Section 2.15. 
 In addition to any other applicable requirements, for a nomination to be made by a stockholder, such stockholder must have given timely notice thereof in proper written form to the secretary of the corporation. To be timely, a
stockholder’s notice to the secretary must be delivered to or mailed and received at the principal executive offices of the corporation, in the case of an annual meeting, in accordance with the provisions set forth in Section 2.14 of these
bylaws, and, in the case of a special meeting of stockholders called for the purpose of electing directors, not later than the close of business on the tenth (10th) day following the day on which notice of the date of the special meeting was
mailed or public disclosure of the date of the special meeting was made, whichever first occurs. 
 To be in proper written form, a
stockholder’s notice to the secretary must set forth: 
 (a) as to each person whom the stockholder proposes to nominate
for election as a director (i) the name, age, business address and residence address of the person, (ii) the principal occupation or employment of the person, (iii) the class or series and number of shares of capital stock of the
corporation which are owned beneficially or of record by the person, (iv) a description of all arrangements or understandings between the stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to
which the nominations are to be made by the stockholder, and (v) any other information relating to such person that is required to be disclosed in solicitations of proxies for elections of directors, or is otherwise required, in each case
pursuant to Regulation 14A under the Exchange Act (including without limitation such person’s written consent to being named in the proxy statement, if any, as a nominee and to serving as a director if elected); and 
 (b) as to such stockholder giving notice, the information required to be provided pursuant to Section 2.14 of these bylaws.

 No person shall be eligible for election as a director of the corporation unless nominated in accordance with the procedures set forth in
this Section 2.15. If the chairperson of the meeting properly determines that a nomination was not made in accordance with the foregoing procedures, the chairperson shall declare to the meeting that the nomination was defective and such
defective nomination shall be disregarded. 
  

 5 

 ARTICLE III — DIRECTORS 
 3.1 POWERS. 
 Subject to the provisions of
the DGCL and any limitations in the Certificate, the business and affairs of the corporation shall be managed and all corporate powers shall be exercised by or under the direction of the Board. 
 3.2 NUMBER OF DIRECTORS. 
 The authorized
number of directors shall be determined from time to time by resolution of the Board, provided the Board shall consist of at least one member. No reduction of the authorized number of directors shall have the effect of removing any director before
that director’s term of office expires. 
 3.3 ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS. 
 Except as provided in Section 3.4 and Section 3.13 of these bylaws, directors shall be elected at each annual meeting of stockholders to hold
office until the next annual meeting. Directors need not be stockholders unless so required by the Certificate or these bylaws. The Certificate or these bylaws may prescribe other qualifications for directors. Each director, including a director
elected to fill a vacancy, shall hold office until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal. 
 All elections of directors shall be by written ballot, unless otherwise provided in the Certificate. If authorized by the Board, such requirement of a
written ballot shall be satisfied by a ballot submitted by electronic transmission, provided that any such electronic transmission must be either set forth or be submitted with information from which it can be determined that the electronic
transmission was authorized. 
 3.4 RESIGNATION AND VACANCIES. 
 Any director may resign at any time upon written notice or by electronic transmission to the corporation. 
 Unless the Board otherwise determines, newly created directorships resulting from any increase in the authorized number of directors, or any vacancies on the Board resulting from the death, resignation, retirement, disqualification, removal
from office or other cause shall, unless otherwise required by law, be filled by the affirmative vote of a majority of the remaining directors then in office, even though less than a quorum of the Board, or by a sole remaining director. When one or
more directors resigns and the resignation is effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such
resignation or resignations shall become effective, and each director so chosen shall hold office as provided in this Section 3.4 in the filling of other vacancies. 
 3.5 PLACE OF MEETINGS; MEETINGS BY TELEPHONE. 
 The Board may hold meetings, both regular and special, either
within or outside the State of Delaware. 
 Unless otherwise restricted by the Certificate or these bylaws, members of the Board, or any
committee designated by the Board, may participate in a meeting of the Board, or any committee, by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and
such participation in a meeting shall constitute presence in person at the meeting. 
 3.6 REGULAR MEETINGS. 
 Regular meetings of the Board may be held without notice at such time and at such place as shall from time to time be determined by the Board. 

 

 6 

 3.7 SPECIAL MEETINGS; NOTICE. 
 Special meetings of the Board for any purpose or purposes may be called at any time by the chairperson of the Board, the chief executive officer, the
president, the secretary or a majority of the authorized number of directors. The person(s) authorized to call special meetings of the Board may fix the place and time of the meeting. 
 Notice of the time and place of special meetings shall be: 
 (a) delivered personally by hand, by courier or by telephone; 
 (b) sent by United States first-class mail,
postage prepaid; 
 (c) sent by facsimile; or 
 (d) sent by electronic mail, 
 directed to each director at that director’s address, telephone number, facsimile number
or electronic mail address, as the case may be, as shown on the corporation’s records. 
 If the notice is (i) delivered personally
by hand, by courier or by telephone, (ii) sent by facsimile or (iii) sent by electronic mail, it shall be delivered or sent at least 24 hours before the time of the holding of the meeting. If the notice is sent by United States mail, it
shall be deposited in the United States mail at least four days before the time of the holding of the meeting. Any oral notice may be communicated either to the director or to a person at the office of the director who the person giving notice has
reason to believe will promptly communicate such notice to the director. The notice need not specify the place of the meeting if the meeting is to be held at the corporation’s principal executive office nor the purpose of the meeting.

 3.8 QUORUM. 
 Except as
otherwise required by law or the Certificate, at all meetings of the Board, a majority of the authorized number of directors (as determined pursuant to Section 3.2 of these bylaws) shall constitute a quorum for the transaction of business,
except to adjourn as provided in Section 3.11 of these bylaws. The vote of a majority of the directors present at any meeting at which a quorum is present shall be the act of the Board, except as may be otherwise specifically provided by
statute, the Certificate or these bylaws. 
 3.9 WAIVER OF NOTICE. 
 Whenever notice is required to be given under any provisions of the DGCL, the Certificate or these bylaws, a written waiver thereof, signed by the person
entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of
notice of such meeting, except when the person attends a meeting solely for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the
business to be transacted at, nor the purpose of, any regular or special meeting of the directors, or members of a committee of directors, need be specified in any written waiver of notice or any waiver by electronic transmission unless so required
by the Certificate or these bylaws. 
 3.10 BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING. 
 Unless otherwise restricted by the Certificate or these bylaws, any action required or permitted to be taken at any meeting of the Board, or of any
committee thereof, may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing or by electronic transmission and the writing or writings or electronic transmission or transmissions are
filed with the minutes of proceedings of the Board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form. 
 3.11 ADJOURNED MEETING; NOTICE. 
 If a quorum
is not present at any meeting of the Board, then a majority of the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present. 
  

 7 

 3.12 FEES AND COMPENSATION OF DIRECTORS. 
 Unless otherwise restricted by the Certificate or these bylaws, the Board shall have the authority to fix the compensation of directors. 
 3.13 REMOVAL OF DIRECTORS. 
 Any director or
the entire Board may be removed from office at any time, with or without cause, by the affirmative vote of the holders of at least a majority of the voting power of the issued and outstanding shares of capital stock of the corporation then entitled
to vote in the election of directors. 
 3.14 INTERESTED DIRECTORS. 
 No contract or transaction between the corporation and one or more of its directors or officers, or between the corporation and any other corporation,
partnership, association or other organization in which one or more of its directors or officers are directors or officers, or have a financial interest, shall be void or voidable solely for this reason, or solely because the director or officer is
present at or participates in the meeting of the Board or committee thereof which authorizes the contract or transaction, or solely because his, her or their votes are counted for such purpose, if (i) the material facts as to his, her or their
relationship or interest and as to the contract or transaction are disclosed or are known to the Board or the committee, and the Board or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of the
disinterested directors, even though the disinterested directors be less than a quorum, or (ii) the material facts as to his, her or their relationship or interest and as to the contract or transaction are disclosed or are known to the
stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders, or (iii) the contract or transaction is fair as to the corporation as of the time it is authorized,
approved or ratified by the Board, a committee thereof or the stockholders. Common or interested directors may be counted in determining the presence of a quorum at a meeting of the Board or of a committee which authorizes the contract or
transaction. 
 ARTICLE IV — COMMITTEES 
 4.1 COMMITTEES OF DIRECTORS. 
 The Board may designate one or more committees, each committee to consist of
one or more of the directors of the corporation. The Board may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or
disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act
at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the Board or in these bylaws, shall have and may exercise such lawfully delegable powers and duties as the Board
may confer. 
 4.2 COMMITTEE MINUTES. 
 Each committee shall keep regular minutes of its meetings and report to the Board when required. 
 4.3 MEETINGS AND ACTION OF
COMMITTEES. 
 Meetings and actions of committees shall be governed by, and held and taken in accordance with, the provisions of: 

(a) Section 3.5 (relating to place of meetings and meetings by telephone); 
 (b) Section 3.6 (relating to regular meetings); 
 (c) Section 3.7 (relating to special meetings and notice); 
 (d) Section 3.8 (relating to quorum); 
 (e) Section 3.9 (relating to waiver of notice); 
  

 8 

 (f) Section 3.10 (relating to action without a meeting); and 
 (g) Section 3.11 (relating to adjournment and notice of adjournment) 
 of these bylaws, with such changes in the context of those bylaws as are necessary to substitute the committee and its members for the Board and its members. 
 Notwithstanding the foregoing: 
 (i) the time of regular meetings of committees may be determined either by resolution of the Board or by resolution of the committee; 
 (ii) special meetings of committees may also be called by resolution of the Board; and 
 (iii) notice of special meetings of committees shall also be given to all alternate members, who shall have the right to attend all meetings of the committee. The Board may adopt rules for the governance of any committee not inconsistent
with the provisions of these bylaws. 
 ARTICLE V — OFFICERS 
 5.1 OFFICERS. 
 The officers of the
corporation shall be a president and a secretary. The corporation may also have, at the discretion of the Board, a chairperson of the Board, a vice chairperson of the Board, a chief executive officer, a chief financial officer or treasurer, one or
more vice presidents, one or more assistant vice presidents, one or more assistant treasurers, one or more assistant secretaries, and any such other officers as may be appointed in accordance with the provisions of these bylaws. Any number of
offices may be held by the same person. 
 5.2 APPOINTMENT OF OFFICERS. 
 The Board shall appoint the officers of the corporation, except such officers as may be appointed in accordance with the provisions of Section 5.3 of
these bylaws, subject to the rights, if any, of an officer under any contract of employment. Each officer shall hold office until his or her successor is elected and qualified or until his or her earlier resignation or removal. A failure to elect
officers shall not dissolve or otherwise affect the corporation. 
 5.3 SUBORDINATE OFFICERS. 
 The Board may appoint, or empower the chief executive officer or, in the absence of a chief executive officer, the president, to appoint, such other
officers and agents as the business of the corporation may require. Each of such officers and agents shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws or as the Board may from time to
time determine. 
 5.4 REMOVAL AND RESIGNATION OF OFFICERS. 
 Any officer may be removed, either with or without cause, by an affirmative vote of the majority of the Board at any regular or special meeting of the Board or, except in the case of an officer appointed by the Board,
by any officer upon whom such power of removal may be conferred by the Board. 
 Any officer may resign at any time by giving written notice
to the corporation. Any resignation shall take effect at the date of the receipt of that notice or at any later time specified in that notice. Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall not be
necessary to make it effective. Any resignation is without prejudice to the rights, if any, of the corporation under any contract to which the officer is a party. 
 5.5 VACANCIES IN OFFICES. 
 Any vacancy occurring in any office of the corporation may only be filled by the
Board or as provided in Section 5.3 of these bylaws. 
  

 9 

 5.6 REPRESENTATION OF SHARES OF OTHER CORPORATIONS. 
 The chairperson of the Board, the chief executive officer, the president, any vice president, the treasurer, the secretary or assistant secretary of this
corporation, or any other person authorized by the Board, the chief executive officer, the president or a vice president, is authorized to vote, represent, and exercise on behalf of this corporation all rights incident to any and all shares or other
equity interests of any other corporation or entity standing in the name of this corporation. The authority granted herein may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly
executed by such person having the authority. 
 5.7 AUTHORITY AND DUTIES OF OFFICERS. 
 In addition to the foregoing authority and duties, all officers of the corporation shall respectively have such authority and perform such duties in the
management of the business of the corporation as may be designated from time to time by the Board. 
 ARTICLE VI — RECORDS AND REPORTS

 6.1 MAINTENANCE AND INSPECTION OF RECORDS. 
 The corporation shall, either at its principal executive office or at such place or places as designated by the Board, keep a record of its stockholders listing their names and addresses and the number and class of
shares held by each stockholder, a copy of these bylaws, as may be amended to date, minute books, accounting books and other records. 
 Any
such records maintained by the corporation may be kept on, or by means of, or be in the form of, any information storage device or method, provided that the records so kept can be converted into clearly legible paper form within a reasonable time.
The corporation shall so convert any records so kept upon the request of any person entitled to inspect such records pursuant to the provisions of the DGCL. When records are kept in such manner, a clearly legible paper form produced from or by means
of the information storage device or method shall be admissible in evidence, and accepted for all other purposes, to the same extent as an original paper form accurately portrays the record. 
 Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under oath stating the purpose thereof, have the right
during the usual hours for business to inspect for any proper purpose the corporation’s stock ledger, a list of its stockholders, and its other books and records and to make copies or extracts therefrom. A proper purpose shall mean a purpose
reasonably related to such person’s interest as a stockholder. In every instance where an attorney or other agent is the person who seeks the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other
writing that authorizes the attorney or other agent to so act on behalf of the stockholder. The demand under oath shall be directed to the corporation at its registered office in Delaware or at its principal executive office. 
 6.2 INSPECTION BY DIRECTORS. 
 Any director
shall have the right to examine the corporation’s stock ledger, a list of its stockholders, and its other books and records for a purpose reasonably related to his or her position as a director. 
 ARTICLE VII — GENERAL MATTERS 
 7.1 CHECKS; DRAFTS; EVIDENCES OF INDEBTEDNESS. 
 From time to time, the Board shall determine by resolution which person or persons
may sign or endorse all checks, drafts, other orders for payment of money, notes or other evidences of indebtedness that are issued in the name of or payable to the corporation, and only the persons so authorized shall sign or endorse those
instruments. 
 7.2 EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS. 
 Except as otherwise provided in these bylaws, the Board, or any officers of the corporation authorized thereby, may authorize any officer or officers, or
agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the corporation; such authority may be general or confined to specific instances. 
  

 10 

 7.3 STOCK CERTIFICATES; PARTLY PAID SHARES. 
 The shares of the corporation shall be represented by certificates, provided that the Board may provide by resolution or resolutions that some or all of
any or all classes or series of its stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the corporation. Notwithstanding the adoption of such a
resolution by the Board, every holder of stock represented by certificates and upon request every holder of uncertificated shares shall be entitled to have a certificate signed by, or in the name of the corporation by the chairperson or
vice-chairperson of the Board, or the president or vice-president, and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary of the corporation representing the number of shares registered in certificate form. Any or
all of the signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar
before such certificate is issued, it may be issued by the corporation with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue. 
 The corporation may issue the whole or any part of its shares as partly paid and subject to call for the remainder of the consideration to be paid
therefor. Upon the face or back of each stock certificate issued to represent any such partly paid shares, and upon the books and records of the corporation in the case of uncertificated partly paid shares, the total amount of the consideration to
be paid therefor and the amount paid thereon shall be stated. Upon the declaration of any dividend on fully paid shares, the corporation shall declare a dividend upon partly paid shares of the same class, but only upon the basis of the percentage of
the consideration actually paid thereon. 
 7.4 SPECIAL DESIGNATION ON CERTIFICATES. 
 If the corporation is authorized to issue more than one class of stock or more than one series of any class, then the powers, designations, preferences,
and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights shall be set forth in full or summarized on the face or back
of the certificate that the corporation shall issue to represent such class or series of stock; provided, however, that, except as otherwise provided in Section 202 of the DGCL, in lieu of the foregoing requirements there may be set
forth on the face or back of the certificate that the corporation shall issue to represent such class or series of stock a statement that the corporation will furnish without charge to each stockholder who so requests the powers, designations,
preferences, and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights. 
 7.5 LOST CERTIFICATES. 
 Except as provided
in this Section 7.5, no new certificates for shares shall be issued to replace a previously issued certificate unless the latter is surrendered to the corporation and cancelled at the same time. The corporation may issue a new certificate of
stock or uncertificated shares in the place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the corporation may require the owner of the lost, stolen or destroyed certificate, or such owner’s
legal representative, to give the corporation a bond sufficient to indemnify it against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or
uncertificated shares. 
 7.6 DIVIDENDS. 
 The Board, subject to any restrictions contained in either (a) the DGCL or (b) the Certificate, may declare and pay dividends upon the shares of its capital stock. Dividends may be paid in cash, in property, or in shares of the
corporation’s capital stock. 
 The Board may set apart out of any of the funds of the corporation available for dividends a reserve or
reserves for any proper purpose and may abolish any such reserve. 
 7.7 FISCAL YEAR. 
 The fiscal year of the corporation shall be fixed by resolution of the Board and may be changed by the Board. 
  

 11 

 7.8 SEAL. 
 The corporation may adopt a corporate seal, which shall be adopted and which may be altered by the Board. The corporation may use the corporate seal by causing it or a facsimile thereof to be impressed or affixed or
in any other manner reproduced. 
 7.9 TRANSFER OF STOCK. 
 Transfers of stock shall be made only upon the transfer books of the corporation kept at an office of the corporation or by transfer agents designated to transfer shares of the stock of the corporation. Except where a
certificate is issued in accordance with Section 7.5 of these bylaws, an outstanding certificate for the number of shares involved shall be surrendered for cancellation before a new certificate is issued therefore. Upon surrender to the
corporation or the transfer agent of the corporation of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignation or authority to transfer, it shall be the duty of the corporation to issue a new certificate
to the person entitled thereto, cancel the old certificate, and record the transaction in its books. 
 7.10 STOCK TRANSFER AGREEMENTS.

 The corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes or
series of stock of the corporation to restrict the transfer of shares of stock of the corporation of any one or more classes or series owned by such stockholders in any manner not prohibited by the DGCL. 
 7.11 REGISTERED STOCKHOLDERS. 
 The
corporation: 
 (a) shall be entitled to recognize the exclusive right of a person registered on its books as the owner of
shares to receive dividends and to vote as such owner; 
 (b) shall be entitled to hold liable for calls and assessments on
partly paid shares the person registered on its books as the owner of shares; and 
 (c) shall not be bound to recognize any
equitable or other claim to or interest in such share or shares on the part of another person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware. 
 7.12 WAIVER OF NOTICE. 
 Whenever notice is
required to be given under any provision of the DGCL, the Certificate or these bylaws, a written waiver, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the
time of the event for which notice is to be given, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting solely for the express purpose
of objecting at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders
need be specified in any written waiver of notice or any waiver by electronic transmission unless so required by the Certificate or these bylaws. 
 ARTICLE VIII — NOTICE BY ELECTRONIC TRANSMISSION 
 8.1 NOTICE BY ELECTRONIC TRANSMISSION. 
 Without limiting the manner by which notice otherwise may be given effectively to stockholders pursuant to the DGCL, the Certificate or these bylaws, any
notice to stockholders given by the corporation under any provision of the DGCL, the Certificate or these bylaws shall be effective if given by a form of electronic transmission consented to by the stockholder to whom the notice is given. Any such
consent shall be revocable by the stockholder by written notice to the corporation. Any such consent shall be deemed revoked if: 
 (a) the corporation is unable to deliver by electronic transmission two consecutive notices given by the corporation in accordance with such consent; and 
  

 12 

 (b) such inability becomes known to the secretary or an assistant secretary of the
corporation or to the transfer agent, or other person responsible for the giving of notice. 
 However, the inadvertent failure to treat such inability as a
revocation shall not invalidate any meeting or other action. 
 Any notice given pursuant to the preceding paragraph shall be deemed given:

 (i) if by facsimile telecommunication, when directed to a number at which the stockholder has consented to receive notice;

 (ii) if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive
notice; 
 (iii) if by a posting on an electronic network together with separate notice to the stockholder of such specific
posting, upon the later of (A) such posting and (B) the giving of such separate notice; and 
 (iv) if by any other
form of electronic transmission, when directed to the stockholder. 
 An affidavit of the secretary or an assistant secretary or of the
transfer agent or other agent of the corporation that the notice has been given by a form of electronic transmission shall, in the absence of fraud, be prima facie evidence of the facts stated therein. 
 8.2 DEFINITION OF ELECTRONIC TRANSMISSION. 
 An “electronic transmission” means any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved, and reviewed by a recipient thereof, and that may be
directly reproduced in paper form by such a recipient through an automated process. 
 8.3 INAPPLICABILITY. 
 Notice by a form of electronic transmission shall not apply to Section 164 (relating to failure to pay for stock; remedies), Section 296
(relating to adjudication of claims; appeal), Section 311 (relating to revocation of voluntary dissolution), Section 312 (relating to renewal, revival, extension and restoration of certificate of incorporation) or Section 324
(relating to attachment of shares of stock or any option, right or interest therein) of the DGCL. 
 ARTICLE IX — INDEMNIFICATION OF
DIRECTORS AND OFFICERS 
 9.1 POWER TO INDEMNIFY IN ACTIONS, SUITS OR PROCEEDINGS OTHER THAN THOSE BY OR IN THE RIGHT OF THE CORPORATION.

 Subject to Section 9.3 of these bylaws, the corporation shall indemnify, to the fullest extent permitted by the DGCL, as now or
hereafter in effect, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the
right of the corporation) by reason of the fact that such person (or the legal representative of such person) is or was a director or officer of the corporation or any predecessor of the corporation, or is or was a director or officer of the
corporation serving at the request of the corporation as a director or officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses (including attorneys’
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or
not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person’s conduct was unlawful. The termination of any action, suit or proceeding by judgment,
order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not
opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that such person’s conduct was unlawful. 
  

 13 

 9.2 POWER TO INDEMNIFY IN ACTIONS, SUITS OR PROCEEDINGS BY OR IN THE RIGHT OF THE CORPORATION.

 Subject to Section 9.3 of these bylaws, the corporation shall indemnify, to the fullest extent permitted by the DGCL, as now or
hereafter in effect, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that such
person (or the legal representative of such person) is or was a director or officer of the corporation or any predecessor of the corporation, or is or was a director or officer of the corporation serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection
with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation; except that no indemnification shall be made
in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine
upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem
proper. 
 9.3 AUTHORIZATION OF INDEMNIFICATION. 
 Any indemnification under this Article IX (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the director or officer is proper in the
circumstances because such person has met the applicable standard of conduct set forth in Section 9.1 or Section 9.2 of these bylaws, as the case may be. Such determination shall be made, with respect to a person who is either a director
or officer at the time of such determination or a former director or officer, (i) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, or (ii) by a committee of such
directors designated by a majority vote of such directors, even though less than a quorum, or (iii) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (iv) by the
stockholders (but only if a majority of the directors who are not parties to such action, suit or proceeding, if they constitute a quorum of the board of directors, presents the issue of entitlement to indemnification to the stockholders for their
determination). To the extent, however, that a present or former director or officer of the corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding described above, or in defense of any claim, issue or
matter therein, such person shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith, without the necessity of authorization in the specific case. 
 9.4 GOOD FAITH DEFINED. 
 For purposes of any
determination under Section 9.3 of these bylaws, to the fullest extent permitted by applicable law, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best
interests of the corporation, or, with respect to any criminal action or proceeding, to have had no reasonable cause to believe such person’s conduct was unlawful, if such person’s action is based on the records or books of account of the
corporation or another enterprise, or on information supplied to such person by the officers of the corporation or another enterprise in the course of their duties, or on the advice of legal counsel for the corporation or another enterprise or on
information or records given or reports made to the corporation or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the corporation or another enterprise. The term
“another enterprise” as used in this Section 9.4 shall mean any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise of which such person is or was serving at the request of the
corporation as a director, officer, employee or agent. The provisions of this Section 9.4 shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of
conduct set forth in Section 9.1 or 9.2 of these bylaws, as the case may be. 
 9.5 INDEMNIFICATION BY A COURT. 
 Notwithstanding any contrary determination in the specific case under Section 9.3 of this Article IX, and notwithstanding the absence of any
determination thereunder, any director or officer may apply to the Court of Chancery in the State of Delaware for indemnification to the extent otherwise permissible under Section 9.1 and Section 9.2 of these bylaws. The basis of such
indemnification by a court shall be a determination by such court that 
  

 14 

 indemnification of the director or officer is proper in the circumstances because such person has met the applicable
standards of conduct set forth in Section 9.1 or Section 9.2 of these bylaws, as the case may be. Neither a contrary determination in the specific case under Section 9.3 of these bylaws nor the absence of any determination thereunder
shall be a defense to such application or create a presumption that the director or officer seeking indemnification has not met any applicable standard of conduct. Notice of any application for indemnification pursuant to this Section 9.5 shall
be given to the corporation promptly upon the filing of such application. If successful, in whole or in part, the director or officer seeking indemnification shall also be entitled to be paid the expense of prosecuting such application. 

9.6 EXPENSES PAYABLE IN ADVANCE. 
 To the
fullest extent not prohibited by the DGCL, or by any other applicable law, expenses incurred by a person who is or was a director or officer in defending any civil, criminal, administrative or investigative action, suit or proceeding shall be paid
by the corporation in advance of the final disposition of such action, suit or proceeding; provided, however, that if the DGCL requires, an advance of expenses incurred by any person in his or her capacity as a director or officer (and not in any
other capacity) shall be made only upon receipt of an undertaking by or on behalf of such person to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the corporation as authorized in this
Article IX. 
 9.7 NONEXCLUSIVITY OF INDEMNIFICATION AND ADVANCEMENT OF EXPENSES. 
 The indemnification and advancement of expenses provided by or granted pursuant to this Article IX shall not be deemed exclusive of any other rights to
which those seeking indemnification or advancement of expenses may be entitled under the Certificate, any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person’s official capacity and
as to action in another capacity while holding such office, it being the policy of the corporation that indemnification of the persons specified in Section 9.1 and Section 9.2 of these bylaws shall be made to the fullest extent permitted
by law. The provisions of this Article IX shall not be deemed to preclude the indemnification of any person who is not specified in Section 9.1 or Section 9.2 of these bylaws but whom the corporation has the power or obligation to
indemnify under the provisions of the DGCL, or otherwise. The corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees or agents respecting indemnification and advances, to the
fullest extent not prohibited by the DGCL, or by any other applicable law. 
 9.8 INSURANCE. 
 To the fullest extent permitted by the DGCL or any other applicable law, the corporation may purchase and maintain insurance on behalf of any person who
is or was a director, officer, employee or agent of the corporation, or is or was a director, officer, employee or agent of the corporation serving at the request of the corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the
corporation would have the power or the obligation to indemnify such person against such liability under the provisions of this Article IX. 
 9.9 CERTAIN DEFINITIONS. 
 For purposes of this Article IX, references to “the corporation” shall include, in addition to
the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors
or officers, so that any person who is or was a director or officer of such constituent corporation, or is or was a director or officer of such constituent corporation serving at the request of such constituent corporation as a director, officer,
employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, shall stand in the same position under the provisions of this Article IX with respect to the resulting or surviving corporation
as such person would have with respect to such constituent corporation if its separate 
  

 15 

 existence had continued. For purposes of this Article IX, references to “fines” shall include any excise taxes
assessed on a person with respect to an employee benefit plan; and references to “serving at the request of the corporation” shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or
involves services by, such director or officer with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the
participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the corporation” as referred to in this Article IX. 
 9.10 SURVIVAL OF INDEMNIFICATION AND ADVANCEMENT OF EXPENSES. 
 The rights to indemnification and advancement of expenses conferred by this Article IX shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors,
administrators and other personal and legal representatives of such a person. 
 9.11 LIMITATION ON INDEMNIFICATION. 
 Notwithstanding anything contained in this Article IX to the contrary, except for proceedings to enforce rights to indemnification (which shall be
governed by Section 9.5 of these bylaws), the corporation shall not be obligated to indemnify any director or officer in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was
authorized or consented to by the board of directors of the corporation. 
 9.12 INDEMNIFICATION OF EMPLOYEES AND AGENTS. 
 The corporation may, to the extent authorized from time to time by the board of directors, provide rights to indemnification and to the advancement of
expenses to employees and agents of the corporation similar to those conferred in this Article IX to directors and officers of the corporation. 
 9.13 EFFECT OF AMENDMENT OR REPEAL. 
 Neither any amendment or repeal of any Section of this Article IX, nor the adoption of any
provision of the Certificate or the bylaws inconsistent with this Article IX, shall adversely affect any right or protection of any director, officer, employee or other agent established pursuant to this Article IX existing at the time of such
amendment, repeal or adoption of an inconsistent provision, including without limitation by eliminating or reducing the effect of this Article IX, for or in respect of any act, omission or other matter occurring, or any action or proceeding accruing
or arising (or that, but for this Article IX, would accrue or arise), prior to such amendment, repeal or adoption of an inconsistent provision. 
 ARTICLE X — MISCELLANEOUS 
 10.1 PROVISIONS OF CERTIFICATE GOVERN. 
 In the event of any inconsistency between the terms of these bylaws and the Certificate, the terms of the Certificate will govern. 
 10.2 CONSTRUCTION; DEFINITIONS. 
 Unless the
context requires otherwise, the general provisions, rules of construction, and definitions in the DGCL shall govern the construction of these bylaws. Without limiting the generality of this provision, the singular number includes the plural, the
plural number includes the singular, and the term “person” includes both a corporation and a natural person. 
 10.3 SEVERABILITY.

 In the event that any bylaw or the application thereof becomes or is declared by a court of competent jurisdiction to be illegal, void or
unenforceable, the remaining bylaws will continue in full force and effect. 
 10.4 AMENDMENT. 
 Neither these Bylaws nor any provision herein may be amended, altered, or repealed by the shareholders of the corporation, nor shall any provision of
these Bylaws of the corporation inconsistent with any such provision be 
  

 16 

 adopted by the stockholders of the Corporation, unless approved by the affirmative vote of at least seventy-five percent
(75%) of the issued and outstanding shares of Common Stock. These Bylaws may be amended, altered, or repealed by the affirmative vote of at least seventy-five percent (75%) of the whole Board of Directors at any regular or special meeting
of the Board. 
 BOULDER SPECIALTY BRANDS, INC. 
 a Delaware corporation 
 CERTIFICATE OF ADOPTION OF BYLAWS 
 The undersigned hereby certifies that he or she is the duly elected, qualified, and acting Secretary of Boulder Specialty Brands, Inc., a Delaware
corporation, and that the foregoing bylaws were adopted as the corporation’s bylaws by the corporation’s board of directors effective June 10, 2005. 
 IN WITNESS WHEREOF, the undersigned has hereunto set his or her hand this 22nd day of June, 2005. 
  

			
	By:	 	 /s/ JAMES E. LEWIS

	Print Name:	 	James E. Lewis
	Title:	 	Vice Chairman and Secretary

 Schedule 2.1(b) 
 Subsidiaries 
 BSB Acquisition Co., Inc. 
 The Company, pursuant to the terms of the Financing Letter, is required to pledge the stock of its subsidiaries in support of its obligations in connection with the
transactions contemplated by the Financing Letter. 

 Schedule 2.1(c) 
 Approvals 
 The transactions contemplated by the SB Merger Agreement and the transactions
contemplated by this Agreement and the Documents (including, without limitation, the adoption of the Restated Certificate) require the approval of the Company’s stockholders pursuant to: 
 1. The Delaware General Corporation Law. 
 2. The Company’s Certificate
of Incorporation and bylaws. 
 3. Underwriting Agreement between the Company and Citigroup Global Markets, Inc., as amended. 

 Schedule 2.1(e) 
 Consents and Approvals 
 All approvals necessary for the
consummation of the transactions contemplated by the SB Merger Agreement. 
 All approvals necessary for the consummation of
the transactions contemplated by the Financing Letter. 
 Approval by the Commission of the Company’s proxy statement
with respect to the stockholders’ meeting. 
 Any filings required under Regulation D under the Securities Act of 1933.

 Any “blue sky” filings in connection with the transactions contemplated hereby. 
 Any filing required of any Investor, including, without limitation, any Hart-Scott-Rodino filing. 
 Any filings and approvals necessary in connection with the listing of the Common Stock pursuant to Section 4.13 hereof. 

Any filings and approvals necessary in connection with the registration of the Registrable Shares, as defined in and required by the Registration Rights Agreement.

 Consent of the parties to the Founders Registration Rights Agreement to the amendments set forth on Exhibit E.

 Schedule 2.1(f) 
 Capitalization 
 1,000,000 warrants issued under the
Founder’s Warrant Agreement. 
 12,760,840 warrants issued under the Public Warrant Agreement. 
 Any stock option or stock grant plan adopted by the Company with the approval of the Company’s Board of Directors and shareholders, as permitted pursuant to the
Agreement. 
 The existing shareholders of the Company have the right to convert their shares of stock of the Company pursuant to Article XII of the
Company’s Certificate of Incorporation. 

 Schedule 2.1(g) 
 Defaults 
 None 

 Schedule 2.1 (h) 
 SEC Reports 
 As a result of its interpretation of EITF 00-19, the Company determined
that it was required to restate its financial statements to record liabilities arising in connection with the issuance of the Redeemable Common Stock Purchase Warrants of the Company which were sold with each share of the Company’s common stock
in its initial public offering. As a result, the Company filed a restated Form 10-Q for the period ending March 31, 2006, a restated Form 10-K for the period ending December 31, 2005, and a restated Form 8-K for the period ended
December 21, 2005. 

 Schedule 2.1(i) 
 Liabilities 
 Any and all indebtedness to be incurred, and fees and expenses payable, in
connection with the consummation of the transactions contemplated by the Financing Letter. 
 All obligations of the Company pursuant to the SB Merger
Agreement. 
 Any fees of third parties required to be paid by the Company pursuant to the terms of this Agreement or any of the Documents. 
 The Company has agreed to pay professional fees and expenses of Goodwin & Procter LLP of up to $50,000.00 incurred by Citigroup Global Markets, Inc. in
connection with a private offering of the Company’s securities. 
 The Company has incurred fees payable to a number of professional service firms,
including, without limitation, the following parties: 
 Alvarez & Marsal 
 Banc of America Securities, LLC 
 Citigroup Global Markets, Inc. 
 Core Communications Partners LLC 
 Davis & Kuelthau, S.C. 
 Duff & Phelps, LLC 
 Ehrhardt Keefe Steiner & Hottman, P.C. 
 Ellenoff Grossman & Schole LLP 
 Frederic Cook and Co. 
 Foley & Lardner 
 RR Donnelly 
 Amounts owed to Katherine Miano for administrative services 
 Pursuant to Statement of Financial Accounting Standards Number 5, the Company may be
required to record a liability with respect to certain contingent liabilities arising under the existing Registration Rights Agreement. As of the date hereof, the Company has determined that no such liability need be recorded, however, the Company
is required to periodically revisit the issue and the Company may, in the future, determine that a liability must be recorded. 

 Pursuant to EITF 00-19, the Company may have to record liabilities with respect to the warrants being issued in
connection with the redemption of the Series A Preferred Stock and the conversion rights of the Series A Preferred Shares. 
 The Series A Preferred Shares
outstanding may be required to be treated as mezzanine financing for financial reporting purposes (however, the Series A Preferred Shares will be treated as equity for tax purposes). 
 Obligation to pay Roth Capital Partners, LLC’s attorneys fees incurred in connection with any dispute regarding fees payable as set forth in more detail in note 5 to the Company’s financial statements
attached to the Company’s Form 10-K for the period ending December 31, 2005. 
 Insurance premiums and related interest expense associated with the
financing of insurance premiums for the Company’s insurance policies. 
 Obligation to reimburse officers and directors for out-of -pocket expenses
incurred for the benefit of the Company. 
 Accrued federal income taxes, State of Colorado income taxes and Delaware franchise taxes. 
 Obligation to pay those shareholders of the Company electing to convert some or all of the shares of stock of the Company in connection with a stockholder vote on a
business combination, including pro rata share of interest earned in trust. 
 Obligations of the Company under the
contracts listed on Schedule 2.1(o). 
 Any contingent liabilities disclosed in the footnotes to the latest audited balance sheet included in the SEC
Reports. 

 Schedule 2.1(j) 
 Changes 
 See disclosures contained on Schedules 2.1(g), 2.1(h) and 2.1(i). 

The Company will incur debt in connection with the consummation of the transactions contemplated by the Financing Letter. 
 The assets of the Company and its subsidiaries will be subject to Encumbrances pursuant to the documents executed in connection with the consummation of the transactions
contemplated by the Financing Letter. 
 The Company will issue shares of common stock, preferred stock and warrants pursuant to the terms of the Securities
Purchase Agreement to which this schedule is attached. 
 The Company has requested confidential treatment with respect to a
number of matters from the Commission. 

 Schedule 2.1(k) 
 Liens 
 The assets of the Company and its subsidiaries will be subject to Encumbrances
pursuant to the documents executed in connection with the consummation of the transactions contemplated by the Financing Letter. 

 Schedule 2.1(l)(ii) 
 Company Intellectual Property 
 Boulderspecialtybrands.com 
 The content of the Company’s website 

 Schedule 2.1(l)(vii) 
 Intellectual Property - Work for Hire 
 No employee of
the Company has executed an agreement described in Section 2.1(l)(vii). 

 Schedule 2.1(m) 
 Employees 
 Consultants may have claims for amount earned but not yet paid. 

Chris Wolf may have a claim pursuant to the terms of his Consulting Agreement in the event the Company does not hire him as an employee of the Company. 

 Schedule 2.1(n) 
 ERISA 
 Any stock option or stock grant plan adopted as
set forth on Schedule 2.1(f). 

 Schedule 2.1(o) 
 Contracts 
 The Financing Letter. 
 Letter of Intent with SB, as extended. 
 Nondisclosure Agreement with SB.

 Nondisclosure Agreements with various parties having access to confidential information related to the SB Transaction. 
 The SB Merger Agreement. 
 Agreements with professional service providers,
including the following providers: 
 Banc of America Securities, LLC 
 Citigroup Global Markets, Inc. 
 Davis & Kuelthau, S.C. 
 Duff & Phelps, LLC 
 Ehrhardt Keefe Steiner & Hottman, P.C. 
 Ellenoff Grossman & Schole LLP 
 Frederic Cook and Co. 
 Foley & Lardner 
 RR Donnelley 
 Willis of Arizona 
 Engagement Letters with Duff & Phelps, LLC regarding issuance of fairness opinion and purchase price allocation

 Founders Warrant Agreement and warrants issued thereunder, as amended. 
 Public Warrant Agreement and warrants issued thereunder. 
 Registration Rights Agreement among the Company and the initial
stockholders 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Stephen B. Hughes 

 Letter Agreement among the Company, Roth Capital Partners, LLC and James E. Lewis 
 Letter Agreement among the Company, Roth Capital Partners, LLC and William E. Hooper 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Robert F. McCarthy 
 Letter Agreement among the Company,
Roth Capital Partners, LLC and Michael R. O’Brien 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Gerald J. Laber 
 Letter Agreement among the Company, Roth Capital Partners, LLC and John T. Stofko 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Caroline Elise Hughes Irrevocable Trust 
 Letter Agreement among the Company,
Roth Capital Partners, LLC and John Trevelyn Hughes Irrevocable Trust 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Henry Thomas
Hughes Irrevocable Trust 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Stephen Feldhaus 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Janis M. Lewis 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Jeffrey R. Nieder 
 Letter Agreement among the Company, Roth Capital Partners,
LLC and Peter Mazula 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Lee Anne Lewis 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Robert J. Gillespie 
 Letter Agreement among the Company, Roth Capital Partners, LLC and Robyn L Duda 
 Letter Agreement among the Company, Roth
Capital Partners, LLC and Earl E. Hoellen 
 Letter Agreement among the Company, Citigroup Global Markets Inc. and Robert S. Gluck 
 Indemnity Agreements with each of the Company’s officers and directors 
 Stock Escrow Agreement among the Company, the initial stockholders and Continental Stock Transfer & Trust Company 
 Investment Management
Trust Agreement by and between the Company and Continental Stock Transfer & Trust Company 
 Noncompete Agreements with all officers and directors
of the Company 

 Letter Agreement among the Company, Hughes Consulting, Inc. and Jeltex Holdings, LLC. 
 The Company has agreed to repay monetary advances made by Steven Hughes, James Lewis, Robert Gluck, Robert Gillespie, William Hooper, Gerald Laber, John Stofko and
Robert McCarthy to or on behalf of the Company for travel, office and other business expenses (as of June 30, 2006, the Company owed Hughes Consulting, Inc. and Jeltex Holdings, LLC $65,161 pursuant to the Letter Agreement described above and
$70,932 to certain stockholders for travel and related expenses and advances during the period commencing July 1, 2006, through the date of the Agreement do not exceed $100,000). 
 Contractor Agreement by and between the Company and Christopher Wolf. 
 Underwriting Agreement between the Company and
Citigroup Global Markets, Inc., as amended 
 Steven Hughes and James Lewis may be obligated in certain circumstances to ensure that the proceeds in the
trust account are not reduced by the claims of various vendors that are owed money by the Company or other parties with which the Company has contracted. 
 Insurance Policy YDCZ91440023015 (Property) - Employers Insurance Company of Wausau 
 Insurance Policy YDCZ91440023015 (General Liability) -
Employers Insurance Company of Wausau 
 Insurance Policy YDCZ91440023015 (Automobile) - Employers Insurance Company of Wausau 
 Insurance Policy EBU9039180 (Umbrella) - National Fire Insurance Company of Pittsburgh (AIG) 
 Insurance Policy ELU09085605 (Directors & Officers) - XL Specialty Insurance Company 
 Insurance Policy ELU09085705
(Directors & Officers - Side A) - XL Specialty Insurance Company 
 Insurance Policy NHS620437 (Excess Directors & Officers) - RSUI
Indemnity Company 
 Obligation to pay Roth Capital Partners, LLC’s attorneys fees incurred in connection with any dispute regarding fees payable as set
forth in more detail in note 5 to the Company’s financial statements attached to the Company’s Form 10-K for the period ending December 31, 2005. 
 This Agreement, the Documents and the Financing Letter all include restrictions and limitations on the Company’s operation of its business. 
 The Nondisclosure Agreement with SB restricts the use and disclosure of information obtained by the Company regarding SB and its business. 

 Schedule 2.1(p) 
 Permits 
 None. 

 Schedule 2.1(q) 
 Employees 
 Steven Hughes - Chief Executive Officer

 James L. Lewis - Vice Chairman 
 Robert S. Gluck - Vice Chairman 

 Schedule 2.1(r) 
 Litigation 
 See Note 6 to the Company’s Unaudited Financial Statements attached to
the Company’s Form 10-Q for the period ended June 30, 2006. In the event of a controversy described therein, the Company may be obligated to pay certain legal fees and expenses of up to $500,000. 

 Schedule 2.1(s) 
 Taxes 
 Extension for 2005 state and federal income tax
return until September 15, 2006. 

 Schedule 2.1(t) 
 Related Party Transactions 
 Letter Agreement among the Company, Hughes Consulting, Inc.
(an affiliate of Steven Hughes) and Jeltex Holdings, LLC (an affiliate of James Lewis). 
 The Company has agreed to repay monetary advances made by certain
stockholders of the Company. 
 Robert S. Gluck and his consulting firm, Matthew Robert Associates, LLC, were party to a letter agreement with the Company,
which agreement was rescinded on November 1, 2005. 

 Schedule 2.1(w) 
 Compliance 
 The Company has not yet evaluated the internal control over financial
reporting or the disclosure controls and procedures of SB and its subsidiaries. The Company will, as promptly as practicable following the consummation of the SB Transaction, (i) evaluate such internal control and disclosure controls and
procedures and (ii) use commercially reasonable efforts to remedy any deficiencies contained therein to comply with all applicable provisions of the Exchange Act and the Sarbanes-Oxley Act of 2002 within all prescribed time periods. 

 Schedule 2.1(ff) 
 Registration Rights 
 Rights under the Founders Registration Rights AgreementForm of Registration Rights Agreement

 Exhibit 10.3 
 REGISTRATION RIGHTS AGREEMENT, dated as of _______ __, 200_ (the “Agreement”) among Smart Balance, Inc. (F/K/A Boulder Specialty Brands, Inc.), a Delaware corporation (the
“Corporation”), and the INVESTORS (as herein defined). 
 The Investors own or have the right to purchase or
otherwise acquire shares of the Common Stock (as hereinafter defined) of the Corporation. The Corporation and the Investors deem it to be in their respective best interests to set forth their rights in connection with public offerings and sales of
the Common Stock and are entering into this Agreement as a condition to and in connection with the Investors entering into the Securities Purchase Agreement (as herein defined). 
 NOW, THEREFORE, in consideration of the premises and mutual covenants and obligations hereinafter set forth, the Corporation and the Investors
hereby agree as follows: 
 Section 1. Definitions. 
 As used in this Agreement, the following terms shall have the following meanings: 
 “Affiliate” means, with respect to any Person, any (a) director, officer, limited or general partner, member or
stockholder holding 5% or more of the outstanding capital stock or other equity interests of such Person, (b) any spouse, parent, sibling or descendant of such Person (or a spouse, parent, sibling or descendant of a Person specified in clause
(a) above relating to such Person) and (c) other Person that, directly or indirectly, through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person. The term “control” includes,
without limitation, the possession, directly or indirectly, of the power to direct the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 
 “Board” means the Board of Directors of the Corporation. 
 “Commission” means the Securities and Exchange Commission or any other agency at the time administering the Securities
Act. 
 “Common Stock” means the common stock, $0.0001 par value per share, of the Corporation. 

“Effectiveness Date” means, with respect to the Registration Statement required to be filed pursuant to
Section 2 hereunder, the earlier of (a) the 30th calendar day following the Filing Date (or 60th calendar day in the event of a full review by the Commission) and (b) the fifth (5th) Business Day following the date on
which the Corporation is notified by the 

 
Commission that the Registration Statement will not be reviewed or is no longer subject to further review and comments. 
 “Effectiveness Period” shall have the meaning set forth in Section 2(a). 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and
regulations of the Commission promulgated thereunder, all as the same shall be in effect from time to time. 
 “Filing
Date” means, with respect to the Registration Statement required to be filed pursuant to Section 2 hereunder, the 14th calendar day following the date hereof. 
 “Free Writing Prospectus” means a free writing prospectus as defined in Rule 405 under the Securities Act. 
 “Investors” means the holders of Restricted Shares identified on Annex I hereto and includes any successor to, or
assignee or transferee of, any such Person who or which agrees in writing to be treated as an Investor hereunder and to be bound by the terms and comply with all applicable provisions hereof. 
 “Issuer Free Writing Prospectus” means an issuer free writing prospectus as defined in Rule 433 under the Securities Act.

 “Other Shares” means at any time those shares of Common Stock which do not constitute Primary Shares or
Registrable Shares hereunder. 
 “Permitted Free Writing Prospectus” shall have the meaning set forth in
Section 22. 
 “Person” shall be construed in the broadest sense and means and includes a natural
person, a partnership, a corporation, an association, a joint stock company, a limited liability company, a trust, a joint venture, an unincorporated organization and any other entity and any federal, state, municipal, foreign or other government,
governmental department, commission, board, bureau, agency or instrumentality, or any private or public court or tribunal. 
 “Primary Shares” means at any time authorized but unissued shares of Common Stock. 
 “Prospectus” means the prospectus included in the Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective
registration statement in reliance upon Rule 430A), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Shares covered by the Registration Statement, and all other
amendments and supplements to the Prospectus, including post–effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus. 
 “Registrable Shares” means the Restricted Shares held by the Investors. 
  

 -2- 

 “Registration Statement” means the registration statement required to be
filed pursuant to Section 2 hereunder, including the Prospectus, amendments and supplements to the registration statement or Prospectus, including pre– and post–effective amendments, and all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in the Registration Statement. 
 “Requisite
Investors” means any Investor or group of Investors who hold at least 40% of the Registrable Shares at such time. 
 “Requisite Sale Investors” means with respect to any particular sale or offering, any Investor or group of Investors who hold at least 40% of the Registrable Shares participating in such applicable sale or offering.

 “Restated Certificate” means the Restated Certificate of Incorporation of the Corporation dated as of or
about the date hereof, as may be amended from time to time. 
 “Restricted Shares” means shares of Common
Stock, shares of Common Stock issued as a dividend or other distribution with respect to or in exchange for or in replacement of shares of Common Stock, and shares of Common Stock issuable upon exercise, exchange or conversion of any other
securities which by their terms are exercisable or exchangeable for or convertible into Common Stock (including exercised or unexercised warrants for or convertible preferred stock or convertible debt securities in each case for preferred stock or
Common Stock). As to any particular Restricted Shares held by an Investor, once issued, such Restricted Shares shall cease to be Restricted Shares when (i) all such shares of Common Stock have been registered under the Securities Act, the
registration statement in connection therewith has been declared effective and they have been disposed of pursuant to such effective registration statement, (ii) all such shares of Common Stock are eligible to be sold or distributed pursuant to
Rule 144(k) in a single transaction by such Investor without limitation and without volume restrictions, or (iii) they shall have ceased to be outstanding. 
 “Rule 144” means Rule 144 promulgated under the Securities Act or any successor rule thereto or any complementary rule
thereto (including, without limitation, Rule 144A). 
 “Rule 405” means Rule 405 promulgated by the
Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
 “Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from
time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
 “Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the
Commission having substantially the same effect as such Rule. 
  

 -3- 

 “Rule 430A” means Rule 430A promulgated by the Commission pursuant to
the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
 “Securities Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations of
the Commission thereunder, all as the same shall be in effect from time to time. 
 “Securities Purchase
Agreement” means the Securities Purchase Agreement dated as of September 25, 2006, among the Corporation and the Investors, as the same may be modified, supplemented or amended from time to time. 
 “Trading Day” means a day on which the Common Stock is trading on a Trading Market. 
 “Trading Market” means the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the Nasdaq Capital Market, the American Stock Exchange, the New York Stock Exchange, the Nasdaq Global Market or the OTC Bulletin Board. 
 “Warrants” means the warrants to purchase Common Stock of the Corporation issued pursuant to the Securities Purchase
Agreement, as they may be amended from time to time. 
 Section 2. Mandatory Registration. 
 (a) On or prior to the Filing Date, the Corporation shall prepare and file with the Commission the Registration Statement covering the
resale of all of the Registrable Shares for an offering to be made on a continuous basis pursuant to Rule 415, or if Rule 415 is not available for offers or sales of the Registrable Shares, for such other means of distribution of Registrable Shares
as the Investors may specify. The Registration Statement required hereunder shall be on Form S–3 (except if the Corporation is not then eligible to register for resale the Registrable Shares on Form S–3, in which case the Registration
Statement shall be on another appropriate form in accordance herewith). The Registration Statement required hereunder shall contain (except if otherwise directed by the Investors) the “Plan of Distribution” attached hereto as Annex
A. Each Investor agrees to furnish to the Corporation a completed Questionnaire in the form attached to this Agreement as Annex B (a “Selling Shareholder Questionnaire”) not less than five (5) Trading Days prior to
the Filing Date. The Corporation shall use its reasonable best efforts to cause the Registration Statement to be declared effective under the Securities Act (unless it becomes effective automatically upon filing) as promptly as possible after the
filing thereof, and shall use its reasonable best efforts to keep such Registration Statement continuously effective under the Securities Act (including the filing of any necessary amendments, post-effective amendments and supplements) until such
date when there are no longer any Registrable Shares outstanding (the “Effectiveness Period”). The Corporation shall telephonically request effectiveness of the Registration Statement (unless it becomes effective automatically upon
filing) as of 5:00 pm Eastern Time on a Trading Day. The Corporation shall promptly notify the Investors via facsimile or email of the effectiveness of a Registration Statement on the same 

  

 -4- 

 
Trading Day that the Corporation telephonically confirms effectiveness with the Commission (if possible, otherwise as soon as practicable on the following
Trading Day), which shall be the date requested for effectiveness of a Registration Statement (the “Effective Date”), unless the Registration Statement becomes automatically effective upon filing, in which case the “Effective
Date” shall be the date on which the Registration Statement was filed. The Corporation shall, by 9:30 am Eastern Time on the Trading Day after the Effective Date, file a Rule 424(b) prospectus with the Commission. 
 (b) If: (i) the Registration Statement is not filed on or prior to the Filing Date (if the Corporation files the Registration
Statement without affording the Investors the opportunity to review and comment on the same as required by Section 5(b), the Corporation shall not be deemed to have satisfied this clause (i)); or (ii) the Registration
Statement does not become automatically effective or is not declared effective by the Commission on or before the Effectiveness Date or (iii) after the Effectiveness Date, a Registration Statement ceases for any reason to remain continuously
effective as to all Registrable Shares for which it is required to be effective, or the Investors are not permitted to utilize the Prospectus therein to resell such Registrable Shares in either event for 45 consecutive calendar days or for more than
an aggregate of 90 calendar days during any 12-month period (which need not be consecutive Trading Days); provided, no suspension period may begin until at least five (5) days have passed since any previous 45 consecutive calendar day
suspension period (any such failure or breach being referred to as an “Event,” and for purposes of clause (i) or (ii) the date on which such breach occurs, and for purposes of clause (iii) the date on which such 45 or
90 calendar day period, as applicable, is exceeded, being referred to as an “Event Date”), then in addition to any other rights or remedies the Investors may have hereunder or under applicable law, Investors shall have the rights
set forth in Section 9(e) of the Restated Certificate, Section 4(c) of the Warrants and each holder of Registrable Shares that are shares of Common Stock shall have the right to be issued by the Corporation, on each ninety
(90) day anniversary of the Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured with respect to each such share of Common Stock, a fractional share of Common Stock calculated by
dividing (x) the decrease in the Conversion Price (as defined in the Restated Certificate) of a Series A Preferred Share (as defined in the Restated Certificate) as a result of the same Event pursuant to Section 9(e) of
Article IV of the Restated Certificate for the same period by (y) $7.46 (subject to equitable adjustment as a result of any stock dividend, stock split, combination, reverse split, reclassification or similar event after the date
hereof). In no event will the holder of Series A Preferred Shares or Warrants be entitled to receive a cash settlement or other consideration in lieu of the adjustments, rights and remedies provided in this Section 2(b) in respect of any
Event with respect to the Series A Preferred Shares or Warrants so held (and not with respect to other equity securities that may be held by such holder). 
 (c) In the event that, in the reasonable judgment of the Corporation, it is advisable to suspend use of a Registration Statement or Prospectus therein due to pending material developments or other events that have not
yet been publicly disclosed and as to which the Corporation believes public disclosure would be detrimental to the Corporation, the Corporation shall notify all holders of Registrable Shares to such effect, and, upon receipt of such notice,
each of the holders of Registrable Shares shall immediately discontinue any sales of Registrable Shares pursuant to such Registration Statement and/or Prospectus until each of such holders has received copies of a supplemented or amended
prospectus or until the holders 

  

 -5- 

 
are advised in writing by the Corporation that the then current prospectus may be used and has received copies of any additional or supplemental filings that
are incorporated or deemed incorporated by reference in such prospectus. Notwithstanding anything to the contrary herein, the Corporation shall not exercise its rights under the preceding sentence to suspend sales of Registrable Shares for
a period in excess of 45 consecutive calendar days or for more than an aggregate of 90 calendar days during any 12-month period (which need not be consecutive Trading Days); provided, no suspension period may begin until at least five
(5) days have passed since any previous 45 consecutive calendar day suspension period. 
 Section 3. Piggyback Registration.

 Anything contained in Section 2 to the contrary notwithstanding, if, at any time the Corporation proposes for
any reason to register Primary Shares or Other Shares under the Securities Act whether or not pursuant to registration rights granted to other holders of its securities and whether or not for sale for its own account (other than on Form S-4 or Form
S-8 promulgated under the Securities Act (or any successor forms thereto)) in an underwritten offering, the Corporation shall give written notice to the Investors of its intention to so register such Primary Shares or Other Shares at least 30 days
before the initial filing of the registration statement related thereto and, upon the request, delivered to the Corporation within 20 days after delivery of any such notice by the Corporation, of any of the Investors to include in such registration
Registrable Shares (which request shall specify the number of Registrable Shares proposed to be included in such registration and the Person owning such Registrable Shares), the Corporation shall use its reasonable best efforts to cause all such
Registrable Shares to be included in such registration on the same terms and conditions as the securities otherwise being sold in such registration; provided, however, that if the managing underwriter advises the Corporation that the
inclusion of all Registrable Shares requested to be included in such registration would interfere with the successful marketing (including pricing) of the Primary Shares or Other Shares proposed to be registered by the Corporation, then the number
of Primary Shares, Registrable Shares and Other Shares proposed to be included in such registration shall be as follows: 
 (i) If the registration is of Primary Shares undertaken for the Corporation’s account: 
 (A) first, the
Primary Shares; 
 (B) second, the Registrable Shares and any shares of Common Stock, if any, as to which registration has
been requested pursuant to written contractual piggy-back registration rights of security holders set forth in the Registration Rights Agreement dated on or about December 16, 2005 by and among the Company and the parties thereto (the
“Founders Registration Rights Agreement”) (or, if necessary, such Registrable Shares and other registrable shares pro rata among the holders thereof based upon the number of Registrable Shares and other registrable shares requested
to be registered by each such holder); and 
 (C) third, the Other Shares; and 
  

 -6- 

 (ii) If the registration is a “demand” registration undertaken at the demand of
Persons other than the holders of Registrable Shares pursuant to Section 2.1 of the Founders Registration Rights Agreement or that have been granted after the date hereof as permitted hereunder: 
 (A) first, the shares of Common Stock for the account of the demanding Persons pursuant to Section 2.1 of the Founders
Registration Rights Agreement, and Registrable Shares pursuant to Section 3 hereof (or, if necessary, such Registrable Shares and other registrable shares pro rata among the holders thereof based upon the number of Registrable Shares and
other registrable shares requested to be registered by each such holder); 
 (B) second, the Primary Shares; 
 (C) third, the Other Shares. 
 Section 4. Holdback Agreement. 
 If the Corporation at any time pursuant to Section 2 shall
register under the Securities Act Registrable Shares for sale to the public pursuant to an underwritten offering, the Corporation shall not, without the prior written consent of the Requisite Sale Investors, effect any public sale or distribution of
the Corporation’s equity securities similar to those being registered, or any securities convertible into or exercisable or exchangeable for such equity securities, for such period as shall be determined by the managing underwriters, which
period shall not begin more than ten (10) days prior to the effectiveness of the registration statement pursuant to which such public offering shall be made and shall not last more than 90 days after the effective date of such registration
statement. 
 Section 5. Preparation and Filing. 
 If and whenever the Corporation is under an obligation pursuant to the provisions of this Agreement to effect the registration of any
Registrable Shares, the Corporation shall, as expeditiously as practicable: 
 (a) use its reasonable best efforts to cause a
registration statement that registers such Registrable Shares to become and remain effective until all of such Registrable Shares have been disposed of; 
 (b) furnish, at least two (2) business days before filing of the Registration Statement or other registration statement that registers such Registrable Shares, the Prospectus or other prospectus relating thereto
or any amendments or supplements relating to such a registration statement or prospectus, to the Investors, one counsel selected by the holders of Registrable Shares (which counsel shall initially be O’Melveny & Myers LLP until such
time as notice otherwise given in writing by the Requisite Investors) requesting such registration (the “Investors’ Counsel”), and any other counsel of such holders copies of all such documents proposed to be filed which
documents shall be subject to review thereof (it being understood that such two-business-day period need not apply to successive drafts of the same document proposed to be filed so long as such successive drafts are supplied to such holders, the
Investors’ 

  

 -7- 

 
Counsel and such other counsel in advance of the proposed filing by a period of time that is customary and reasonable under the circumstances). The
Corporation shall not file the Registration Statement or any such Prospectus, or any other registration statements or prospectuses hereunder or any amendments or supplements thereto to which the Requisite Investors reasonably object in good faith as
to the adequacy of such Registration Statement or any such Prospectus or the compliance of such document with applicable laws; 
 (c) prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to ensure the inclusion of all Registrable Shares in such applicable
registration statement and/or prospectus and as may be necessary to keep such registration statement effective until all of such Registrable Shares have been disposed of and to comply with the provisions of the Securities Act with respect to the
sale or other disposition of such Registrable Shares; cause the related Prospectus to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to Rule 424; and respond as promptly as
reasonably possible to any comments received from the Commission with respect to the Registration Statement or any amendment thereto; 
 (d) notify in writing the holders of Registrable Shares participating in such registration, their counsel and the Investors’ Counsel (i) of the receipt by the Corporation of any notification with respect to
any comments by the Commission with respect to such registration statement or prospectus or any amendment or supplement thereto or any request by the Commission for the amending or supplementing thereof or for additional information with respect
thereto, (ii) of the receipt by the Corporation of any notification with respect to the issuance by the Commission of any stop order suspending the effectiveness of such registration statement or prospectus or any amendment or supplement
thereto or the initiation or threatening of any proceeding for that purpose, (iii) of the receipt by the Corporation of any notification with respect to the suspension of the qualification of such Registrable Shares for sale in any jurisdiction
or the initiation or threatening of any proceeding for such purposes and (iv) of the existence of any fact or the happening of any event that causes the Corporation to become an “ineligible issuer,” as defined in Rule 405; 

(e) use its reasonable best efforts to register or qualify such Registrable Shares under such other securities or blue sky laws of such
jurisdictions as the holders of Registrable Shares reasonably request and do any and all other acts and things which may be reasonably necessary or advisable to enable such holders to consummate the disposition in such jurisdictions of the
Registrable Shares owned by the holders; provided, however, that the Corporation will not be required to qualify generally to do business, subject itself to general taxation or consent to general service of process in any jurisdiction
where it would not otherwise be required to do so but for this paragraph (e); 
 (f) use its reasonable best efforts to
avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order suspending the effectiveness of the Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the
Registrable Shares for sale in any jurisdiction, at the earliest practicable moment; 
  

 -8- 

 (g) furnish to the Investors such number of copies of a summary prospectus, if any, or
other prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as such Investors may reasonably request in order to facilitate the public sale or other disposition of such
Registrable Shares; 
 (h) without limiting subsection (e) above, use its reasonable best efforts to cause such
Registrable Shares to be registered with or approved by such other governmental agencies or authorities as may be necessary by virtue of the business and operations of the Corporation to enable the Investors holding such Registrable Shares to
consummate the disposition of such Registrable Shares; 
 (i) notify the Investors holding such Registrable Shares immediately
at any time when a prospectus relating to such Registrable Shares or any document related thereto includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein not misleading in light of the circumstances then existing and, at the request of the Investors prepare and furnish to such Investors a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so
that, as thereafter delivered to the offerees of such shares, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing; 
 (j) make available upon reasonable notice and during normal
business hours, for inspection by the Investors holding such Registrable Shares, any underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other agent retained by the Investors or
underwriter (collectively, the “Inspectors”), all pertinent financial and other records, pertinent documents and properties of the Corporation (collectively, the “Records”), as shall be reasonably necessary to
enable them to exercise their due diligence responsibility, and cause the Corporation’s officers, directors, employees, counsel and independent certified public accountants to supply all information (together with the Records, the
“Information”) reasonably requested by any such Inspector in connection with such registration statement. Any of the Information which the Corporation determines in good faith to be confidential, and of which determination the
Inspectors are so notified, shall not be disclosed by the Inspectors unless (i) the disclosure of such Information is necessary to avoid or correct a material misstatement or omission in the registration statement, (ii) the release of such
Information is ordered pursuant to a subpoena or other order from a court or governmental agency or authority of competent jurisdiction, (iii) such Information has been made generally available to the public through no breach of the
nondisclosure obligations of the Inspectors or their Affiliates or (iv) such disclosure is required to be made under applicable law; 
 (k) if requested by one or more Requisite Sale Investors, (i) engage one or more nationally recognized firms of investment bankers reasonably acceptable to the Corporation and selected by the Requisite Sale
Investors, to act as lead managing underwriter or underwriters on a “firm commitment” basis in connection with such offering and shall select any additional investment bankers and managers to be used in connection with such offering and
(ii) enter into an underwriting agreement with such applicable underwriters which agreement shall include terms and provisions customary for transactions of this type, including representations 

  

 -9- 

 
and warranties, closing conditions, covenants and indemnification (as set forth in Section 7 hereof); in such event, the right of any holder of
Registrable Shares to include its Registrable Shares in such registration or prospectus supplement, as applicable, shall be conditioned upon such holder’s participation in such underwriting and the willingness of such holder to execute the
underwriting agreement, or designate a nominee to execute the underwriting agreement, as a selling stockholder, provided no holder of Registrable Shares included in such underwritten offering shall be required to make any representations or
warranties in the underwriting agreement except, if applicable, with respect to such holder’s organization, good standing, authority, title to Registrable Shares, lack of conflict of such sale with such holder’s material agreements and
organizational documents, and with respect to written information relating to such holder that such holder has furnished in writing expressly for inclusion in such registration statement or prospectus supplement, as applicable; 
 (l) if necessary, use its reasonable best efforts to obtain from its independent certified public accountants “cold comfort”
letters in customary form and at customary times and covering matters of the type customarily covered by cold comfort letters and deliver such letters to any applicable underwriters; 
 (m) use its reasonable best efforts to obtain from its counsel an opinion or opinions in customary form and deliver such opinions to any
applicable underwriters; 
 (n) issue and deliver customary officer’s and other closing certificates to any applicable
underwriters; 
 (o) provide a transfer agent and registrar (which may be the same entity and which may be the Corporation)
for such Registrable Shares; 
 (p) promptly issue to any underwriter to which the Investors holding such Registrable Shares
may sell shares in such offering certificates evidencing such Registrable Shares; 
 (q) list such Registrable Shares on any
national securities exchange (including the New York Stock Exchange, American Stock Exchange and the Nasdaq Stock Exchange) on which any shares of the Common Stock are listed or, if the Common Stock is not listed on a national securities exchange,
use its reasonable best efforts to qualify such Registrable Shares for inclusion on the automated quotation system of the National Association of Securities Dealers, Inc. (the “NASD”), or such other national securities exchange as
the Requisite Sale Investors shall reasonably request; provided, in no event with the holder of Series A Preferred Shares or Warrants be entitled to receive a cash settlement or other consideration in lieu of the adjustments provided in
Section 9(e) of the Restated Certificate or Section 4(c) of the Warrants with respect to a default as to the foregoing with respect to the Series A Preferred Shares or Warrants so held (and not with respect to other equity
securities that may be held by the Holder); 
 (r) otherwise use its reasonable best efforts to comply with all applicable
rules and regulations of the Commission and make available to its securityholders, as soon as reasonably practicable, earning statements meeting the requirements of Section 11(a) of the 

  

 -10- 

 
Securities Act or Rule 158 thereunder covering a period of 12 months beginning within three months after the effective date of the subject registration
statement; 
 (s) if requested by a selling holder of Registrable Shares, the Corporation shall (i) as soon as
practicable incorporate in a prospectus supplement or post-effective amendment such information as such holder reasonably requests to be included therein relating to the sale and distribution of Registrable Shares, including, without limitation,
information with respect to the number of Registrable Shares being offered or sold, the purchase price being paid therefor and any other terms of the offering of the Registrable Shares to be sold in such offering; (ii) as soon as practicable
make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) as soon as practicable, supplement
or make amendments to any Registration Statement reasonably requested by such holder; 
 (t) otherwise use its reasonable best
efforts to take all other steps necessary to effect the registration of such Registrable Shares contemplated hereby; 
 (u) if
an Investor is or is to be identified by the Commission or the NASD as an “underwriter”, at the request of such Investor, the Corporation shall (A) furnish to such Investor, on the date of the effectiveness of the Registration
Statement and thereafter from time to time on such dates as such Investor may reasonably request (i) a letter, dated such date, from the Corporation’s independent certified public accountants in form and substance as is customarily given
by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Investors, and (ii) an opinion, dated as of such date, of counsel representing the Corporation for purposes of such Registration
Statement, in form, scope and substance as is customarily given in an underwritten public offering, addressed to the Investors, and (B) permit such Investor to participate in good faith in the preparation of such registration or comparable
statement and to require the insertion therein of material, furnished to the Corporation in writing, which in the reasonable judgment of such holder and its counsel should be included, subject to review by the Corporation and their counsel after
consultation with such holder. Notwithstanding anything herein to the contrary, no Investor shall be designated as an “underwriter” by the Corporation in any Registration Statement without the consent of such Investor; and 

(v) in connection with the due diligence efforts of any Investor who is or is to be identified as an “underwriter,” the
Corporation shall make available for inspection during business hours and upon reasonable advance request by (i) any Investor, (ii) counsel for such Investor and (iii) one firm of accountants or other agents retained by such Investor
(collectively, the “Deemed Underwriter Inspectors”), all Records, as shall be reasonably deemed necessary by each Deemed Underwriter Inspector, and cause the Corporation’s officers, directors and employees to supply all
information which any Deemed Underwriter Inspector may reasonably request. 
 The Corporation shall not permit any officer,
director, underwriter, broker or any other person acting on behalf of the Corporation to use any Free Writing Prospectus in connection with the Registration Statement covering Registrable Shares, without the prior written consent of the Requisite
Sale Investors which consent shall not be unreasonably withheld 

  

 -11- 

 
or delayed. Any consent to the use of a Free Writing Prospectus included in an underwriting agreement to which the Requisite Sale Investors are parties shall
be deemed to satisfy the requirement for such consent. Each holder of the Registrable Shares, upon receipt of any notice from the Corporation of any event of the kind described in Section 5(i) hereof, shall forthwith discontinue
disposition of the Registrable Shares pursuant to the registration statement covering such Registrable Shares until such holder’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 5(i) hereof,
and, if so directed by the Corporation, such holder shall deliver to the Corporation all copies, other than permanent file copies then in such holder’s possession, of the prospectus covering such Registrable Shares at the time of receipt of
such notice. 
 Section 6. Expenses. 
 All expenses incurred by the Corporation, and all expenses separately incurred by the Investors (up to $500,000 in the aggregate for the expenses separately incurred by the Investors), in complying with their
obligations pursuant to this Agreement and in connection with the registration and disposition of Registrable Shares, including, without limitation, all registration and filing fees (including all filing fees incident to filing with the NASD), fees
and expenses of complying with securities and blue sky laws, printing expenses, fees and expenses of the Corporation’s counsel and accountants and fees and expenses of the Investors’ Counsel, up to a maximum of $200,000 in the aggregate
for the Investors’ Counsel per registration and underwriting, as applicable, shall be paid by the Corporation, including all underwriting fees and expenses (including legal expenses and expenses of the Corporation’s other advisors);
provided, however, that all underwriting discounts and selling commissions applicable to the Registrable Shares and Other Shares shall be borne by the holders selling such Registrable Shares and Other Shares, in proportion to the
number of such Registrable Shares and Other Shares sold by each such holder. 
 Section 7. Indemnification. 
 (a) In connection with any registration of any Registrable Shares under the Securities Act pursuant to this Agreement, the Corporation
shall indemnify and hold harmless the holders of Registrable Shares, each of such holder’s officers, directors, employees, members, partners, and advisors and their respective Affiliates, each underwriter, broker or any other person acting on
behalf of the holders of Registrable Shares and each other Person, if any, who controls any of the foregoing Persons within the meaning of the Securities Act against any losses, claims, damages, liabilities, or actions joint or several (or actions
in respect thereof), to which any of the foregoing persons may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue
statement or allegedly untrue statement of a material fact contained in the registration statement under which such Registrable Shares were registered under the Securities Act, any preliminary prospectus or final prospectus contained therein or
otherwise filed with the Commission, any amendment or supplement thereto or any document incident to registration or qualification of any Registrable Shares, or any Issuer Free Writing Prospectus, or arise out of or are based upon the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or, with respect to any prospectus, necessary to make the statements therein in light of the circumstances

  

 -12- 

 
under which they were made not misleading, or any violation by the Corporation of the Securities Act or state securities or blue sky laws applicable to the
Corporation or relating to action or inaction required of the Corporation in connection with such registration or qualification under such state securities or blue sky laws; and shall reimburse such Persons for any legal or other expenses reasonably
incurred by any of them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Corporation shall not be liable in any such case to the extent that any such loss,
claim, damage, liability or action (including any legal or other expenses incurred) arises out of or is based upon an untrue statement or allegedly untrue statement or omission or alleged omission made in said registration statement, preliminary
prospectus, final prospectus, amendment, supplement, Issuer Free Writing Prospectus or document incident to registration or qualification of any Registrable Shares in reliance upon and in conformity with written information furnished to the
Corporation by the holders of Registrable Shares specifically for use in the preparation thereof or for such holders’ failure to deliver a prospectus, Issuer Free Writing Prospectus or for selling any shares of Common Stock pursuant to such
prospectus after the Corporation has provided to such holder written notice of the Corporation’s receipt of a stop order relating to such Registration Statement or for selling any shares of Common Stock pursuant to such prospectus after the
holder has received written notice pursuant to Section 2(c). 
 (b) In connection with any registration of
Registrable Shares under the Securities Act pursuant to this Agreement, each holder of Registrable Shares shall severally (based on the percentage of all Registrable, Primary and Other Shares included in such registration that were owned by such
holder) and not jointly and severally indemnify and hold harmless the Corporation, each director of the Corporation, each employee and advisor of the Corporation, each officer of the Corporation who shall sign such registration statement, each
underwriter, broker or other person acting on behalf of the holders of Registrable Shares, the Affiliates of each of the foregoing, and each person who controls any of the foregoing persons within the meaning of the Securities Act with respect to
any statement or omission from such registration statement, any preliminary prospectus or final prospectus contained therein or otherwise filed with the Commission, any amendment or supplement thereto or Issuer Free Writing Prospectus or any
document incident to registration or qualification of any Registrable Shares, if such statement or omission was made in reliance upon and in conformity with written information furnished to the Corporation or such underwriter by such holder of
Registrable Shares specifically for use in connection with the preparation of such registration statement, preliminary prospectus, final prospectus, amendment, supplement, document or Issuer Free Writing Prospectus or for such holders’ failure
to deliver a prospectus or Issuer Free Writing Prospectus, or for selling any shares of Common Stock pursuant to such prospectus after the Corporation has provided to such holder written notice of the Corporation’s receipt of a stop order
relating to such Registration Statement or for selling any shares of Common Stock pursuant to such prospectus after the holder has received written notice pursuant to Section 2(c); provided, however, that the maximum amount
of liability in respect of such indemnification shall be limited, in the case of each holder of Registrable Shares, to an amount equal to the net proceeds actually received by such holder from the sale of Registrable Shares effected pursuant to such
registration. 
 (c) Promptly after receipt by an indemnified party of notice of the commencement of any action involving a
claim referred to in this Section 7, such indemnified 

  

 -13- 

 
party will, if a claim in respect thereof is made against an indemnifying party, give written notice to the latter of the commencement of such action. The
failure of any indemnified party to notify an indemnifying party of any such action shall not (unless such failure shall have a material adverse effect on the indemnifying party) relieve the indemnifying party from any liability in respect of such
action that it may have to such indemnified party hereunder. In case any such action is brought against an indemnified party, the indemnifying party will be entitled to participate in and to assume the defense thereof, jointly with any other
indemnifying party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of its election so to assume the defense
thereof, the indemnifying party shall not be responsible for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof; provided, however, that if any indemnified party shall have
reasonably concluded that there may be one or more legal or equitable defenses available to such indemnified party which are additional to or conflict with those available to the indemnifying party, or that such claim or litigation involves or could
have an effect upon matters beyond the scope of the indemnity agreement provided hereunder, the indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified party (but shall have the right to
participate therein with counsel of its choice) and such indemnifying party shall reimburse such indemnified party and any Person controlling such indemnified party for that portion of the fees and expenses of any counsel retained by the indemnified
party which is reasonably related to the matters covered by the indemnity agreement provided hereunder. If the indemnifying party assumes the defense of a claim, the indemnified party shall agree to any settlement, compromise or discharge of a claim
that the indemnifying party may recommend that has as the sole remedy monetary damages, that by its terms obligates the indemnifying party to pay the full amount of the liability in connection with such claim, and that has no finding or admission of
any violation of any law or regulation or of the rights of any Person and no effect on any other claims that may be made against the indemnified party. If the indemnifying party is not entitled to, or elects not to, assume the defense of a
claim, it will not be obligated to pay the fees and expenses of more than one counsel with respect to such claim. 
 (d) If
the indemnification provided for hereunder is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, claim, damage, liability or action referred to herein, then the indemnifying party, in lieu
of indemnifying such indemnified party hereunder, shall contribute to the amounts paid or payable by such indemnified party as a result of such loss, claim, damage, liability or action in such proportion as is appropriate to reflect the relative
fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions which resulted in such loss, claim, damage, liability or action as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The parties agree that it would not be just and equitable if contribution pursuant hereto does not take account of the equitable considerations referred to herein. No person guilty or liable of fraudulent misrepresentation shall be entitled to
contribution from any person. 
  

 -14- 

 Section 8. Information by Holder. 
 The Investors shall furnish to the Corporation such written information regarding the Investors and the distribution proposed by any
Investors as the Corporation may reasonably request in writing and as shall be reasonably required in connection with any registration referred to in this Agreement. 
 Section 9. Exchange Act Compliance. 
 The Corporation shall comply with all of the
reporting requirements of the Exchange Act applicable to it and shall comply with all other public information reporting requirements of the Commission which are conditions to the availability of Rule 144. The Corporation shall cooperate with the
Investors in supplying such information as may be necessary for the Investors to complete and file any information reporting forms presently or hereafter required by the Commission as a condition to the availability of Rule 144. The Corporation
shall cause its counsel to issue a legal opinion to the Corporation’s transfer agent if required by the Corporation’s transfer agent to effect the removal of any legend to the extent that such legend is permitted to be removed in
accordance with the terms of Rule 144, this Agreement and the other applicable rules and regulations. 
 Section 10. No Conflict of
Rights; Future Rights. 
 The Corporation shall not, after the date hereof, grant any registration rights which conflict
with or impair the rights granted to the Investors hereby. If at any time following the date hereof, the Corporation shall grant to any present or future stockholder of the Corporation rights to in any manner cause or participate in any registration
statement of the Corporation that, in the judgment of the Requisite Investors, are superior to or conflict with the rights granted to the Investors hereby, such grant shall be null, void and ultra vires. Notwithstanding anything to the
contrary in this Section 10, the Company may, without the further consent of any other party hereto, amend Annex I hereto upon delivery of a counterpart signature page by any party, or an Affiliate or assignee thereof, who
receives shares of Common Stock pursuant to Section 2.13 of the SB Merger Agreement (as defined in the Securities Purchase Agreement) to add such party as an “Investor” hereunder. 
 Section 11. Termination. 
 This Agreement shall terminate and be of no further force or effect following the expiration of the Effectiveness Period, except for Sections 2(b), 6 and 7 hereof. 
 Section 12. Benefits of Agreement; Third Party Beneficiaries. 
 Except as provided herein, this Agreement shall bind and inure to the benefit of the Corporation, the Investors and subject to
Section 13, the respective successors and permitted assigns of the Corporation and the Investors. 
  

 -15- 

 Section 13. Assignment. 
 Each Investor may assign its rights hereunder to any purchaser or transferee of Registrable Shares; provided, however, that
such purchaser or transferee shall, as a condition to the effectiveness of such assignment, be required to execute a counterpart to this Agreement agreeing to be treated as an Investor whereupon such purchaser or transferee shall have the benefits
and liabilities of, and shall be subject to the restrictions contained in, this Agreement as if such purchaser or transferee was originally included in the definition of an Investor herein and had originally been a party hereto. The Corporation may
not assign any rights hereunder without the consent of the Requisite Investors. 
 Section 14. Entire Agreement. 
 This Agreement, and the other writings referred to herein or delivered pursuant hereto, contain the entire agreement among the parties
hereto with respect to the subject matter hereof and supersede all prior and contemporaneous arrangements or understandings with respect thereto. 
 Section 15. Notices. 
 All notices, requests, consents and other communications hereunder to any party shall
be deemed to be sufficient if contained in a written instrument delivered in person or sent by telecopy, electronic transmission, nationally-recognized overnight courier or first class registered or certified mail, return receipt requested, postage
prepaid, addressed to such party at the address set forth below or such other address as may hereafter be designated in writing by such party to the other parties: 
 (i) if to the Corporation, to: 
 Smart Balance, Inc. 
 (F/K/A Boulder Specialty Brands, Inc.) 
 6106 Sunrise Ranch Drive 
 Longmont, Colorado 80503 
 Telephone: (303) 682-1978 
 Facsimile: 
 Email: 
 Attention: Robert S. Gluck 
 with a copy to: 
 Davis & Kuelthau, S.C. 
 111 East Kilbourn Ave. Suite 1400 
 Milwaukee, WI 53202-6613 
 Telephone: (414) 225-1434 
 Facsimile: (414) 278-3634 
 Email: nmatar@dkattorneys.com 
 Attention. Norman Matar, Esq. 
 and 
  

 -16- 

 Ellenoff Grossman & Schole LLP 
 370 Lexington Avenue, 19th Floor 
 New York, NY 10017 
 Telephone: (212) 370-1300 
 Facsimile: (212) 370-7889 
 Email: ellenoff@egsllp.com 
 Attention: Douglas S. Ellenoff, Esq 
 (ii) if to the Investors, to their respective addresses set forth on Annex 1 hereto. 
 (iii) if to the Investor’s Counsel, to 
 O’Melveny & Myers LLP 
 Times Square Tower 
 7 Times Square 
 New York, New York 10036 
 Telephone: 212-326-2000 
 Facsimile: 212-326-2061 
 Attn: Ilan S. Nissan, Esq. 
 All such notices, requests, consents and other communications shall be deemed to have been delivered (a) in the case of personal
delivery or delivery by telecopy, on the date of such delivery, (b) in the case of dispatch by nationally-recognized overnight courier, on the next business day following such dispatch and (c) in the case of email, upon receipt of
acknowledgement of receipt (d) in the case of mailing, on the fifth business day after the posting thereof. 
 Section 16.
Modifications; Amendments; Waivers. 
 The terms and provisions of this Agreement may not be modified or amended except
pursuant to a writing signed by the Corporation and Investors holding at least a majority of all Registrable Shares then outstanding. Any waiver of any provision of this Agreement requested by any party hereto must be granted in advance, in writing
by the party granting such waiver; provided, however, that the holders of a majority of all then outstanding Registrable Shares may grant a waiver on behalf of all Investors. Notwithstanding anything to the contrary in this
Section 16, (a) no such modification, amendment or waiver shall reduce the percentage of Registrable Shares required to amend or modify this Agreement or the percentage of Registrable Shares required to waive the obligations of the
Corporation or the rights of the Investors hereunder, and (b) any such modification, amendment or waiver that materially and adversely affects any Investor with respect to the rights or obligations in respect of such Investor’s Registrable
Shares in a manner disproportionate to how it materially and adversely affects the rights or obligations in respect of Registrable Shares of other Investors shall not be effective without the prior written consent of such holder. 
  

 -17- 

 Section 17. Counterparts; Facsimile Signatures. 
 This Agreement may be executed in any number of original or facsimile counterparts, and each such counterpart hereof shall be deemed to be
an original instrument, but all such counterparts together shall constitute but one agreement. 
 Section 18. Headings. 
 The headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be
a part of this Agreement. 
 Section 19. Governing Law; Consent to Jurisdiction and Venue; Waiver of Jury Trial. 
 This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to any law
or rule that would cause the laws of any jurisdiction other than the State of New York to be applied. 
 ANY ACTION OR
PROCEEDING AGAINST THE PARTIES RELATING IN ANY WAY TO THIS AGREEMENT MAY BE BROUGHT AND ENFORCED IN THE COURTS OF THE STATE OF NEW YORK OR THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, TO THE EXTENT SUBJECT MATTER
JURISDICTION EXISTS THEREFOR, AND THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING. EACH OF THE PARTIES IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION THAT
THEY MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH ACTION OR PROCEEDING IN THE COURTS OF THE STATE OF NEW YORK LOCATED IN NEW YORK COUNTY OR THE SOUTHERN DISTRICT OF NEW YORK AND ANY CLAIM THAT ANY SUCH ACTION OR PROCEEDING BROUGHT IN
ANY SUCH COURT HAS BEEN BROUGHT IN ANY INCONVENIENT FORUM. ANY JUDGMENT MAY BE ENTERED IN ANY COURT HAVING JURISDICTION THEREOF. 
 EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT. 
 Section 20. Severability. 
 It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under the law and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, in
the event that any provision of this Agreement would be held in any jurisdiction to be invalid, prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions
of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not be invalid, prohibited or unenforceable in such
jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining 

  

 -18- 

 
provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. 
 Section 21. Independent Nature of Investor’ Obligations and Rights. 
 The obligations of each Investor hereunder are several and not joint with the obligations of any other Investor hereunder, and no Investor
shall be responsible in any way for the performance of the obligations of any other Investor hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Investor pursuant hereto or
thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert with respect to such obligations or the
transactions contemplated by this Agreement. Each Investor shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Investor
to be joined as an additional party in any proceeding for such purpose. Each Investor has been represented by its own separate legal counsel in their review and negotiation of this Agreement. The Corporation has elected to provide all Investors with
the same terms herein for the convenience of the Corporation and not because it was required or requested to do so by the Investors. 
 Section 22. Free Writing Prospectus. Each Investor represents that it has not prepared or had prepared on its behalf or used or referred to or distributed, and agrees that it will not prepare or have prepared on its behalf or use or
refer to or, except as contemplated by this Agreement, distribute, any Free Writing Prospectus with respect to the sale of its Registrable Shares pursuant to the Registration Statement, in each case, without the prior written consent of the
Corporation not to be unnecessarily withheld and, in connection with any underwritten offering, the underwriters. Any such Free Writing Prospectus consented to by the Corporation and the underwriters, as the case may be, is hereinafter referred to
as a “Permitted Free Writing Prospectus.” The Corporation represents and agrees that it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, including in respect of
timely filing with the Commission, legending and record keeping. 
 * * * * 
  

 -19- 

 IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement on the date first
written above. 
  

			
	SMART BALANCE, INC.
	
	(F/K/A BOULDER SPECIALTY BRANDS, INC.)
		
	By:	 	  
		 	Name:
		 	Title:

					
	INVESTOR:
		
		 	OZ MASTER FUND, LTD.
		
		 	By: OZ Management, L.L.C., its Investment Manager
			
		 	By:	 	  
		 		 	Name: Joel Frank
		 		 	Title: Chief Financial Officer
		
		 	OZ Global Special Investments Master Fund, L.P.
		
		 	By: OZ Management, L.L.C., its Investment Manager
			
		 	By:	 	  
		 		 	Name: Joel Frank
		 		 	Title: Chief Financial Officer
		
		 	GPC LVII, LLC
		
		 	By: OZ Management, L.L.C., its Investment Manager
			
		 	By:	 	  
		 		 	Name: Joel Frank
		 		 	Title: Chief Financial Officer
		
		 	Fleet Maritime, Inc.
		
		 	By: OZ Management, L.L.C., its Investment Manager
			
		 	By:	 	  
		 		 	Name: Joel Frank
		 		 	Title: Chief Financial Officer

					
	INVESTOR:
		
		 	Aragon Trading Company, L.P.
			
		 	By:	 	  
		 		 	Name: Brian Yeatman
		 		 	Title: General Partner

					
	INVESTOR:
		
		 	Westmount Investments LLC
			
		 	By:	 	  
		 		 	Name: Robert J. Gillespie
		 		 	Title: Principal

					
	INVESTOR:
		
		 	Investcorp Interlachen Multi-Strategy Master Fund Limited
		
		 	By: Interlachen Capital Group LP
			
		 	By:	 	  
		 		 	Name: Gregg T. Colburn
		 		 	Title: Authorized Signatory

					
	INVESTOR:
		
		 	 UBS AG

			
		 	By:	 	  
		 		 	Name: Chris Coward
		 		 	Title: Director

					
	INVESTOR:
		
		 	Glenhill Capital Overseas Master Fund, L.P.
		
		 	 By: Glenhill Capital Overseas G.P. Ltd.

			
		 	By:	 	  
		 		 	Name: Glenn J. Krevlin
		 		 	Title: Director

					
	INVESTOR:
		
		 	 Glenhill Capital, L.P.

		
		 	 By: Glenhill Capital Management, LLC

			
		 	By:	 	  
		 		 	Name: Glenn J. Krevlin
		 		 	Title: Managing Member

 INVESTOR: 
  

					
	 Glenview Capital Partners, L.P.

		
	 By:
	 	Glenview Capital Management, LLC its
	investment manager
		
	 By:
	 	  
		 	 Name:
	 	 Richard Barrera

		 	 Title:
	 	 Managing Member

	
	Glenview Institutional Partners, L.P.
		
	By:	 	Glenview Capital Management, LLC its
	investment manager
		
	By:	 	  
		 	 Name:
	 	 Richard Barrera

		 	 Title:
	 	 Managing Member

	
	GCM Little Arbor Partners, L.P.
		
	By:	 	Glenview Capital Management, LLC its
	investment manager
		
	 By:
	 	  
		 	 Name:
	 	 Richard Barrera

		 	 Title:
	 	 Managing Member

	
	GCM Little Arbor Institutional Partners, L.P.
		
	By:	 	 Glenview Capital Management, LLC its

	investment manager
		
	 By:
	 	  
		 	 Name:
	 	 Richard Barrera

		 	 Title:
	 	 Managing Member

					
	 GCM Little Arbor Master Fund Ltd.

		
	 By:
	 	Glenview Capital Management, LLC its
	investment manager
		
	 By:
	 	  
		 	 Name:
	 	 Richard Barrera

		 	 Title:
	 	 Managing Member

	
	Glenview Capital Master Fund Ltd.
		
	By:	 	Glenview Capital Management, LLC its
	investment manager
		
	By:	 	  
		 	 Name:
	 	 Richard Barrera

		 	 Title:
	 	 Managing Member

 INVESTOR: 
  

			
	 Fort Mason Partners, LP

	 By: Fort Mason Capital, LLC

		
	By:	 	  

			
	Name:	 	 Dan German

	Title:	 	 Managing Member

 INVESTOR: 
  

			
	 Fort Mason Master, LP

	 By: Fort Mason Capital, LLC

		
	By:	 	  

			
	Name:	 	 Dan German

	Title:	 	 Managing Member

 INVESTOR: 
  

			
	 Adage Capital Partners, L.P.

		
	By:	 	  

			
	Name:	 	 D. Lehan

	Title:	 	 C.O.O.

 INVESTOR: 
  

			
	Canyon Capital Advisors LLC, on behalf of its managed funds and accounts
		
	By:	 	  

			
	Name:	 	 Joshua S. Friedman

	Title:	 	 Authorized Signatory

 INVESTOR: 
  

			
	 Highbridge International LLC

	 By: Highbridge Capital Management, LLC

		
	By:	 	  

			
	Name:	 	 Ari I. Storch

	Title:	 	 Managing Director

 INVESTOR: 
  

			
	 Old Lane, L.P. on behalf of

	 Old Lane US Master Fund, L.P.

		
	By:	 	  

			
	Name:	 	 John Havens

	Title:	 	 Managing Director

 INVESTOR: 
  

			
	 Old Lane, L.P. on behalf of

	 Old Lane Cayman Master Fund, L.P.

		
	By:	 	  

			
	Name:	 	 John Havens

	Title:	 	 Managing Director

 INVESTOR: 
  

			
	 Old Lane, L.P. on behalf of

	 Old Lane HMA Master Fund, L.P.

		
	By:	 	  

			
	Name:	 	 John Havens

	Title:	 	 Managing Director

 INVESTOR: 
  

			
	 SF Capital Partners Ltd.

		
	By:	 	  

			
	Name:	 	 Brian H. Davidson

	Title:	 	 Managing Director

 INVESTOR: 
  

			
	 Citigroup Global Markets, Inc.

		
	By:	 	  

			
	Name:	 	 Tyler G. Dickson

	Title:	 	 Managing Director

 INVESTOR: 
  

			
	 Kings Road Investments LTD

		
	 By:
	 	 Kings Road

		
	By:	 	  

			
	Name:	 	 Brandon L. Jones

	Title:	 	 Co-head, Private Investments

 Annex I 
 OZ Master Fund, Ltd. 
 c/o Och-Ziff Capital Management Group, L.L.C. 
 9 West 57th St., 39th floor 
 New York, NY 10019 
 Telephone: (212) 790-0160 
 Facsimile: (212) 790-0060 
 Attn:  Joel M. Frank 
   David Stonehill 
 OZ Global Special Investments Master Fund, L.P. 
 c/o Och-Ziff Capital
Management Group, L.L.C. 
 9 West 57th St., 39th floor 
 New
York, NY 10019 
 Telephone: (212) 790-0160 
 Facsimile:
(212) 790-0060 
 Attn:  Joel M. Frank 
   David Stonehill 
 GPC LVII, LLC 
 c/o
Och-Ziff Capital Management Group, L.L.C. 
 9 West 57th St., 39th floor 
 New York, NY 10019 
 Telephone: (212) 790-0160 
 Facsimile: (212) 790-0060 
 Attn:  Joel M. Frank 
   David Stonehill 
 Fleet Maritime, Inc. 
 c/o Och-Ziff Capital Management Group, L.L.C. 
 9 West 57th St., 39th floor 
 New York, NY 10019 
 Telephone: (212) 790-0160 
 Facsimile: (212) 790-0060 
 Attn:  Joel M. Frank 
   David Stonehill 
 in each case, with a copy to:

 O’MELVENY & MYERS LLP 
 Times Square Tower

 7 Times Square 
 New York, New York 10036 
 Telephone: 212-326-2000 
 Facsimile: 212-326-2061 
 Attn: Ilan S. Nissan, Esq. 

 Glenview Capital Partners, L.P. 
 c/o Glenview Capital Management, LLC 
 767 Fifth Avenue, 44th Floor 
 New York, NY 10153 
 phone: 212.812.4720 
 fax: 212.812.4701 
 Attn: Mark Horowitz 
 Glenview
Institutional Partners, L.P. 
 c/o Glenview Capital Management, LLC 
 767 Fifth Avenue, 44th Floor 
 New York, NY 10153 
 phone: 212.812.4720 
 fax: 212.812.4701 
 Attn: Mark
Horowitz 
 GCM Little Arbor Partners, L.P. 
 c/o Glenview
Capital Management, LLC 
 767 Fifth Avenue, 44th Floor 
 New
York, NY 10153 
 phone: 212.812.4720 
 fax: 212.812.4701

 Attn: Mark Horowitz 
 GCM Little Arbor Institutional Partners,
L.P. 
 c/o Glenview Capital Management, LLC 
 767 Fifth Avenue,
44th Floor 
 New York, NY 10153 
 phone: 212.812.4720 

fax: 212.812.4701 
 Attn: Mark Horowitz 
 GCM Little Arbor Master Fund, Ltd. 
 c/o Glenview Capital Management, LLC

 767 Fifth Avenue, 44th Floor 
 New York, NY 10153 

phone: 212.812.4720 
 fax: 212.812.4701 
 Attn: Mark Horowitz 

 Glenview Capital Master Fund Ltd. 
 c/o Glenview Capital Management, LLC 
 767 Fifth Avenue, 44th Floor 
 New York, NY 10153 
 phone: 212.812.4720 
 fax: 212.812.4701 
 Attn: Mark Horowitz 
 Glenhill
Capital, L.P. 
 c/o Glenhill Capital Management, L.L.C. 
 598
Madison Ave., 12th Floor 
 New York, NY 10022 
 Telephone:
(646) 432-0625 
 Facsimile: (646) 432-0666 
 Attn:
Kevin Corb 
 Glenhill Capital Overseas Master Fund, L.P. 
 c/o
Glenhill Capital Management, L.L.C. 
 598 Madison Ave., 12th Floor 
 New York, NY 10022 
 Telephone: (646) 432-0625 
 Facsimile: (646) 432-0666 
 Attn: Kevin Corb 
 in
each case, with a copy to: 
 Glenhill Capital Management, L.L.C. 
 598 Madison Ave., 12th Floor 
 New York, NY 10022 
 Telephone: (646) 432-0605 
 Facsimile: (646) 432-0666 
 Attn: Glenn Krevlin 
 Adage Capital Partners, L.P. 
 200 Clarendon Street, 52nd Floor 
 Boston, MA 02116 
 Telephone: (617) 867-2800 
 Facsimile: (617) 867-2801 
 with a copy to: 
 SCHULTE ROTH & ZABEL LLP 
 919 Third Avenue 
 New York, NY 10022 
 Attn: Peter
Halasz, Esq. 

 SF Capital Partners Ltd. 
 c/o Stark Offshore Management, LLC 
 3600 South Lake Drive 
 St. Francis, WI 53235 
 Attn: Brian H. Davidson 
 Telephone: (414) 294-7000 
 Facsimile: (414) 294-7700 
 Investcorp Interlachen Multi-Strategy Master Fund Limited 
 c/o Interlachen Capital Group LP 
 800 Nicollet Mall, Suite 2500 
 Minneapolis, MN 55402 
 Attn: Gregg Colburn and Legal Department 
 Telephone: (612) 659-4407

 Facsimile: (612) 659-4457 
 Aragon Trading Company, L.P.

 P.O. Box 178 
 Glenbrook, NV 89413 
 Telephone: (916) 663-1823 
 Facsimile: (916) 663-1824 
 with a copy to: 
 John Yeatman 
 1313 Gold Hill Road 
 Newcastle, CA 95658 
 Canyon Capital Advisors LLC 
 9665 Wilshire Blvd. 
 Suite 200 
 Beverly Hills, CA 90212 
 Telephone: (310) 247-2700 
 Facsimile: (310) 247-2700 
 Citigroup Global Markets, Inc. 
 390 Greenwich St., 5th Floor 
 New York, NY 10013

 Telephone: (212) 723-7916 
 Facsimile: (646) 291-5597

 with a copy to: 
 Aren C. Leekong 
 Colleen Gerard 
 Brooke Gottshall 
 390 Greenwich St., 5th Floor

 New York, NY 10013 

 Kings Road Investments, LTD. 
 (Registration name: UBS Securities, LLC F/B/O Kings Road Investments Ltd.) 
 c/o Polygon Investment Partners LP 
 598 Madison Avenue 14th Floor

 New York, NY 10022 
 with a copy to: 
 Schulte Roth & Zabel LLP 
 919 Third Avenue 
 New York, New York 10022 
 Attention: Eleazer Klein, Esq. 
 Telephone: (212) 756-2376 
 Facsimile: (212) 593-5955 
 UBS AG 
 Attention: Chris Coward 
 1285 6th Ave 
 NY, NY 10019 
 Telephone: (212) 649-7588 
 Facsimile: (212) 713-6222 
 Fort Mason Master, LP 
 4 Embarcadero Ctr, Ste 2050 

	San	Francisco, CA 94111 

 Attn: KC Lynch 
 Telephone: (415) 288-8100 
 Facsimile: (415) 288-8113 
 Fort Mason Partners, LP 
 4 Embarcadero Ctr, Ste 2050 

	San	Francisco, CA 94111 

 Attn: KC Lynch 
 Telephone: (415) 288-8100 
 Facsimile: (415) 288-8113 
 Old Lane, L.P. 
 on behalf of Old Lane US Master Fund, L.P. 
 Old Lane L.P. 
 500 Park Avenue 2nd Floor 
 New York, NY 10022 

 with a copy to: 
 Frederick Yoon/Steven Weiss 
 Old Lane L.P. 
 500 Park Avenue 2nd Floor 
 New York, NY 10022 
 Telephone: (212) 572-3206 
 Telephone: (212) 572-3293 
 Facsimile: (212) 572-2917 
 Old Lane, L.P. 
 on behalf of Old Lane HMA Master Fund, L.P. 
 Old Lane L.P. 
 500 Park Avenue 2nd Floor 
 New York, NY 10022 
 with a copy to: 
 Frederick Yoon/Steven Weiss 
 Old Lane L.P. 
 500 Park Avenue 2nd Floor 
 New York, NY 10022 
 Telephone: (212) 572-3206 
 Telephone: (212) 572-3293 
 Facsimile: (212) 572-2917 
 Old Lane, L.P. 
 on behalf of Old Lane Cayman Master Fund, L.P. 
 Old Lane L.P. 
 500 Park Avenue 2nd Floor 
 New York, NY 10022 
 with a copy to: 
 Frederick Yoon/Steven Weiss 
 Old Lane L.P. 
 500 Park
Avenue 2nd Floor 
 New York, NY 10022 
 Telephone:
(212) 572-3206 
 Telephone: (212) 572-3293 
 Facsimile:
(212) 572-2917 
 Highbridge International LLC 
 c/o
Highbridge Capital Management, LLC 
 9 West 57th Street, 27th Floor 
 New York, NY 10019 
 Attn: Ari J. Storch/Adam J. Chill 
 Telephone: (212) 287-4720 
 Facsimile: (212) 751-0755 

 Westmount Investments LLC 
 350 West Passaic Street 
 Rochelle Park, NJ 07662 
 Phone Number: (201) 226-0701 
 Fax Number: (201) 226-0703 
 with copy to: 
 Robert J. Gillespie 
 c/o Westmount Investments LLC 
 350 West Passaic Street 
 Rochelle Park, NJ 07662 

 ANNEX A 
 Plan of Distribution 
 The shares covered by this prospectus may be offered and sold from time to time by the selling
stockholders. The term “selling stockholder” includes pledgees, donees, transferees or other successors in interest selling shares received after the date of this prospectus from each selling stockholder as a pledge, gift, partnership
distribution or other non–sale related transfer. The number of shares beneficially owned by a selling stockholder will decrease as and when it effects any such transfers. The plan of distribution for the selling stockholders’ shares sold
hereunder will otherwise remain unchanged, except that the transferees, pledgees, donees or other successors will be selling stockholders hereunder. To the extent required, we may amend and supplement this prospectus from time to time to describe a
specific plan of distribution. The selling stockholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. 
 The selling stockholders may make these sales at prices and under terms then prevailing or at prices related to the then current market price. The selling stockholders may also make sales in negotiated transactions.
The selling stockholders may offer their shares from time to time pursuant to one or more of the following methods: 
  

	 	•	 	ordinary brokerage transactions and transactions in which the broker–dealer solicits purchasers; 

  

	 	•	 	one or more block trades in which the broker–dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the
transaction; 

  

	 	•	 	purchases by a broker–dealer as principal and resale by the broker–dealer for its account; 

  

	 	•	 	an exchange distribution in accordance with the rules of the applicable exchange; 

  

	 	•	 	public or privately negotiated transactions; 

  

	 	•	 	on the New York Stock Exchange, American Stock Exchange, Nasdaq Capital Market or Nasdaq Global Market (or through the facilities of any national securities exchange or U.S.
inter–dealer quotation system of a registered national securities association, on which the shares are then listed, admitted to unlisted trading privileges or included for quotation); 

  

	 	•	 	through underwriters, brokers or dealers (who may act as agents or principals) or directly to one or more purchasers; 

  

	 	•	 	a combination of any such methods of sale; and 

  

	 	•	 	any other method permitted pursuant to applicable law. 

 In connection with distributions of the shares or otherwise, the selling stockholders may: 
  

	 	•	 	enter into hedging transactions with broker–dealers or other financial institutions, which may in turn engage in short sales of the shares in the course of hedging the
positions they assume; 

  

	 	•	 	sell the shares short after the effective date of the registration statement of which this prospectus forms a part and redeliver the shares to close out such short positions;

  

	 	•	 	enter into option or other transactions with broker–dealers or other financial institutions which require the delivery to them of shares offered by this prospectus, which they
may in turn resell; and 

  

	 	•	 	pledge shares to a broker–dealer or other financial institution, which, upon a default, they may in turn resell. 

 In addition to the foregoing methods, the selling stockholders may offer their shares from time to time in transactions involving principals or brokers
not otherwise contemplated above, in a combination of such methods or described above or any other lawful methods. The selling stockholders may also transfer, donate or assign their shares to lenders, family members and others and each of such
persons will be deemed to be a selling stockholder for purposes of this prospectus. The selling stockholders or their successors in interest may from time to time pledge or grant a security interest in some or all of the shares of common stock, and
if the selling stockholders default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from to time under this prospectus; provided however in the event of a pledge or then
default on a secured obligation by the selling stockholder, in order for the shares to be sold under this registration statement, unless permitted by law, we must distribute a prospectus supplement and/or amendment to this registration statement
amending the list of selling stockholders to include the pledgee, secured party or other successors in interest of the selling stockholder under this prospectus. 
 The selling stockholders may also sell their shares pursuant to Rule 144 under the Securities Act, which permits limited resale of shares purchased in a private placement subject to the satisfaction of certain
conditions, including, among other things, the availability of certain current public information concerning the issuer, the resale occurring following the required holding period under Rule 144 and the number of shares being sold during any
three–month period not exceeding certain limitations. Sales through brokers may be made by any method of trading authorized by any stock exchange or market on which the shares may be listed or quoted, including block trading in negotiated
transactions. Without limiting the foregoing, such brokers may act as dealers by purchasing any or all of the shares covered by this prospectus, either as agents for others or as principals for their own accounts, and reselling such shares pursuant
to this prospectus. 
 The selling stockholders may effect such transactions directly, or indirectly through underwriters,
broker–dealers or agents acting on their behalf. In effecting sales, 

 
broker–dealers or agents engaged by the selling stockholders may arrange for other broker–dealers to participate. Broker–dealers or agents may
receive commissions, discounts or concessions from the selling stockholders, in amounts to be negotiated immediately prior to the sale (which compensation as to a particular broker–dealer might be in excess of customary commissions for routine
market transactions). 
 NASD Notice to Members 88-101 states that in the event a selling stockholder intends to sell any of the shares
registered for resale in this registration statement through a member of the NASD participating in a distribution of our securities, such member is responsible for insuring that a timely filing is first made with the Corporate Finance department of
the NASD and disclosing to the NASD the following: 
  

	 	•	 	it intends to take possession of the registered securities or to facilitate the transfer of such certificates; 

  

	 	•	 	the complete details of how the selling stockholders shares are and will be held, including location of the particular accounts; 

  

	 	•	 	whether the member firm or any direct or indirect affiliates thereof have entered into, will facilitate or otherwise participate in any type of payment transaction with the selling
stockholders, including details regarding any such transactions; and 

  

	 	•	 	in the event any of the securities offered by the selling stockholders are sold, transferred, assigned or hypothecated by any selling stockholder in a transaction that directly or
indirectly involves a member firm of the NASD or any affiliates thereof, that prior to or at the time of said transaction the member firm will timely file all relevant documents with respect to such transaction(s) with the Corporate Finance
Department of the NASD for review. 

 The Corporation has advised the selling stockholders that the anti-manipulation rules of
Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. 
 In offering the shares covered by this prospectus, the selling stockholders, and any broker–dealers and any other participating broker–dealers who execute sales for the selling stockholders, may be deemed to
be “underwriters” within the meaning of the Securities Act in connection with these sales. Any profits realized by the selling stockholders and the compensation of such broker–dealers may be deemed to be underwriting discounts and
commissions. 
 The Corporation is required to pay all of the Corporation’s fees and expenses incident to the registration of the shares
as well as certain of the expenses of the selling stockholders. 
 The Corporation has agreed to indemnify the selling stockholders against
certain losses, claims, damages and liabilities, including liabilities under the Securities Act. 

 ANNEX B 
  

	
	
	   
	Name of Selling Stockholder

  

	 	A.	SMART BALANCE, INC. (F/K/A BOULDER SPECIALTY BRANDS, INC.) 

 QUESTIONNAIRE FOR SELLING STOCKHOLDERS 
 SENT ON:
[            ], 200   
 PLEASE RETURN BY:
[            ], 200   
 This Questionnaire is
being furnished to all selling stockholders of Smart Balance, Inc. (F/K/A Boulder Specialty Brands, Inc.), a Delaware corporation (the “Company”), and relates to certain information required to be disclosed in the registration
statement (the “Registration Statement”) being prepared on behalf of you and the Company for filing with the United States Securities and Exchange Commission (the “SEC”). 
 Selling stockholders of the Company may be personally liable under the federal securities laws of the United States if the Registration Statement
contains any statement which is false or misleading as to any material fact or omits to state any material fact necessary in order to make the statements therein not false or misleading. 
 Your careful completion of this Questionnaire will help ensure that the Registration Statement will be complete and accurate. Careful consideration of
the instructions and definitions contained in the endnotes to various items is essential to an understanding of the questions. 
 PLEASE
PROVIDE A RESPONSE TO EVERY QUESTION, indicating “None” or “Not Applicable” where appropriate. Please complete, sign, and fax one copy of this Questionnaire NO LATER THAN
[            ], 200   to: 
 [            ] 
 Unless stated otherwise, answers should be given as of
the date you complete this Questionnaire. However, it is your responsibility to inform us of any changes that may occur to your situation between the date you complete the Questionnaire and the effective date of the Registration Statement. If
there is any situation about which you have any doubt, please give relevant facts so that the information may be reviewed. 

 QUESTIONNAIRE 
 STOCK OWNERSHIP 
  

	Item 1.	Beneficial Ownership. 

 a. Deemed
Beneficial Ownership. Please state the amount of securities of the Company you own as of [            ], 200  , assuming, if applicable, the conversion of your
shares of Preferred Stock into, and exercise of warrants for, shares of Common Stock. (If none, please so state in each case.) 
  

			
	 Amount Beneficially Owned1
	  	 Number of Shares of Common Stock Owned
 (on an as-converted basis, as applicable)

		
	Total Shares:	  	 ________________________________________

		
	 Of such shares:
  
 Shares as to which you have sole voting power:
	  	
 ________________________________________

		
	 Shares as to which you have shared voting power:
	  	 ________________________________________

		
	 Shares as to which you have sole investment power:
	  	 ________________________________________

		
	 Shares as to which you have shared investment power:
	  	 ________________________________________

		
	Please state the number of shares owned by family members, trusts and other organizations with which you have a relationship, and any other shares of which you may be deemed to be the
“beneficial owner”1:	  	
		
	Total Shares:	  	 ________________________________________

		
	 Of such shares:
  
 Shares as to which you have sole voting power:
	  	
 _________________________________

		
	 Shares as to which you have shared voting power:
	  	 _________________________________

		
	 Shares as to which you have sole investment power:
	  	 _________________________________

		
	 Shares as to which you have shared investment power:
	  	 _________________________________

			
	Shares which you will have a right to acquire before [date 60 days from expected filing date], through the exercise of options, warrants or otherwise:	 	_________________________________
		
	Shares of Common Stock you intend to offer for sale pursuant to the Registration Statement:	 	_________________________________
		
	Shares of Common Stock that you will hold after the offering for sale of Common Stock that is the subject of the Registration Statement:	 	_________________________________
		
	Do you have any present plans to exercise options or otherwise acquire, dispose of or transfer shares of Common Stock (on an as-converted basis) of the Company between the date you complete this
Questionnaire and [date 60 days from expected filing date]?	 	

 Answer: 
 If so, please describe. 
 b. Pledged Securities. If any of such securities have been pledged or otherwise deposited as
collateral or are the subject matter of any voting trust or other similar agreement or of any contract providing for the sale or other disposition of such securities, please give the details thereof. 
 Answer: 
 c. Disclaimer of Beneficial
Ownership. Do you wish to disclaim beneficial ownership1 of any of the shares reported in response to
Item 1(a)? 
 Answer: 
 If
the answer is “Yes”, please furnish the following information with respect to the person or persons who should be shown as the beneficial owner(s)1 of the shares in question. 
  

					
	 Name and Address of

 Actual Beneficial Owner
	  	 Relationship of

 Such Person To You
	  	 Number of Shares

 Beneficially Owned

		  		  	
		  		  	
		  		  	

	Item 2.	Major Shareholders. Please state below the names of persons or groups known by you to own beneficially1 more than 5% of the Company’s Common Stock. 

 Answer: 
  

	Item 3.	Change of Control. Do you know of any contractual arrangements, including any pledge of securities of the Company, the operation of which may at a subsequent date
result in a change of control of the Company? 

 Answer: 
  

	Item 4.	Relationship with the Company. Please state the nature of any position, office or other material relationship you have, or have had within the past three years, with
the Company or its affiliates. 

  

			
	 Name
	  	 Nature of Relationship

		  	
		  	

  

	Item 5.	Correct Name. Please confirm that your name or your organization’s name, as it appears on the signature page to this Questionnaire, is exactly as it should
appear in the “Principal and Selling Stockholder” section of the Registration Statement: 

  

			
	  ̈ Yes, this name is
correct.
	 	
		
	  ̈ No, the correct name should be:
	 	 _________________________________

 SIGNATURE 
 If at any time any of the information set forth in my responses to this Questionnaire has changed due to passage of time, or any development occurs which requires a change in any of my answers, or has for any other
reason become incorrect, I agree immediately to furnish to the individual to whom a copy of this Questionnaire is to be sent, as indicated and at the address shown on the first page hereof, any necessary or appropriate correcting information.
Otherwise, the Company is to understand that the above information continues to be, to the best of my knowledge, information and belief, complete and correct. 
 I understand that the information that I am furnishing to you herein will be used by the Company in the preparation of its Registration Statement on Form S-[1] and hereby consent to the inclusion of such information
in the Registration Statement. 
  

									
		 		 		 	Name of Stockholder:	 	  
				
	Date: _______________, 200_	 		 	Signature:	 	  
					
		 		 		 	Print Name:	 	  
					
		 		 		 	Title (if applicable):	 	  
				
		 		 		 	Address:
					
		 		 		 	  	 	  
		 		 		 	Street
		 		 		 	  
		 		 		 	City                        State             
           Zip Code
		 		 		 	  
		 		 		 	Telephone Number
		 		 		 	  
		 		 		 	Facsimile Number

 ENDNOTE 
  

  

	1.	Beneficial Ownership. You are the beneficial owner of a security, as defined in Rule 13d-3 under the Securities Exchange Act of 1934 (the “Exchange
Act”), if you, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise have or share: (1) voting power, which includes the power to vote, or to direct the voting of, such security, and/or
(2) investment power, which includes the power to dispose, or to direct the disposition of, such security. You are also the beneficial owner of a security if you, directly or indirectly, create or use a trust, proxy, power of attorney, pooling
arrangement or any other contract, arrangement, or device with the purpose or effect of divesting yourself of beneficial ownership of a security or preventing the vesting of such beneficial ownership. 

 You are deemed to be the beneficial owner of a security if you have the right to acquire beneficial ownership of such security at any time within sixty
days including, but not limited to, any right to acquire such security (a) through the exercise of any option, warrant or right, (b) through the conversion of a security, or (c) pursuant to the automatic termination of, or the
power to revoke a trust, discretionary account, or similar arrangement. 
 Ordinarily, shares held in the name of your spouse or minor child
should be considered as beneficially owned by you absent special circumstances to indicate that you do not have, as a practical matter, voting power or investment power over such shares. Similarly, absent countervailing facts, securities held in the
name of relatives who share your home are to be reported as being beneficially owned by you. In addition, securities held for your benefit in the name of others, such as nominees, trustees and other fiduciaries, securities held by a partnership of
which you are a partner, and securities held by a corporation controlled by you should be regarded as beneficially owned by you. 
 This
definition of beneficial ownership is very broad; therefore, even through you may not actually have or share voting or investment power with respect to securities owned by persons in your family or living in your home, you should include such shares
in your beneficial ownership disclosure and may then disclaim beneficial ownership of such securities. Please note, however, that shares in which you have an economic interest but over which you have no voting or investment control (for example,
shares in a trust of which you are the beneficiary but not the trustee) are not deemed beneficially owned by you for the purposes of this questionnaire.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]